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their$ small$ effect$ size.$ In$ contrast,$ the$ utilization$ of$ expression$ co+variation$ of$ a$
group$ of$ genes$ increases$ statistical$ power$ in$ detecting$ trans-acting$ variations.$
However,$ unknown$ batch$ effects$ are$ also$ causes$ of$ expression$ co+variation$ for$ a$
large$number$of$genes.$Therefore,$in$this$study$we$aimed$to$identify$and$distinguish$
co+varying$genes$caused$by$either$trans.effects$or$batch$effects.$$
We$ identified$ 8723,$ 8582$ and$ 5846$ trans. target$ genes$ from$ Yoruba$ Yale,$ Yoruba$
Argonne$and$Caucasian$data,$respectively.$To$determine$whether$trans.target$genes$
can$ be$ better$ explained$ by$ biological$ origin$ or$ batch$ effects$ we$ carried$ out$ 5$
analyses:$ 1.$ The$ replication$ test$ of$ trans. target$ genes$ identified$ from$ datasets$ of$








to$ identify$ groups$ of$ genes$ under$ the$ influences$ of$ bound$ TF$ combinations.$ To$
detect$ trans. effects$ from$ shared$ bound$ TFs,$ we$ tested$ whether$ gene$ pairs$ with$
shared$bound$TFs$are$significantly$better$correlated$than$gene$pairs$without$shared$






To$ explore$ potential$ phenotypic$ consequences$ due$ to$ expression$ co+variations$ of$
trans.target$genes,$we$tested$the$enrichment$of$functional$pathways$in$trans.target$
genes,$ and$ found$ multiple$ enriched$ pathways,$ which$ suggests$ that$ different$
phenotypic$consequences,$such$as$susceptibility$to$Huntington’s$disease,$Parkinson’s$
disease$and$Alzheimer's$disease,$could$be$expected$in$individuals$with$co+variations$
of$ trans. target$ genes.$ We$ also$ tested$ whether$ proteins$ encoded$ by$ trans. target$
genes$ are$ more$ frequently$ physically$ interacted$ than$ chance$ expectation.$
Enrichments$ of$ KEGG$ pathways$ and$ more$ frequent$ protein+protein$ interactions$






































































































































The$purpose$of$ this$project$ is$ to$ identify$genes$under$ the$ influence$of$ trans-acting$
genetic$ variations$ by$ genome+wide$ analysis$ of$ gene$ expression$ in$ lymphoblastoid$
cell$ lines$ (LCLs)$ from$ multiple$ human$ individuals.$ In$ order$ to$ elaborate$ the$
background$of$this$study,$we$will$first$ introduce$basic$concepts$of$genetic$variation$
and$expression$quantitative$trait$loci$(eQTL).$Then$we$will$describe$known$molecular$
mechanisms$of$how$genetic$variations$ influence$gene$expression$ levels.$After$ that,$
we$ will$ discuss$ the$ challenge$ and$ progress$ of$ recent$ trans-eQTL$ studies,$ and$
highlight$ the$ rationale$ of$ utilizing$ expression$ co+variation$ to$ detect$ the$ collective$
behavior$ of$ trans-regulated$ genes.$ However,$ the$ co+varying$ pattern$ of$ gene$
expression$levels$can$be$confounded$by$batch$effects,$which$may$result$in$spurious$





Then$ we$ will$ discuss$ the$ significance$ of$ eQTL$ studies$ in$ understanding$ gene$
expression$regulation$and$etiology$of$complex$traits$and$diseases.$$
1.1.1 Genetic&variations&and&gene&expression&
Genetic$ variations$ (GVs)$ are$differences$of$DNA$ sequences$among$ individuals$with$
many$ different$ forms,$which$ can$ be$ classified$ into$ 2$major$ classes$ based$ on$ their$
nucleotide$ composition:$ single$ nucleotide$ polymorphism$ (SNPs),$ which$ are$ single$
nucleotide$ differences$ observed$ in$ the$ same$ position$ of$ genomes$ from$ different$




2010;$ Frazer$ et$ al.$ 2009).$ The$ recent$1000$Genomes$Project$ (Abecasis$ et$ al.$ 2012)$
has$discovered$38$million$SNPs,$1.4$million$short$insertions$and$deletions,$and$more$
than$14,000$larger$deletions$from$1,092$human$individuals.$$
Genetic$ variations$ residing$ in$ different$ locations$ of$ genome$ may$ have$ different$
functional$consequences.$While$genetic$variations$have$been$found$associated$with$
numerous$human$phenotypic$traits$and$diseases,$one$fundamental$function$of$GVs$
is$ influencing$ gene$ expression$ levels$ (Nica$ &$ Dermitzakis$ 2013).$ The$ amount$ of$
mRNA,$or$ generally$ referred$ to$as$ gene$expression$ level,$ is$ one$of$ the$most$easily$
measurable$ molecular$ phenotypes$ by$ either$ microarray$ hybridization$ or$ RNA$
sequencing$using$the$next$generation$sequencing$methodology.$Since$the$influences$
of$DNA$variations$on$gene$expression$are$inheritable,$the$study$of$genetic$variations$
influencing$ gene$ expression$ is$ referred$ to$ as$ “genetics$ of$ gene$ expression”$
(Rockman$&$Kruglyak$2006;$Cheung$&$Spielman$2009).$Expression$quantitative$trait$




There$ are$ two$ major$ reasons$ why$ we$ should$ conduct$ eQTL$ studies.$ Firstly,$ eQTL$
studies$ can$ unveil$ molecular$ mechanisms$ of$ gene$ expression$ regulation.$ eQTL$
mapping$studies$are$large+scale$data+driven$analysis,$which$enable$to$identify$many$
unknown$ regulator+target$ relationships$ without$ prior$ knowledge$ (Cheung$ &$
Spielman$2009).$ Furthermore,$different$mechanisms$of$ gene$expression$ regulation$
can$ be$ revealed$ by$ combining$ eQTL$ results$ with$ chromatin$ immunoprecipitation$
(ChIP)$ followed$ by$ high+throughput$ DNA$ sequencing$ (ChIP+seq)$ data$ or$
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deoxyribonuclease$ (DNase)$ I$hypersensitive$sites$sequencing$ (DNase+seq)$data$ (see$
detail$ in$section$1.2.2).$These$results$suggest$ that$genetic$variations$can$alter$ their$
target$gene$expression$ levels$by$facilitating$or$blocking$the$binding$of$transcription$
factors$ (TFs)$ or$ changing$ the$ chromatin$ accessibility.$ There$ are$ also$ studies$
suggesting$ that$ functions$ of$ genetic$ variations$ depend$ on$ their$ physical$ locations,$
e.g.$genetics$variations$in$3’$ends$of$target$genes$may$have$impact$on$the$stability$of$
mRNA$ (Fritsche$ et$ al.$ 2008),$ while$ variations$ in$ 5’$ ends$ or$ within$ genes$ may$
influence$the$binding$of$TFs$(Göring$et$al.$2007).$$
Secondly,$the$study$of$genetic$variations$influencing$gene$expression$levels$can$also$
provide$ explanations$ for$ the$ etiological$ mechanism$ of$ human$ diseases$ and$ help$
understanding$many$ complex$ traits$ (Cookson$ et$ al.$ 2009).$ It$ has$ been$ found$ that$
changes$ of$ gene$ expression$ levels$ are$ the$ cause$ for$ variations$ of$ many$ different$
quantitative$ traits,$ such$ as$ height$ (Gudbjartsson$ et$ al.$ 2008),$ weight$ (Willer$ et$ al.$
2009)$and$blood$lipid$(Kathiresan$et$al.$2009).$Therefore,$gene$expression$level$can$
be$considered$as$the$intermediate$trait$connecting$many$physiological$traits$to$their$
causal$ genetic$ variations.$ Nicolae$ et$ al.$ (2010)$ reported$ that$ trait$ associated$ SNPs$
are$more$ likely$ to$be$eQTLs$ in$ their$ study$on$1,598$ trait+associated$SNPs$ from$the$
GWAS$(genome+wide$association$study)$Catalog$(URL:$http://www.ebi.ac.uk/gwas/).$
Besides,$Lappalainen$et$al.$(2013)$found$that$16%$of$6,473$trait$associated$SNPs$are$
also$ eQTLs,$ which$ suggests$ that$ in$ many$ cases$ GVs$ influencing$ gene$ expression$





acting$ eQTL.$ We$ will$ then$ review$ different$ molecular$ mechanisms$ of$ how$ GVs$
influence$gene$expression$levels.$
1.2.1 Classification&of&cis@&and&trans!eQTL&
Genetic$ variations$ influencing$ gene$expression$ can$be$ classified$ into$cis+acting$and$
trans-acting$ variations$ depending$ on$ their$molecular$mechanism,$ i.e.$ whether$ the$
GV$regulates$ its$ target$gene$ in$cis$or$ trans,$or$ they$can$be$classified$ into$ local$and$
distant$variations$depending$on$the$distance$between$the$physical$locations$of$GVs$
and$ their$ target$ genes$ (Williams$ et$ al.$ 2007).$ However,$ in$ most$ eQTL$ mapping$
studies$cis+acting$variations$and$trans-acting$variations$are$presumed$to$be$ located$
in$ local$ and$distant$ regions,$ respectively$ (Gaffney$2013).$ This$presumption$may$be$
not$precise$ as$pointed$out$by$Rockman$et$ al.$ (Rockman$&$Kruglyak$2006)$ that$we$
don't$know$the$exact$mechanism$of$eQTLs$when$local$or$distal$eQTLs$were$mapped.$
The$fact$is$that$a$distant$eQTL$may$act$in$cis,$and$local$eQTL$may$act$in$trans.as$well.$$
Most. cis+acting$variations$are$ found$ to$be$ located$ in$ the$proximate$ region$of$ their$
target$ genes.$ It$ is$ assumed$ that$ cis+acting$ variations$ affect$ the$ binding$ affinity$ of$
regulatory$ elements$ interacting$ with$ transcription$ factors$ (TFs)$ (Kasowski$ et$ al.$
2010).$On$the$other$hand,$trans-variations$are$influencing$the$expression$of$distant$
genes,$or$genes$located$in$different$chromosomes.$For$example,$GVs$may$influence$
the$ expression$ of$ their$ target$ genes$ located$ distant$ away$ from$ the$ GVs$ through$
modifying$either$mRNA$production$level$or$mutating$the$coding$region$of$a$TF$gene.$
The$effects$of$cis+variations$on$gene$expression$are$usually$referred$to$as$cis$effects,$






is$ dynamically$ regulated$ at$ multiple$ stages$ including$ transcription,$ post+
transcriptional$modification,$mRNA$transport,$translation,$and$mRNA$degradation.$In$
theory,$ any$ GV$ affecting$ regulatory$ sequences$ or$ proteins$ involved$ in$ these$ gene$
regulation$ stages$ may$ have$ influence$ on$ gene$ expression$ levels.$ Cis+eQTLs$ are$
usually$ GVs$ located$ in$ cis+regulatory$ elements$ affecting$ nearby$ genes,$ such$ as$
promoters,$ enhancers$or$ splice$ sites.$Trans+eQTLs$ are$GVs$ affecting$ the$ activity$ or$
expression$level$of$their$overlapped$or$nearby$trans-acting$regulators,$such$as$TFs$or$




Transcription$ is$ the$ molecular$ process$ in$ which$ a$ segment$ of$ DNA$ sequence$ is$
transcribed$ into$ its$ complementary$ RNA$ sequence$ by$ RNA$ polymerase$ in$ the$ cell$
nucleus.$In$eukaryotes$RNA$polymerase$can$only$be$recruited$to$the$core$promoter$
and$initiate$the$transcription$when$a$group$of$basal$transcription$factors$are$already$
bound$ to$ the$ promoter.$ During$ this$ process$ the$ transcription$ rate$ of$ gene$ is$
regulated$ by$ multiple$ cis+regulatory$ elements,$ such$ as$ promoter,$ enhancer$ and$
silencer,$and$many$kinds$of$ transcription$factors$ (TFs)$acting$as$either$activators$or$
repressors.$ Hence$ GVs$ residing$ in$ any$ cis+regulatory$ element$ may$ affect$ the$
initiation$of$ transcription.$ Lalonde$et$ al.$ (2011)$ estimated$ that$ about$75%$of$ eQTL$
target$ gene$ expression$ variance$ could$ be$ explained$ by$ regulation$ at$ the$ level$ of$






binding$ can$ influence$ expressions$ of$ nearby$ genes.$ Therefore,$ TF$ occupancy$ is$
considered$as$an$ important$ intermediate$phenotype$connecting$GVs$ to$changes$of$
gene$ expression$ levels.$ One$ popular$ approach$ to$ determine$ genome+wide$
occupancy$of$ individual$ TFs$ is$ChIP-seq.$ For$example,$Kasowski$ et$ al.$ (2010)$ found$
from$ their$ ChIP+seq$ experiments$ that$ genetic$ variations$ might$ influence$ gene$
expressions$ through$ modifying$ the$ binding$ affinity$ of$ DNA$ sequences$ for$ their$
interacting$transcription$factors.$Lappalainen$et$al.$(2013)$found$eQTLs$with$3.3$fold$




Gaffney$ (2013)$ pointed$ out$ that$ one$ limitation$ of$ the$ application$ of$ ChIP+seq$
experiments$ is$ the$ lack$ of$ high$ quality$ antibodies$ for$ a$ large$ number$ of$ TFs.$ An$
alternative$ is$ to$ find$ active$ cis+regulatory$ elements$ by$ measuring$ the$ chromatin$
accessibility$ regardless$which$TFs$are$bound.$Active$cis+regulatory$elements$can$be$
identified$ in$a$genome+wide$scale$using$DNase+seq.$Degner$et$al.$ (2012)$estimated$
that$ 55%$ of$ eQTLs$ are$ also$ DNase$ I$ sensitivity$ quantitative$ trait$ loci$ (dsQTLs),$
suggesting$ that$ a$ substantial$ fraction$ of$ GVs$ regulate$ gene$ expressions$ through$
modulating$ the$ activity$ of$ nearby$ cis+regulatory$ elements$ and$ chromatin$
accessibility$in$the$same$region.$$
Epigenetic&modification&
GVs$ may$ have$ effects$ on$ gene$ expressions$ epigenetically$ through$ changing$ the$
pattern$of$DNA$methylation.$But$ the$underlying$mechanism$through$which$variant$
$ 7$
methylations$ change$ gene$ expressions$ is$ still$ not$ entirely$ revealed$ yet$ (Gaffney$
2013).$Bell$et$al.$(2011)$found$significant$enrichment$of$eQTLs$in$the$most$significant$
180$ SNPs$ associated$ with$ methylation,$ suggesting$ that$ GVs$ can$ regulate$ gene$
expression$ through$methylation.$ Similar$ conclusions$were$drawn$ independently$by$
(Gibbs$et$al.$2010;$Zhang$et$al.$2010)$from$their$studies$of$DNA$methylation$levels$in$
human$ brain$ samples$ across$ multiple$ individuals.$ However,$ Fraser$ et$ al.$ (2012)$
found$that$only$6$of$55$methylation+associated$SNPs$(mSNPs)$identified$in$LCLs$from$





ribonucleoprotein$ complex$ (Matlin$ et$ al.$ 2005).$ In$ this$ process$ some$ alternative$
exons$ are$ subject$ to$ selective$ splicing,$ where$ different$ mRNA$ transcripts$ can$ be$
produced$ from$ a$ single$ gene.$ Different$ types$ of$ transcripts$ produced$ from$ their$
cognate$ genes$ are$ regulated$ depending$ on$ different$ cell$ types,$ developmental$
stages$and$extracellular$ signals.$Moreover,$GVs$can$also$have$substantial$effect$on$
the$diversity$of$ transcripts$being$produced.$Majewski$et$al.$ (2011)$pointed$out$ the$
possibility$that$unstable$mRNA$transcripts$produced$by$GVs$tend$to$be$degraded$fast,$
which$ can$ change$ gene$ expression$ levels$ indirectly$ through$ RNA$ splicing.$ For$
example,$ Coulombe+Huntington$ et$ al.$ (2009)$ identified$ 17$ genes$ with$ SNPs$
associated$with$both$splicing$pattern$and$gene$expression$ levels,$ indicating$shared$
mechanism$of$gene$expression$ regulation$and$RNA$splicing.$Besides,$ Lalonde$et$al.$








because$mRNA$ stability$ is$ directly$ related$ to$ the$ protein$ amount$ being$ produced$
(Tourrière$ et$ al.$ 2002).$ Translationally$ inactive$ mRNAs$ are$ usually$ subject$ to$
degradation$by$the$exosome$complex$after$poly+A$tail$deadenylation$and$decapping.$





15%$ (171$ out$ of$ 1,147)$ of$ eQTLs$ are$ also$ rdQTLs,$ and$ hence$ these$ eQTLs$ can$ be$
explained$by$ variant$mRNA$decay$ rates.$ They$ also$ found$ significant$ enrichment$of$
miRNA$binding$sites$in$rdQTLs,$suggesting$altered$mRNA$decay$rates$through$variant$
miRNA$binding,$which$in$turn$mediates$gene$expression$levels.$$





LCLs$ of$ 149$ individuals.$ Parts$ et$ al.$ (2012)$ identified$ that$ SNPs$ associated$ with$
expression$ levels$of$miRNA$hsa+miR+197+3p$and$hsa+miR+378d$also$ regulate$mRNA$
levels$of$GNAI3$and$CRMP1,$respectively,$suggesting$a$cis+acting$regulation$process$






multiple$ gene$ regulation$ stages.$ However,$ it$ is$ worth$ noting$ that$ a$ single$ gene$
regulation$ stage$ does$ not$ determine$ the$ final$ gene$ expression$ level.$ It$ is$ possible$
that$genes$with$low$transcription$rate$result$in$large$amount$of$mRNA$accumulation$











proteins$ with$ DNA+binding$ domains,$ which$ recognize$ and$ bind$ to$ specific$ DNA$
sequences$ (motifs).$ The$ recent$ encyclopedia$ of$ DNA$ elements$ (ENCODE)$ project$
found$ out$ that$ TF$ binding$ regions$ cover$ 8.1%$ of$ human$ genome$ (Bernstein$ et$ al.$
2012).$ The$ binding$ of$ TFs$ to$ cis+regulatory$ elements$ located$ in$ promoters$ or$
enhancers$ can$ either$ activate$ or$ repress$ the$ transcription$ initiation$ of$ their$ target$
genes$by$either$promoting$or$blocking$the$recruitment$of$RNA$polymerase.$




Heinig$ et$ al.$ (2010)$ found$ that$ an$ IRF7$ (interferon$ regulatory$ factor)$ driven$
inflammatory$ gene$ network$ is$ associated$ with$ type$ 1$ diabetes$ risk.$ Small$ et$ al.$
(2011)$observed$that$ transcription$ factor$KLF14$acts$as$a$master$ trans-regulator$of$
gene$ expression$ in$ adipose$ tissue.$Moreover,$ Fairfax$ et$ al.$ (2012)$ found$KLF4$ and$
CREB1$ as$ cell$ type$ specific$ master$ regulators$ in$ human$ B$ cell$ and$ monocyte,$
respectively.$Westra$et$al.$ (2013)$ found$that$some$trait+associated$trans-eQTLs$are$




could$ be$ sources$ of$ trans-acting$ influences,$ which$ may$ play$ an$ important$ role$ in$
complex$traits$and$diseases.$$$$
1.3.2 TFs&binding&and&its&function&
The$ identification$ of$ target$ genes$ of$ individual$ TFs$ is$ not$ an$ easy$ task$ since$ no$
standard$ method$ has$ been$ developed$ yet.$ A$ common$ approach$ based$ on$ the$
physical$proximity$is$that$genes$whose$promoter$regions$bound$by$a$specific$TF$are$
defined$as$the$bound$target$genes$of$that$TF.$However,$the$definition$of$“promoter$
region”$ differs$ in$ studies.$ For$ example,$ Kasowski$ et$ al.$ (2010)$ used$ the$ 2$ kbp$





it$ is$ not$ guaranteed$ that$when$a$ specific$ TF$protein$ is$ variant,$ all$ its$ bound$ target$
genes$ will$ be$ influenced$ on$ gene$ expression$ levels.$ This$ idea$ can$ be$ tested$ by$
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examining$ sets$ of$ genes$ that$ are$ differentially$ expressed$ (DE)$ before$ and$ after$ a$
specific$ TF$ gene$ is$ knockdown$ by$ siRNA$ in$ the$ same$ cell$ line$ or$ tissue.$ To$ test$
whether$ genes,$ whose$ promoter$ regions$ are$ bound$ by$ a$ TF,$ are$ also$ functional$
target$genes$of$ the$same$TF,$we$combined$data$ from$two$different$ studies.$ In$ the$
study$by$Cusanovich$et$ al.$ (2014)$ artificial$ knockdown$of$59$ individual$ TF$genes$ in$








<$ 3.1$ ×$ 10+3.$ In$ Table$ 1.1$ we$ showed$ that$ 6$ out$ of$ 16$ TF$ genes$ (SP1,. YY1,. IRF4,.
POU2F2,.TCF12,.PAX5)$were$found$with$significant$overlap$between$their$DE$genes$
and$ bound$ target$ genes.$ Moreover,$ Kuntz$ et$ al.$ (2012)$ found$ that$ negatively$
regulated$ target$ genes$ of$ hlh-1$ mutation$ (genes$ whose$ expression$ levels$ were$
increased$ by$ hlh-1$ mutation)$ are$ not$ enriched$ for$ HLH-1$ bound$ target$ genes$ in$
Caenorhabditis. elegans$ embryos.$ From$ these$ results$ we$ may$ conclude$ that$ TF$
binding$ is$ necessary$ but$ not$ sufficient$ for$ TF$ function.$Most$ genes$ are$ under$ the$
regulation$of$multiple$TFs,$where$variations$of$one$TF$may$not$be$sufficient$to$alter$
the$expression$of$its$bound$target$genes.$So$there$are$non+DE$genes$with$TFs$bound,$
which$ can$ be$ explained$ by$ Farnham$ et$ al.$ (2009)$ as$ he$ suggested$ that$ most$ TFs$
bindings$may$not$be$functional.$Li$et$al.$(2011)$suggested$that$the$main$function$of$
TFs$ binding$ could$ be$ maintaining$ the$ chromatin$ accessibility$ in$ some$ specific$
promoter$ regions$ in$ order$ to$ recruit$ other$ key$ factors.$Moreover,$ Spivakov$ (2014)$
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proposed$ a$more$ comprehensive$ “dose$ of$ activation$model”,$ which$ suggests$ that$
multiple$ TF$ bindings$ contribute$ cumulative$ doses$ of$ activating$ signal$ to$ the$
regulation$of$their$target$gene.$When$the$total$input$doses$from$TFs$binding$exceed$
a$ threshold,$ mutations$ at$ a$ single$ transcription$ factor$ binding$ site$ (TFBS)$ may$ be$
tolerable.$ But$ if$ the$ total$ input$ is$ close$ to$ or$ below$ the$ threshold,$mutations$ at$ a$
single$TFBS$may$cause$significant$gene$expression$change.$$
$
Table& 1.1& Overlaps& between& differentially& expressed& genes& from& individual& TF& gene&
knockdown&and&bound&target&genes&of&the&same&TF&






TF&gene& N.DE& N.bound& N.overlap& Fold& Fisher.P&
SP1$ 3131$ 5251$ 1593$ 1.5$ 3.10E+24$
YY1$ 1606$ 6554$ 977$ 1.4$ 8.40E+10$
IRF4$ 3304$ 1378$ 459$ 1.4$ 4.80E+08$
POU2F2$ 738$ 3980$ 301$ 1.5$ 1.20E+06$
TCF12$ 803$ 3120$ 243$ 1.3$ 0.0013$
PAX5$ 2123$ 4152$ 782$ 1.2$ 0.002$
USF1$ 454$ 2522$ 117$ 1.3$ 0.0048$
EP300$ 2479$ 590$ 143$ 1.3$ 0.011$
RAD21$ 2381$ 1212$ 265$ 1.2$ 0.019$
RELA$ 369$ 1102$ 44$ 1.4$ 0.035$
IRF3$ 99$ 589$ 9$ 2$ 0.05$
TAF1$ 659$ 3825$ 224$ 1.1$ 0.079$
BCL3$ 468$ 556$ 28$ 1.3$ 0.087$
BATF$ 175$ 797$ 16$ 1.4$ 0.11$
JUND$ 274$ 29$ 1$ 1.6$ 0.48$












such$ as$ direct$ protein+protein$ interactions$ between$ TFs$ and$ their$ co+factors,$
modular$cooperativity$and$collaborative$competition,$were$revealed$in$many$studies$
and$reviewed$by$Lelli$et$al.$ (2012).$ In$a$recent$study$Lee$et$al.$ (2012)$reported$the$
different$ effects$ of$ TF$ combinations$ on$ gene$ expression$ in$ a$ cell+type$ dependent$
manner.$However,$in$many$studies$(Goi$et$al.$2013;$Terada$et$al.$2013;$Jiang$&$Singh$
2014)$the$identification$of$co+localized$TFs$or$motif$enrichments$was$based$solely$on$
DNase+seq$or$ChIP+seq$data.$And$ the$understanding$of$ gene$expression$ regulation$
by$genetic$variations$from$combinations$of$multiple$trans-acting$TFs$is$still$limited.$In$
this$ study,$ we$ are$ going$ to$ explore$ the$ trans-acting$ effect$ of$ TF$ combinations$ on$




The$ mapping$ of$ eQTLs$ is$ usually$ carried$ out$ using$ genome+wide$ linkage$ tests$ or$
association$ tests.$Despite$ the$great$ success$ in$cis+eQTLs$ identification,$ trans-eQTLs$
are$still$poorly$characterized$(Fairfax$et$al.$2012).$The$major$challenge$of$trans-eQTL$
studies$is$its$small$effect$size.$Many$studies$suggested$that$trans-eQTLs$have$smaller$
effect$ size$ than$ cis+eQTLs$ (Gaffney$ 2013;$ Montgomery$ &$ Dermitzakis$ 2011).$ The$
eQTL$study$by$Schadt$et.al$(2008)$suggested$that$trans-acting$variants$have$smaller$
effect$ size$ on$ gene$expression$ than$ cis+acting$ variants.$And$one$possible$ reason$ is$
the$lack$of$statistical$power$to$detect$small$effects$of$trans-acting$eQTLs.$Cheung$et$
al.$ (Cheung$ and$ Spielman,$ 2009)$ gave$ another$ possible$ reason$ that$ most$ gene$
expression$ levels$are$ influenced$by$both$cis+acting$and$ trans-acting$regulators,$and$
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they$are$usually$under$the$influence$of$several$trans-acting$regulators$but$only$one$




Another$ challenging$ issue$ is$ the$ multiple$ testing$ problem.$ Rockman$ et$ al.$ (2006)$
pointed$out$that$when$multiple$statistical$tests$are$performed,$the$number$of$false+
positive$ results$ is$ also$ increased,$ which$ requires$ more$ stringent$ significance$
threshold$ to$ reduce$ the$number$of$ false$ positive$ results.$Unlike$ cis+acting$ variants$
located$ in$ the$ proximate$ region$ of$ their$ target$ gene,$ trans-acting$ variants$ can$ be$
located$in$any$region$of$the$whole$genome.$This$diversity$leads$to$a$greater$multiple$
testing$ problem$ for$ trans-eQTL$ mapping$ because$ millions$ of$ SNPs$ across$ the$
genome$are$to$be$tested,$which$makes$most$studies$underpowered$to$identify$trans.
associations$with$even$small$effect$size.$For$example,$ in$a$hypothetical$eQTL$study$
with$10,000$expressed$genes$and$1,000,000$SNPs$ to$ test$ for$ trans.association,$ the$
estimated$ significance$ threshold$P$<$5$×$10+12$ is$ required$by$Bonferroni$ correction,$
which$could$hardly$be$achieved$in$most$eQTL$studies.$$$$
1.4.2 Progress&of&trans!eQTL&detection&
Despite$so$many$challenges,$ there$are$still$ successes$ in$trans-eQTL$ identification$ in$
recent$years,$when$different$strategies$were$applied$to$improve$the$performance$of$
trans-eQTL$mapping.$Results$from$key$studies$were$summarized$in$Table$1.2.$
Early$ studies$ used$ relatively$ low$ significance$ thresholds$ to$ increase$ sensitivity.$ For$
example,$Wu$ et$ al.$ (2008)$ identified$ 1,659$ “trans-eQTL$ bands”$ in$ adipose$ tissues$
from$28$strains$of$mice$at$the$significance$level$P$<$0.003.$In$another$study$Cheung$
et$al.$(2010)$reported$that$742$trans-regulators$and$917$target$genes$were$identified$





study.$ It$ is$ possible$ that$many$ reported$ eQTLs$ are$ false$ positives$ due$ to$ their$ low$
significance$threshold.$$
In$ recent$ trans-eQTL$ studies$ larger$ sample$ size$was$used$ to$ improve$ the$power$of$
genome+wide$ association$ test.$ For$ example,$ Schadt$ et$ al.$ (2008)$ found$ 236$ genes$
associated$with$trans-eQTL$significantly$at$the$Bonferroni$adjusted$threshold$P$<$1.6$
×$10+12$in$an$eQTL$study$with$400$human$liver$samples.$Later,$Innocenti$et$al.$(2011)$
found$ 353$ genes$ significantly$ associated$with$ trans-eQTL$ in$ liver$ tissues$ from$ 206$





significance$ threshold$ P$ <$ 5$ ×$ 10+8,$ respectively.$ Westra$ et$ al.$ (2013)$ performed$
meta+analysis$in$a$study$with$peripheral$blood$samples$from$5,311$individuals,$then$
identified$and$replicated$trans-eQTLs$for$233$trait+associated$SNPs$in$another$2,775$



























































































































































































































































Previous! studies! reported! the! enrichments! of!many! functional! categories! in! trans&
regulated!genes!based!on!Gene!Ontology!database!(The!Gene!Ontology!Consortium!
2011)! or! KEGG! (Kyoto! encyclopedia! of! genes! and! genomes)! pathway! database!
(Kanehisa! et! al.! 2010).! For! example,! Biswas! et! al.! (2008)! observed! that! trans&
regulated!genes! in!yeast! segregants! share!biological! functions! such!as!“amino!acid!
metabolism”,!“mitochondria”!and! !“heme/fatty!acid!metabolism”.!Wu!et!al.! (2008)!
found! that!pathway!“oxidative!phosphorylation”! is! significantly!overrepresented! in!
trans&regulated! genes! identified! in! adipose! tissues! from!mice.! Rotival! et.al! (2011)!
found! numerous! enrichments! of! GO! terms! in! trans&regulated! gene! modules!
identified! from! human!monocytes,! such! as! “ribosome! biogenesis”,! “nucleosome”,!
“signal! transducer! activity”! and! “immune! response”.! From! these! studies! we!
conclude! that! a! variety! of! biological! functions!might! be! influenced!by! trans&acting!
regulation,!and!we!expect!that!expression!variations!of!genes!under!trans&regulation!
will!result!in!different!functional!outcomes!in!multiple!human!individuals.!
ProteinNprotein! interactions! (PPIs)! can! also! help! us! understand! the! potential!
functional!outcomes!of!groups!of!genes!under!trans&regulation.!Rhodes!et.al!(2005)!
reported!that!human!proteins!encoded!by!gene!pairs!with!either!high!expression!coN
variations! or! shared! functional! annotations! are! more! likely! to! physically! interact.!
Gandhi! et! al.! (2006)! reported! that! proteins! encoded! by! causal! genes! of! the! same!
type!of!disease!are!more! likely! to! interact!based!on!gene!annotations! from!online!
Mendelian! inheritance! in! man! (OMIM)! database.! Lim! et! al.! (2006)! showed! that!
proteins! encoded! by! causal! genes! of! inherited! ataxia! have! more! physically!
interactions.!Therefore,!disease!association!proteinNprotein! link!evaluator! (DAPPLE)!






As! described! in! section! 1.2! the! control! of! gene! expression! is! complex! and!
multifactorial! including!many! gene! regulation! stages! and! factors.! So,! variations! of!
steadyNstate! gene! expression! levels! may! have! many! possible! causes.! Despite! the!
success!of! trans&eQTL!detection! in! studies!with! large!sample! size!as! listed! in!Table!
1.2,! the! detection!of! trans&eQTLs! and! their! target! genes! is! particularly! difficult! for!
studies! with! relatively! small! sample! size,! such! as! the! study! with! gene! expression!
data! in!LCLs!from!69!Yoruba! individuals!(Pickrell!et!al.!2010)!and!the!study!with!60!
Caucasian! individuals! (Montgomery! et! al.! 2010).! One! way! to! facilitate! detecting!
trans'effects!from!gene!expression!data!with!small!sample!size!is!utilizing!expression!
coNvariation!to!detect!the!cumulative!trans&acting!effects!on!groups!of!genes.!In!this!
section!we!will! review! the! definition! and! application! of! expression! coNvariation! in!
recent!eQTL!studies.!!
1.5.1 Co7variation,and,trans&acting,regulation,
Despite! the! challenges! of! trans&eQTL! identification,! in! this! thesis!we!will! focus! on!
detecting! and! characterizing! coNvarying! genes! without! knowing! their! genetic!
determinants!rather!than!detecting!individual!eQTLNgene!pairs!in!conventional!eQTL!
studies.! A! group! of! coNvarying! genes! found! in! the! same! tissue! across! multiple!
individuals!may!be!affected!by!multiple!trans'influences.!Because!no!gene!performs!
its! function! alone,! coNvarying! genes! can! be! treated! as! a! single! functional! unit,! or!




be! necessary! to! know! their! exact! trans&regulators! when! these! “metaNtraits”! are!




We! defined! expression! coNvariation! as! correlated! expression! levels! of! a! group! of!
genes! in! the! same! tissue! or! cell! type! across! multiple! individuals,! which! was! also!
referred! to!as!“coNexpression”! in! some! literatures! (Nayak!et!al.!2009;!Rotival!et!al.!
2011;!Rotival!&!Petretto!2014).!Nayak!et!al.!(2009)!illustrated!the!gene!coNexpression!
network!among!4238!genes! in! LCLs!of!295! individuals,!which! implies! that! complex!
expression!coNvariation!structure! is!a!common!observation!in!gene!expression!data!
due! to! the! influence! of! GVs! among! individuals.! When! expressions! of! a! group! of!
genes! in! the!same! tissue!are!under! the! influence!of! the!same! trans&regulator!with!
functional!GVs!across!multiple!individuals,!expression!coNvariation!of!genes,!or!called!
“coNvarying!genes”,!could!be!observed!in!the!form!of!correlated!amounts!of!mRNAs!
across!multiple! samples.! So! expression! coNvariation! observed! in! a! group! of! genes!





from!2.9%! to!14.0%),! indicating! that!expression!coNvariation!could!be! the! result!of!
shared!influence!from!the!same!trans&eQTL.!!
1.5.2 Utilization,of,co7variation,in,trans&eQTL,study,
With! the! observation! that! genes! under! the! same! trans&acting! influence! show!
expression!coNvariation,! it! is!reasonable!to!ask!whether!expression!coNvariation!can!
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be! utilized! to! detect! shared! trans&acting! influences! on!multiple! genes!with! higher!
statistical!power.!Although!the!effect!of!trans&acting!GVs!on!individual!genes!may!be!
weak,!the!collective!effect!on!multiple!genes!could!be!strong!enough!to!detect.!The!
purpose! of! using! expression! coNvariation! in! trans&eQTL! studies! is! to! facilitate! the!
detection! of! trans&acting! GVs! through! identifying! the! cumulative! trans' effects! on!
expressions!of!multiple!genes.!For!example,!Kompass!et.al!(2011)!identified!282!coN
varying! gene! clusters! and! 338! trans&eQTLs! using! an! approach! combining! gene!
clustering!and!association!test.!Rotival!et!al.!(2011)!utilized!independent!component!




respectively,! where! each! coNvarying! gene! pair! is! regulated! by! interacting! loci.! All!
these!studies!demonstrate!that!utilizing!expression!coNvariation!for!the!detection!of!




be!due! to! shared!effects!of! variant! trans&acting! factors!across!multiple! individuals.!
However,!effects!of!trans&acting!regulation!are!not!the!only!reason!for!coNvariation!
of!gene!expression.!Rotival!et!al.!(2011)!pointed!out!that!patterns!of!expression!coN






levels,! and! therefore! create! spurious! signals! (Stegle! et! al.! 2010).! It! is! known! that!
batch!effects!could!result!in!false!associations!(Kang!et!al.!2008;!Leek!et!al.!2010)!or!
decrease!the!statistical!power!of!association!tests!in!eQTL!studies!(Stegle!et!al.!2010;!
Listgarten! et! al.! 2010).! Furlotte! et! al.! (2011)! also! reported! false! expression! coN
variations!due!to!batch!effects!in!their!data.!In!order!to!avoid!misleading!results,!it!is!
imperative! to! remove! or! correct! batch! effects! in! gene! expression! data! before!
performing!any!following!analysis.!!
Batch!effects! in!microarray!experiments!are!attributed! to!many!different! technical!
or! environmental! factors! including! ozone! levels! (Fare! et! al.! 2003),! laboratory!
technicians! (Irizarry! et! al.! 2005),! temperature! and! reagent! batches! (Altman!2009).!
Altman!(2009)!also!claimed!that!batch!effects!can!be!introduced!in!measuring!gene!
expression!levels!from!every!stage!of!microarray!experiments!including!growing!the!
organism,! tissue! sampling,! RNA! processing,! hybridization! and! data! extraction.! If!
batch! effects! are! not! properly! dealt! with,! spurious! findings! will! come! out.! For!
example,!Williams!et!al.!(2006)!observed!that!there!is!lack!of!concordance!in!linkage!
analysis! results! from! three!microarray! normalization!methods,! demonstrating! that!
the! choice! of! normalization!method! could! have! strong! influence! on! the! results! of!
identifying!eQTLs!and!their!target!genes.!!!
In!recent!years!RNANseq!has!become!a!popular!gene!expressionNprofiling!tool!due!to!
its!high!dynamic! range,!high! replication! rate!and!better! sensitivity! than!microarray!
(Auer! &! Doerge! 2010).! However,! there! are! still! batch! effects! discovered! in! gene!
expression!profiling!using!RNANseq.!For!example,!Pickrell!et!al.! (2010)!reported!the!
GC! content! bias! in! their! RNANseq! experiments,! where! sequencing! lanes! have!
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different!sequencing!preference!for!exons!with!different!GC!contents.!Hansen!et!al.!
(2010)! also! reported! the! nucleotide! composition! bias! due! to! random! hexamer!
priming,! and! Toung! et! al.! (2011)! found! expression! variations! caused! by! limited!
sequencing! depth! in! RNANseq.! Meanwhile,! Hanson! et! al.! (2010)! pointed! out! that!!
there! may! also! be! hidden! factors! that! have! not! been! discovered! or! measured! in!
RNANseq.! In! order! to! remove! spurious! associations! due! to! batch! effects! and! get!
reproducible! results,! it! has! become! a! prerequisite! to! correct! both! known! and!




dates,! their!batch!effects!can!be!usually!corrected!using!standard! linear! regression!
(Leek! et! al.! 2010)! or! ComBat! (Johnson! et! al.! 2007).! However,! Fusi! et! al.! (2012)!
pointed!out! that! in!most! cases! it! is! impossible! to! know!and!measure! all! covariant!
factors! as!potential! sources!of!batch!effects,! but! it! is! critical! to!model! and! correct!
them.!So,!batch!effects!were! learnt!from!gene!expression!data! in! later!studies.!For!
example,! Leek! et! al.! (2007)! introduced! surrogate! variable! analysis! (SVA),! which!
combines! principal! component! analysis! (PCA)! and! permutation! to! construct!
“surrogate! variables”.! Kang! et! al.! (2008)! designed! the! interNsample! correlation!
emended! (ICE)! eQTL! mapping! method! which! corrects! for! complex! interNsample!
correlation!of!expressions!using!a! linear!mixed!model.! In!their!simulation!study!ICE!
was! shown! to! be! better! at! correcting! for!moderate! confounding! effects! than! SVA!
(Kang!et!al.! 2008).! Similarly,! Listgarten!et!al.! (2010)! introduced!LMMNEHNPS,!which!
builds! on! linear! mixedNeffects! models! (LMM)! to! correct! for! both! expression!




approaches.! Then! Fusi! et! al.! (2012)! developed! PANAMA! (Probabilistic! ANAlysis! of!
genoMic!dAta),!which!combines!mixed!linear!models!and!Gaussian!process!to!learn!
hidden!batch!effects.!They!also!reported!that!PANAMA!has!greater!sensitivity!than!
ICE,! SVA! and! PEER! according! to! their! simulation! study.! However,! besides! gene!
expression!data,! extra! information! is! required! for!modeling!and! learning!unknown!




In! order! to! correct! batch! effects! in! gene! expression! data,! the! data! preprocessing!
procedure!PCA!was!widely!used!(Table!1.2).!The!presumption!of!using!PCA!in!these!
studies! is! that! when! a! certain! number! of! sequential! principal! components! (PCs)!
representing!batch!effects!are!removed!from!gene!expression!data,! the!number!of!
detectable!eQTLs!should!be!increased!substantially.!For!example,!in!the!eQTL!study!
with!RNANseq!data!of!human!LCLs! from!69!Yoruba! individuals! (Pickrell!et!al.!2010),!
16! PCs!were! removed! from! gene! expression! data! to!maximize! the! number! of! cisN
eQTLs! being! detected.! In! another! eQTL! study! with! gene! expression! profiling! for!
whole!peripheral!blood! from!1469! individuals,!Fehrmann!et!al.! (2011)! removed!50!
PCs! for! cisNeQTLs! detection! and! 25! PCs! for! trans&eQTLs! detection! considering! the!
tradeoff!between!removed!batch!effects!and!remaining!trans'effects.!Then!Westra!

















be! performed! on! the! gene! expression! data.! Then! to! differentiate! groups! of! coN
varying! genes! caused! by! batch! effects! or! trans' effects,! crossNcomparisons! will! be!
carried! out! under! the! presumption! that! replicable! coNvarying! genes! between! two!
datasets! are!more! likely! due! to! trans' effects.! Based! on! the! presumption! that! coN
varying!gene!groups!due!to!batch!effects!are!not!likely!to!be!overrepresented!for!TF!
regulation,! we! will! carry! out! enrichment! tests! for! TF! bindings! and! differentially!
expressed! genes! from! TF! gene! knockdown! to! support! the! trans&regulation! on! coN
varying!genes.!The!whole!workflow!for!this!chapter!is!illustrated!in!Figure!3.3.!
The! purpose! of! chapter! 4! is! searching! for! evidence! of! TF! regulation! on! gene!
expression!using!combined!RNANseq!data!and!ChIPNseq!data.!The!presumption!here!
is! that! if! a! combination! of! TFs! is! functional,! genes! bound! by! the! same! TF!
combination! should! be! more! correlated! in! expression! levels! than! genes! without!
shared!bound!TFs.!We!will!start!by! identifying!“seed!genes”!bound!by!a!specific!TF!
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combination! with! the! most! trans&regulatory! potential.! The! rest! genes! will! be!
classified! into!“candidate!genes”! (with!the!same!TF!combination)!and!“background!
genes”!(without!that!specific!TF!combination).!Then!correlation!comparisons!will!be!
performed! to! look! for! the!best!PC! for!each!TF!combination!with!evidence!of! trans'
effects.!This!workflow!is!illustrated!in!Figure!4.1.!
The! purpose! of! functional! analysis! in! Chapter! 5! is! two! fold.! First,! it! provides!
biological! evidence! to! support! trans&regulation! on! coNvarying! genes! under! the!
presumption! that! coNvarying! genes! caused! by! batch! effects! are! not! likely! to! be!










to! any! study! with! highNdimensional! gene! expression! data.! This! study! may! also!
demonstrate!both!similarities!and!differences!of!trans&regulation!on!gene!expression!










RNANseq!datasets! from!two!published!eQTL!studies!were!used! in! this! study.! In! the!
eQTL! study! for! Yoruba! individuals! (Pickrell! et! al.! 2010)! sequencing! libraries! were!
prepared! from!mRNAs,!which!were!extracted! from! lymphoblastoid!cell! lines! (LCLs)!
from! 69! Yoruba! individuals! from! the! international! HapMap! Consortium,! and!were!
sequenced! using! Illumina! GAII! platform.! RNA! libraries! from! the! same! 69! Yoruba!
individuals!were!prepared!and!sequenced!once!at!Yale!sequencing!center!using!35!
bp!single!end!reads,!and!once!at!Argonne!sequencing!center!using!46!bp!single!end!
reads,! and! thence!were! referred! to! as! “Yoruba, Yale, data”! and! “Yoruba, Argonne,
data”,! respectively.!Moreover,! there!are!12!LCL! samples!being! sequenced! twice!at!
Yale! sequencing! center,! and! 11! LCL! samples! being! sequenced! twice! at! Argonne!
sequencing!center,!which!resulted!in!81!and!80!sequencing!lanes!in!total!for!Yoruba!
Yale! and! Yoruba! Argonne! data,! respectively.! In! the! eQTL! study! for! Caucasian!
individuals!(Montgomery!et!al.!2010)!sequencing!libraries!were!created!from!mRNAs,!
which! were! extracted! from! LCLs! from! 60! Caucasian! individuals! from! the!
international! HapMap! Consortium.! Then! they!were! sequenced! using! Illumina! GAII!
platform!with!37!bp!paired!end! reads,! and! thence!were! referred! to!as! “Caucasian,
data”.! Numbers! of! reads! generated! from! all! sequencing! lanes! in! this! study! were!
listed!in!Table!A.1.!!
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Read! sequences! (fastq! format)! from! both! Yoruba! Yale! and! Yoruba! Argonne! data!
were! downloaded! from! URL! (http://eqtl.uchicago.edu/RNA_Seq_data/!
unmapped_reads/),! and! Caucasian! data! were! downloaded! from! URL!
(http://jungle.unige.ch/rnaseq_CEU60/).! All! RNANseq! reads! were! mapped! to! the!
human!reference!genome!(hg19)!using!BurrowsNWheeler!Aligner!(BWA)!(Li!&!Durbin!
2009)!v0.5.9,!which!is!the!faster!sequel!to!MAQ!(Li!et!al.!2008)!with!similar!mapping!





of! mapped! reads! divided! by! the! number! of! total! reads! generated! from! each!
sequencing! lane.! Sequencing! lanes!with! abnormally! low!mapping! rates! than! other!
sequencing!lanes!were!excluded.!!
To! compute!mRNA! expression! levels! for! each! gene,! numbers! of! reads!mapped! to!
different! gene! regions! were! counted! using! R! package! Rsamtools! and!
GenomicRanges! (Lawrence!et! al.! 2013)!based!on!gene!annotations! from!ENSEMBL!
Gene! version! 69! (Flicek! et! al.! 2012).! Genes! with! at! least! one!mapped! read! in! all!






distribution! for! all! RNANseq! lanes! within! each! dataset.! RNANseq! lanes! with! outlier!
RPKM!distribution!were!excluded.!!
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To! remove! potential! batch! effects! of! RNA! concentration! and! individual! gender! on!
gene! expression! levels,! linear! regression! on! sample! RNA! concentration! and!
individual! gender! was! performed! sequentially! using! R! function! lm' (R! Core! Team!
2013)!for!Yoruba!Yale!data!and!Yoruba!Argonne!data.!Similarly!linear!regression!on!
individual! gender! was! performed! using! R! function! lm! for! Caucasian! data.! The!
resulting! gene! expression! residue!matrix! from! either! dataset! is! represented! as! X.!
Codes!for!processing!RNANseq!data!were!originally!developed!by!Dr.!Xie!and!adapted!
by!Quan.!
To! display! the! numbers! of! overlapped! genes! identified! from! Yoruba! Yale,! Yoruba!
Argonne!and!Caucasian!dataset,!a!3Nway!Venn!diagram!as!shown!in!Figure!3.6!was!
plotted! using! R! function! vennPlot! developed! by! Thomas! Girke!
(http://faculty.ucr.edu/~tgirke/Documents/R_BioCond/My_R_Scripts/overLapper.R).!
Workflow!charts!Figure!3.3!and!Figure!4.2!were!drawn!using!Microsoft!PowerPoint!






project! SPP! peak! calling! methods! were! used! to! identify! consensus! binding! peaks!
(Gerstein! et! al.! 2012).! We! downloaded! the! BED! format! file!
“wgEncodeRegTfbsClusteredV2.bed.gz”! containing! hg19! coordinates! of! clusters! of!




which! includes! genome! coordinates! of! TF! binding! regions! for! 54! different! TFs.!
Among!these!54!TFs,!6!TFs!of!them!(POU2F2,!YY1,!EP300,!CTCF,!PAX5!and!EBF)!have!
replicated!ChIPNseq!datasets!with!different! antibodies.!We! removed! the! replicated!
ChIPNseq!data!for!these!6!TFs!(with!antibodies!POU2F2,!YY1,!p300_(NN15),!PAX5NN19,!
EBF! and! CTCF)! in! following! analysis! due! to! their! smaller! numbers! of! bound! target!
genes! (defined! later).! ChIPNseq! data! for! 4!more! TFs! (BCL11A,' FOS,'NFE2! and!SIX5)!
































































gene! promoter! regions! were! detected! using! R! function! findOverlaps! from! the!
package!GenomicRanges! (Lawrence! et! al.! 2013).! Then! integer! “1”!was! assigned! to!






PCA! is! an! approach! to! remove! variance! from! gene! expression! data,! which! is!
commonly!used!to!remove!batch!effects!in!eQTL!studies!(Section!1.6.3).!To!generate!
new! expression! matrices! with! different! numbers! of! PCs! being! removed,! we! used!
PCA! to! remove! variance! from!our! expression!data! in! a! sequential!way.! Expression!
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residue!matrix!X!was!first!decomposed!by!singular!value!decomposition!(SVD)!using!




UDnVT = Xn !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(2.2)!
Then! to! compute! new! expression!matrices! Xn! representing! top! nN1! sequential! PCs!
being!removed,!Equation!2.2!was!used!with!the!same!U!and!V!but!modified!D!from!
Equation!2.1.!!The!modified!singular!values!Dn!were!generated!by!replacing!the!top!
nN1! (n!=!2! to!68)! singular!values! from!D! into!0! sequentially.!The! resulting!Xn! is! the!










correlation! coefficient! |ρ|! to! quantify! their! correlation! levels.! To! compute! the!
pairwise!correlation!matrix!Cn!(1!≤!n≤!68)!for!gene!expression!matrix!Xn,!R!function!
cor!was!used!to!perform!the!correlation!analysis.!In!correlation!matrix!Cn!the!number!




as! described! in! section! 3.5.3.! All! absolute! correlation! coefficients! below! the!






processing! steps! were! conducted! as! illustrated! in! Figure! 3.3,! and! were! also!
described!in!detail!in!section!3.6.!!
1.! To! generate! expression! matrices! from! X1! to! X68! with! different! numbers! of!
sequential!PCs!being!removed,!PCA!was!performed!as!described!in!section!2.3.!!
2.! To! identify! “correlating, gene, pairs”! defined! as! gene! pairs! with! correlation!
coefficients!above!the!threshold,!pairNwise!correlations!were!calculated!for!all!gene!
expression!matrices! Xn! using! absolute! Spearman’s! correlation! coefficient! |ρ|.! This!
resulted!in!a!correlation!matrix!Cn!(from!C1!to!C68)!from!its!corresponding!expression!
matrix!Xn.!Correlating!gene!pairs!with!absolute!correlation!coefficient!|ρ|!above!the!
threshold!were! identified! from! each! correlation!matrix! Cn! using! R! package! igraph!
(Csardi!&!Nepusz!2006)!by!treating!Cn!with!the!correlation!threshold!as!an!adjacency!
matrix! (Figure!3.3B).! The!union!of! gene! identities! contained! in!all! correlating!gene!
pairs!from!Cn!was!then!determined!as!Gn.!!
3.!To! identify! “trans' target!genes”,!we!compared! the!gene! set!Gn! from!correlating!
gene!pairs!identified!from!Xn!with!gene!set!Gn+1!from!correlating!gene!pairs!identified!
from! Xn+1! sequentially! (1≤n≤20).!We! defined! genes! that! are! from! gene! pairs! with!
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correlations! above! the! threshold! in! PCn,! but! are! not! from! gene! pairs! with!
correlations!above!the!threshold!in!PCn+1!as!“trans'target,genes”!of!PCn.!For!example,!




To! test! whether! the! number! of! overlapped! genes! observed! between! 2! groups! of!
trans' target! genes! are! larger! than! chance! expectation,! Fisher’s! exact! test! was!
performed!using!R! function! fisher.test' (R!Core!Team!2013).!We! tested! the!overlap!












target! genes,! enrichment! tests! for! bound! target! genes! of! individual! TFs! in! trans'
target!genes!were!performed!by!upperNtailed!hypergeometric!test!using!R!function!
phyper.! All! expressed! genes! identified! from! a! specific! dataset!were! considered! as!
! 35!
background!genes!in!each!test.!The!null!hypothesis!is!that!there!is!no!enrichment!of!




bound! target! genes! of! combinations! of! TFs! were! performed! by! upperNtailed!
hypergeometric!test!using!R!function!phyper.!The!null!hypothesis!is!that!there!is!no!
enrichment!of!any!combination!of!TFs!bound!in!the!promoter!regions!of!trans'target!
genes! comparing!with!background!genes.! Significance! threshold!was! set! to!be!P! <!
2.4!×!10N5!corrected!for!106!different!combinations!of!TFs!with!20!PCs.!!





in! trans' target! genes,! enrichment! tests! were! performed! by! upperNtailed!
hypergeometric!test!using!R!function!phyper.!The!null!hypothesis!is!that!there!is!no!









genes! from! R! package! org.Hs.eg.db! (Carlson! 2013)! including! 5,427! human! genes!
annotated! with! 229! different! KEGG! pathways.! The! enrichment! of! KEGG! pathway!
annotated! genes! in! trans' target! genes!was! tested! by! upperNtailed! hypergeometric!













al.! 2007)! including! 428,430! reported! PPIs.! The! group! of! proteins! in! each! test! are!
defined! as! “input! proteins”.! The! common! protein! interacting! with! any! 2! input!
proteins!identified!from!the!PPI!database!is!defined!as!“common!interactor”!(CI).!In!
this!way!2!input!proteins!can!be!indirectly!connected!through!a!CI.!DAPPLE!measures!
4! different! network! statistics,! including! “Direct.Edges”,! “Direct.Degree”,!!











the! default! 1000.! ! “Common! interactor! binding! degree! cutoff”! was! set! to! be! the!
default! 2! to! allow! only! one! CI! between! any! 2! input! proteins.! After! setting! the!
parameters!and!clicking!“submit”!one!job!was!submitted!to!the!DAPPLE!server.!The!
4!network!statistics!were!first!computed!from!input!proteins!encoded!by!a!group!of!
trans' target! genes,! then! 1,000! permutations! were! performed! to! estimate! the! P!
value.!When! a! test! with! P! <! 0.0025! (Bonferroni! corrected! for! 20! groups! of! trans!
target!genes!from!either!dataset)!was!observed,!we!claimed!that!proteins!encoded!
by! trans! target! genes! in! this! test! are! more! physically! interacted! than! chance!
expectation.!
We! used! PPI! annotations! from! InWeb! database! (Lage! et! al.! 2007)! to! build! PPI!
networks! from! proteins! encoded! by! trans! target! genes.! Then! we! identified! the!
number!of!overlapped!PPIs!between!two!PPI!networks! in!each!test.!The!overlap!of!







the! increasingly! small! cis&'and! trans&acting! influences!on! interNindividual! variations!
of!mRNA!levels.!There!seems!little!alternative!to!increase!the!performance!of!eQTL!
mapping! if! the! goal! of! eQTL! studies! remains! the! detection! of! individual! cis&' and!
trans&eQTLs.!However! it! is! important! to! recognize! that! it! is! the! variation!of!mRNA!
levels! in!the!cell! that! is!the! intermediate!phenotype!and!not! just!the!proportion!of!
variation! due! to! a! specific! eQTL.! The! drive! in! eQTL! analyses! is! predominantly! in!
identifying!the!complete!set!of!eQTLs!that!explain!as!much!variance!of!mRNA!levels!
as!possible.!In!this!respect,!eQTL!research!is!focused!upon!mechanisms!underpinning!
mRNA! variation,! and! the! identification! of! intermediate! phenotypes! is! a! secondary!
product!of!the!analysis.!!
Other! approaches! to! mRNA! level! analysis! are! in! contrast! more! focused! on!
identifying!mRNA!levels!of!multiple!genes!as!a!“metaNtrait”,!which! is!the!combined!
expression! profile! of! different! genes! across! the! same! cell! or! tissue! type! from!
multiple! human! individuals.! The! rationale!here! is! that! variable!mRNA! levels! of! coN
varying! genes! are! controlled! by! many! trans&acting! GVs! whose! cumulative! effect,!








can! be! detected! by! many! approaches,! the! simplest! of! which! is! calculating! the!
correlation!coefficient.!But! it! is!widely!recognized!that!expression!coNvariations!can!
also! have! nonNbiological! origins! such! as! many! sources! of! inter! experimental! or!




et! al.! (2014)! investigated! differentially! expressed! genes! following! knockdown! of!
individual!TF!genes!in!human!LCL.!They!found!that!between!39!and!3,892!genes!are!
differentially!expressed!following!the!knockdown!of! individual!TF!genes!from!59!TF!
genes! using! siRNA.! However,! we! reasoned! that! DE! genes! are! not! the! only! target!
genes!under!TFs!regulation.!To!explore!all!genes!potentially!influenced!by!a!variant!





The!aim!of! this! section! is! to! get! an!overview!of! the! complexity! of! potential! transN
regulation!of!TFs!on!gene!expression!in!human!LCLs.!In!this!section!we!will!describe!
the! identification! of! potential! target! genes! of! TFs! whose! promoter! regions! are!
bound!by!individual!TFs!using!ChIPNseq!data!from!the!ENCODE!project!(Gerstein!et!al,!
2012).!!
In! the! study! by! Gerstein! et! al.! (2012)! ChIPNseq! experiments! for! 119! transcription!
factors!were!performed!in!91!different!human!cell! lines.!“TF!binding!regions”!were!
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defined!as! combined! clusters!of!uniform!peaks!of! TF!binding! identified! from!ChIPN
seq!data!processed!by!ENCODE!Analysis!Working!Group!(Gerstein!et!al,!2012).! !We!





the! 2! kbp! promoter! regions! as! the! genomic! regions! from! upstream! 1! kbp! to!
downstream!1!kbp!of!transcription!start!site!(TSS)!of!all!expressed!genes.!Similarly!5!
kbp!and!10!kbp!promoter!regions!were!defined!as!the!±2.5!kbp!and!±5!kbp!of!TSS!of!
all! genes,! respectively.! Based! on! the! requirement! that! a! TF! binding! region! must!
share!at! least!1!bp!with!a!promoter! region! in!an!overlap,!we!detected!all!overlaps!
between!TF!binding! regions! for!50!TFs!and! the!2!kbp,!5!kbp!and!10!kbp!promoter!
regions!of!expressed!genes! identified! from!Yoruba!Yale!data,! respectively! (Method!
in!section!2.2).!!
In! Figure! 3.1!we! showed! the! distribution! of! TF! binding! regions! for! 50! TFs! located!
proximate! to!TSS.! In! summary!27.7%,!33.2%!and!43.8%!of! total!TF!binding! regions!




DNA.! Therefore,! we! chose! the! 2! kbp! promoter! region! as! the! “census, promoter,
region”! for! the! identification! of! overlaps! between! gene! promoter! regions! and! TF!
binding! regions! for! each! TF! and! each! expressed! gene.! Due! to! the! length! of! TF!
binding!regions,! they!actually!covered! from!N1388!bp!to!+1536!bp!of!TSS!when!we!
considered! overlaps! using! the! 2! kbp! promoter! regions,!while! they! covered! from! N
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3264! bp! to! +3440! bp! of! TSS! when! considering! 5! kbp! promoter! regions,! and! they!








We!defined! genes!with! at! least! 1! bp!overlap!between! the! TF! binding! regions! of! a!
particular!TF!and!the!2!kbp!promoter!regions!of!those!genes!as!“bound,target,genes”!
of!that!TF.!To!summarize!the!statistics!of!bound!target!genes!of!50!individual!TFs,!2!




the! minimum! number! of! 5! bound! target! genes,! while! ELF1! has! the! maximum!
number! of! 7975! bound! target! genes! representing! 65.5%!of! all! expressed! genes! in!
human! LCLs.! We! also! summarized! the! number! of! different! TFs! bound! to! the!
promoter!region!of!each!expressed!gene.!In!Figure!3.2B!we!observed!that!expressed!
genes!are!bound!by!a!median!of!9!different!TFs!and!a!maximum!of!36!different!TFs.!












regions,!while! the! remaining!2120!expressed!genes!are!not!bound!by!any!TF! from!
these! 50! TFs,! indicating! that! the! majority! of! expressed! genes! are! potentially!
regulated! by! multiple! trans&regulators.! We! recognize! that! TF! binding! is! neither!
necessary!nor!sufficient!for!the!modulation!of!expression!levels!of!its!cognate!genes.!
But! these! observations! suggest! that! trans&acting! genetic! variations! located! in! TF!
genes!may!potentially! influence!numbers!of!genes! that!are!differed!by!3!orders!of!
magnitude! range,! which! can! involve! as! many! as! 82.6%! of! expressed! genes.!





A)! Percentage! of! bound! target! genes! among! all! expressed! genes! for! 50! individual! TFs.! B)!













































































































In! conclusion,! the! extensive! complexity! of! TFs! binding! for! expressed! genes! can!be!
seen! from! the! summary!of!bound! target! genes!of! 50! individual! TFs! in!human! LCL.!
We!reason!that!while! the! individual! trans&acting!causes!may!not!be! identifiable!by!
traditional!eQTL!methodology,! the!cumulative!trans'effects! from!multiple!GVs!may!





The! main! purpose! of! this! study! is! two! fold.! Firstly,! we! aim! to! identify! and!





from! RNANseq! data.! We! will! process! raw! RNANseq! data! from! three! datasets,!
including! Yoruba! Yale! data,! Yoruba! Argonne! data! from! the! same! 69! Yoruba!
individuals! from! Pickrell! et! al.! (2010)! and! Caucasian! data! from! 60! Caucasian!
individuals!from!Montgomery!et!al.!(2010).!!
2. In! section! 3.5! we! aim! to! investigate! the! effect! of! variance! removal! on! the!




permutation! tests! to! differentiate! between! biological! meaningful! correlations!
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belonging! to! correlating! gene! pairs! from! gene! expression! matrices! of! two!
consecutive!PCs.!!
4. We! recognize! that! the! causes! of! the! expression! coNvariations! of! trans' target!
genes!might!be!either!due!to!batch!effects!or!trans'effects!from!trans&acting!GVs.!
In! order! to! distinguish! groups! of! trans' target! genes! that! can! be! explained! by!
either! trans' effects! or! batch! effects,! we! will! perform! 3! types! of! analyses! as!
shown!in!Figure!3.3D.!!
a. In!section!3.7!we!will!test!whether!groups!of!trans'target!genes!can!be!
replicated! between! two! datasets! from! technical! replicates,! and! two!




TF! bound! target! genes! in! trans' target! genes,! it! is! more! likely! due! to!
trans&acting!influences!of!TFs!rather!than!batch!effects.!!
c. In! section!3.9!we!will! test!whether!differentially!expressed!genes! from!
the! knockdown! of! 55! TF! genes! from! Cusanovich! et! al.! (2014)! are!
enriched! in! trans' target! genes.! This! test!will! be!performed!based!on!a!
similar!hypothesis! that! if! enrichments!of!differentially!expressed!genes!
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from!TF!knockdown!are!observed!in!trans!target!genes,!it!can!be!better!
explained! by! trans&acting! influences! of! TFs! rather! than! batch! effects.!





















The! mapping! of! RNANseq! reads! to! the! human! reference! genome! grch37! was!
described! in! the!Methods! (section! 2.1).! Lassmann! et! al.! (2009)! pointed!out! that! a!
low! mapping! rate! usually! suggests! low! quality! of! a! sequencing! lane.! In! order! to!
check! the!quality!of!all! sequencing! lanes!before!preforming! following!analyses,!we!
examined! the!mapping! rate!of!our!RNANseq!data,!which! is! the!proportion!of! reads!
mapped! to! the! reference! genome! among! the! total! reads! produced! from! a!
sequencing!lane.!In!Figure!3.4!we!showed!the!mapping!rates!of!all!sequencing!lanes!
from! Yoruba! Yale,! Yoruba! Argonne! and! Caucasian! dataset.! From! either! figure! we!
observed! a! distinct! borderline,! which! divides! all! samples! into! “normal”! and!
“abnormal”! samples.! Therefore,! to! ensure! the! quality! of! sequencing! lanes! used! in!
our!study,!we!removed!sequencing! lanes!with! low!mapping!rate,!which! included!6!
sequencing! lanes! with! fewer! than! 57%! mappable! reads! (SRR031928,! SRR031929,!
SRR031966,!SRR031969,!SRR031970,!SRR031971)!from!Yoruba!Argonne!data,!and!5!





The! XNaxis! is! the! number! of!mapped! reads! for! each! sequencing! sample.! The! YNaxis! is! the!
mapping! rate! for! each! sequencing! sample.! RNANseq! samples! from! Yoruba! Yale,! Yoruba!
Argonne!and!Caucasian!data!are!colored! in!red,!green!and!black,!respectively.!Dashed!lines!
are! the!borderlines! separating!normal! samples! from!abnormal! samples,!which! are!marked!
with!cycles.!
!
In! order! to! calculate! the! genomeNwide! gene! expression! levels! of! human! LCLs,! we!
counted!the!numbers!of!reads!mapped!to!all!gene!regions.!RPKM!(reads!per!kilobase!
of!gene!model!per!million!mapped!reads)!(Mortazavi!et!al.!2008)!values!were!then!
computed! and! log10! transformed.! We! examined! the! overall! sample! RPKM!
distributions! and! compared! them! with! each! other! using! density! plot.! The!
presumption!is!that!any!sample!with!an!abnormal!RPKM!distribution!comparing!with!
other!distributions!may!be!influenced!by!unknown!sequencing!bias!and!thus!should!
be! excluded.! Therefore,! In! Figure! 3.5A! sample! SRR031854! from! Yoruba! Yale! data!
was!excluded.!In!Figure!3.5C!Caucasian!sample!“3125_5”!was!excluded.!!
After!the!removal!of!abnormal!samples,!80!and!74!samples!remained!in!Yoruba!Yale!
dataset! and! Yoruba! Argonne! dataset,! respectively.! Then,! RPKM! values! from! two!
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duplicated!samples!of!the!same!individual!were!averaged,!which!resulted!in!12,171!
expressed! genes! and! 12,385! expressed! genes! detected! in! the! same! 68! Yoruba!




In! Figure! 3.5B! we! also! observed! that! expression! levels! of! over! 10,000! genes!
expressed!in!LCL!samples!are!roughly!normal!distributed!with!an!average!of!around!
RPKM!value!1! in! all! three!datasets.! There! are! also! genes!with! extreme!expression!
levels,! such!as! smaller! than!RPKM!0.01!or!bigger! than!RPKM!100.! In!Figure!3.6!we!
showed! the! overlaps! of! gene! identities! among! 3! gene! expression! datasets.! As!





genes! from! Yoruba! Argonne! data,! and! 97.7%! of! expressed! genes! from! Caucasian!
data)!are! shared!among!expressed!genes! from!3!different!datasets,! indicating! that!









A)! RPKM! distributions! for! 80! RNANseq! samples! from! Yoruba! Yale! data! and! 74! RNANseq!
samples!from!Yoruba!Argonne!data.!The!RPKM!distribution!of!sample!SRR031854!is!marked!
with! an! arrow! due! to! its! abnormally! low! proportion! of! genes! with! low! RPKM.! B)! RPKM!
























































































































































































distributions! for! 54! Caucasian! individuals.! The! RPKM! distribution! of! sample! “3125_5”! is!

















(2013)! reported! that! the! removal! of! PCs! could! simultaneously! remove! both! batch!
effects!and!effects!from!genetic!variations,!which!is!due!to!the!loss!of!genetic!effects!
identified!within!the!PCs!being!removed.!Therefore,!we!suggest!that!the!removal!of!
PCs!may! also! be! an! alternative! approach! to! identify! trans&regulated! genes.! In! this!
section! we! shall! examine! the! effects! of! PC! removal! on! coNvariations! of! gene!
expression!data!from!human!LCLs.!!
Expressed genes in 3 datasets










Following! the!PCA!procedures!as!described! in!Methods! (section!2.4)!we!generated!
68!gene!expression!matrices!X1! to!X68! for!Yoruba!Yale!data,!which!were!defined!as!
gene!expression!matrices!with!0! to!67!PCs!being! removed! (Figure!3.3A).!Following!
the! same! procedures! we! also! generated! 68! and! 54! gene! expression! matrices! for!
Yoruba!Argonne!data!and!Caucasian!data,!respectively.!!












PCs.! The! YNaxis! shows! the! relative! proportions! of! remaining! variance! in! different! gene!



























































we! calculated! pairNwise! expression! correlations! for! 1000! random! genes! using! PC1!
gene!expression!matrix!from!Yoruba!Yale!data,!and!then!divided!them!into!positive!
and! negative! correlations.! Based! on! the! bound! target! genes! of! 50! individual! TFs!
identified!in!section!3.3,!we!also!calculated!the!number!of!shared!bound!TFs!for!all!
gene! pairs.! These! positively! and! negatively! correlated! gene! pairs! were! further!
divided!into!two!groups!–!one!group!with!fewer!shared!bound!TFs!(0!to!1!TFs)!and!
one!group!with!more!shared!bound!TFs!(2!to!26!TFs).!In!both!Figure!3.8A!and!Figure!
3.8B!we!observed! that! correlations!of!gene!pairs!with!more! shared!bound!TFs!are!
slightly! shifted! towards! higher! correlations! comparing! with! correlations! of! gene!
pairs!with! fewer! shared!bound!TFs! in!PC1!gene!expression!matrix,! suggesting! that!






bound! TFs,! and! observed! that! these! two! correlation! distributions! become! more!
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similar!with!more!PCs!being!removed,!indicating!an!association!between!coNvariation!
































































We! applied! a! permutation! procedure! to! determine! the! correlation! threshold.!We!







Then! we! assigned! P! values! to! different! correlation! values! from! our! experimental!
data.! The! assignment! of! P! values! is! based! on! the! ranking! of! a! specific! correlation!
value! among! the! null! distribution! of! correlations.! For! example,! in! Figure! 3.9A! we!
observed! that! 1%! of! correlation! values! from! the! null! correlation! distribution! are!
larger!than!0.7.!Thus,!P!<!0.01!is!assigned!to!the!correlation!coefficient!0.7.!We!also!
observed! that! 5%! of! correlation! values! from! the! null! correlation! distribution! are!
larger!than!0.68.!Thus,!P!<!0.05!is!assigned!to!the!correlation!coefficient!0.68.!!
We! repeated! the! above! procedure! for! 20! gene! expression!matrices!with! different!
numbers!of!PCs!being!removed,!and!observed!that!correlation!values!with!P!<!0.01!





data,! and! the! correlation! threshold! is! |ρ|! >! 0.76! for! Caucasian! data.! The! possible!
reason! for! the! difference! of! correlation! threshold! between! Yoruba! and! Caucasian!
dataset! is! that! the! permutation! procedure! is! sensitive! to! the! sample! size! of! gene!








































































































































































































































































































































In! this! section! in! order! to! evaluate! the! effect! of! PC! removal! on! expression! coN
variation,!we!computed!and!compared!the!numbers!of!correlating!gene!pairs! from!
gene!expression!matrices!generated!by!sequential!PC!removal.!




reaches! its! minimum! value! at! PC21,! then! increases! when! more! than! 20! PCs! are!
removed.! A! similar! pattern! was! also! observed! using! Yoruba! Argonne! dataset! or!
Caucasian!dataset.!When!we!used!a! randomly!permutated!gene!expression!matrix!
Xp!where!individual! labels!were!randomly!sampled,!the!number!of!correlating!gene!






A)!Numbers!of! correlating!gene!pairs! that!were! identified!using!gene!expression!data!with!
different!numbers!of!removed!PCs.!Results!from!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!





To! explain! the! pattern! we! observed! in! Figure! 3.10A,! we! hypothesized! that! coN
variations!of!gene!expression!are!determined!by!biological!effects,!batch!effects!and!
background! noise! combined! together.! Batch! effects! and! biological! effects! tend! to!
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variations! of! gene! pairs.! But! background! noise! is! the! random! effect! on! gene!
expression,! which! is! unlikely! shared! among! genes.! We! classified! the! changes! of!
numbers!of!correlating!gene!pairs!in!Figure!3.10A!into!two!stages!for!each!dataset:!
stage!1!(e.g.!from!PC1!to!PC21!of!Yoruba!Yale!data)!and!stage!2!(e.g.!from!PC22!to!
PC68! of! Yoruba! Yale! data).! In! stage! 1,! both! batch! effects! and! trans' effects! are!
recognized! by! PCA! and! removed! sequentially! with! PCs,! hence! coNvariation! level!
decreases.!When!top!20!PCs!are!removed,!it!is!possible!that!residues!of!both!batch!
effects!and!trans'effects!are!small!and!comparable!in!scale!to!effects!of!background!
noise.! In! stage! 2,!when!more! PCs! are!moved! PCA! starts! to! recognize! and! remove!
background! noise! accounting! for! all! remaining! expression! variance.! The! more!
variance! is! removed! the! less! variance! remains,! which! will! result! in! flatter! gene!




expression!data! using! PCA.! PairNwise! gene! expression! correlations!were! computed!
for! each! expression! matrix! with! different! numbers! of! PCs! being! removed.! We!
observed! an! association! between! expression! coNvariations! and! numbers! of! shared!
bound! TFs! for! gene! pairs.! We! selected! |ρ|! >! 0.7! (for! Yoruba! Yale! and! Yoruba!
Argonne!data)!and!|ρ|!>!0.76!(for!Caucasian!data)!as!the!correlation!threshold!based!















correlating!gene!pairs! from!Xn.!We!compared! the!gene! identities!Gn!with!Gn+1,!and!
identified!the!subset!of!genes!included!in!Gn!but!not!in!Gn+1,!which!were!defined!as!
“trans'target,genes”!of!PCn.!For!example,!trans'target!genes!of!PC1!were!defined!as!
genes! belonging! to! correlating! gene! pairs! from! X1! but! not! any! gene! belonging! to!
correlating! gene! pairs! from! X2.! Moreover,! “trans' target! genes”! were! defined! for!
simplicity,! since! they! are! groups! of! coNvarying! genes! presumably! caused! by! either!
trans' effects! or! batch! effects.! We! will! distinguish! groups! of! trans' target! genes!
caused!by!either!biological!trans'effects!or!batch!effects!in!following!sections.!!




genes! identified! from!each!dataset.!We!observed! that! the! number! of! trans' target!
genes! does! not! decrease! continuously!when!more! and!more! PCs! are! removed.! In!





In! Figure!3.11!we! showed! the!numbers!of! trans' target! genes! identified! from!each!
dataset.!Trans'target!genes!from!Yoruba!Yale!data!have!the!maximum!1861!genes!in!










Numbers! of! genes! in! groups! of! trans! target! genes! identified! from! Yoruba! Yale,! Yoruba!
Argonne!and!Caucasian!data!are!shown!in!3!panels,!respectively.!!
!
To! exclude! the! possibility! that! some! apparent! trans! effects! are! consequence! of!
multiple! cisNvariations,! we! investigated! whether! cisNvariations! contribute! to! the!
identification! of! trans! target! genes.! Our! hypothesis! is! that! if! cisNvariations! have!
significant! contribution! to! the! coNvariations! of! trans! target! genes,! genes! with! cisN






















significance! threshold!P! <! 0.05.! Therefore,!we! conclude! that! coNvariations!of! trans!
target!genes!may!not!be!due!to!shared!influence!of!multiple!cisNvariations.!!







technical! replicates.! Our! hypothesis! is! that! if! trans' target! genes! from! Yoruba! Yale!
and! trans' target! genes! from! Yoruba! Argonne! are! similar! sets! of! genes,! it! is!more!
likely!due!to!shared!biological!effects!between!replicate!samples!rather!than!due!to!
batch! effects! that! are! unlikely! the! same! in! two! experiments.!Moreover,! it! is! also!
interesting!to!compare!trans'target!genes!from!Yoruba!data!and!trans'target!genes!
from!Caucasian!data.!Our!hypothesis!is!that!if!coNvariations!of!trans'target!genes!are!
caused!by! genetic! effects! that! are! shared!between!Yoruba! and!Caucasian!dataset,!
we!should!be!able!to!observe!the!same!genes!from!different!datasets.!However,!we!
do! not! expect! that! shared! genetic! effects! should! be! explained! by! the! same! PCs!
between!two!different!datasets.!
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We! tested! whether! the! number! of! overlapped! genes! between! 2! groups! of! trans'
target! genes! are! significantly! larger! than! chance!expectation!using! Fisher’s! test.! In!
Figure!3.12!A1!we!observed!extensive!overlaps!between!20!groups!of! trans' target!
genes! identified! from! Yoruba! Yale! dataset! and! trans' target! genes! identified! from!








of! PC3! from!Yoruba! Yale! data! are! best! overlapped!with! trans! target! genes! of! PC3!




from! Yoruba! Yale! data! is! best! overlapped! with! trans! target! genes! of! PC12! from!
Yoruba!Argonne!data!(P!=!3!×!10N8).!This!is!because!shared!genetic!effects!may!not!be!
necessarily!explained!by!the!exact!same!PC!between!replicated!datasets.!
Besides! the! replication!of! trans' target!genes!between! technical! replicates,!we!also!
tested! whether! trans' target! genes! from! different! populations! are! replicable.! In!
Figure!3.12!A2,B2!we!found!29!significant!overlaps!between!trans'target!genes!(PC1!
to!PC8,!PC10!to!PC14,!PC16!and!PC18)!from!Yoruba!Yale!data!and!trans'target!genes!





PC8! and! PC10! to! PC13! from! Yoruba! Yale! data.! These! overlaps! suggest! that!
cumulative!trans'effects!from!one!PC!of!a!dataset!may!be!recognized!by!multiple!PCs!
of! another! dataset,! such! as! trans' target! genes! of! PC7! from! Yoruba! Yale! data! and!
trans' target! genes! of! PC6! from! Caucasian! data.! Batch! effects! are! unlikely! to! be!
identical!in!two!RNANseq!datasets!with!different!populations.!Therefore,!it!is!possible!
that! shared! trans! effects! between! Yoruba! and! Caucasian! individuals! contribute! to!
similar!sets!of!trans'target!genes.!However,!there!is!no!expectation!that!all!groups!of!




Some! groups! of! trans' target! genes! are! not! replicated! between! two! datasets,! e.g.!
trans' target! genes! of! PC9,! PC15! from! Yoruba! Yale! data! and! trans' target! genes! of!
PC11! to! PC13! from! Caucasian! data.! This! may! be! due! to! population! specific! trans'
influences! that!are!not! shared!between!Yoruba!and!Caucasian!populations.!Similar!
observations!were! found!comparing! trans' target!genes! from!Yoruba!Argonne!data!
and!trans'target!genes!from!Caucasian!data!(Figure!3.12!A3,B3).!
In!conclusion,!we!observed!multiple!significant!overlaps!between!trans'target!genes!
from! replicated! samples.! There! are! also! overlaps! of! trans' target! genes! from! two!
populations.! These! results! together!provide!evidence! supporting! that! coNvariations!
of! trans' target! genes! are! more! likely! caused! by! shared! trans' effects! between!
datasets! but! not!by!batch!effects.! In! the!next! section!we!will! perform!enrichment!














































Figure, 3.12, Cross7comparisons, of, gene, identities, between, groups, of, trans' target, genes,
from,different,datasets,,
Groups! of! trans' target! genes! from! two! datasets! are! crossNcompared! with! each! other.!
Overlaps!with! P! <! 1.25! ×! 10N4! are! highlighted.! A1)!Numbers! of! overlapped! genes! between!
trans'target!genes!from!Yoruba!Yale!and!Yoruba!Argonne!data.!A2)!Numbers!of!overlapped!
genes! between! Yoruba! Yale! data! and! Caucasian! data.! A3)! Numbers! of! overlapped! genes!
between! Yoruba! Argonne! data! and! Caucasian! data.! B1)! P! values! from! Fisher’s! tests!
comparing!trans!target!genes!from!Yoruba!Yale!and!Yoruba!Argonne!data.!B2)!P!values!from!
Fisher’s!tests!comparing!trans!target!genes!from!Yoruba!Yale!data!and!Caucasian!data.!B3)!P!








In! this! section,! in!order! to! test!whether! coNvariations!of! trans' target! genes!have!a!
biological! origin,! we! will! test! whether! bindings! of! individual! TFs! are! enriched! in!








We! applied! hypergeometric! test! to! test! the! enrichment! of! bound! target! genes! of!
individual! TFs! in! each! group! of! trans' target! genes.! Results! for! all! individual! tests!
were! listed! in! Table! A.2.! In! Table! 3.1! we! summarized! the! enrichments! of! bound!
target! genes! of! individual! TFs! in! trans' target! genes! of!multiple! PCs.!We! observed!
that!trans'target!genes!are!significantly!enriched!for!bound!target!genes!of!35!out!of!
50! individual! TFs! with! significant! enrichment! detected! in! at! least! one! dataset.! In!
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columns! indicate! different! groups! of! trans' target! genes.! Symbol! “N“! is! filled! when! no!
enrichment!is!found!from!its!corresponding!analysis.!
!
ChIP7seq,antibody, Yoruba,Yale, Yoruba,Argonne, Caucasian,
ATF3! 6,10! 6! 5!
BCL3! 7! N! N!
BCLAF1_(M33NP5B11)! 6! 6! N!
CHD2_(NN1250)! 4,6,7,12! 6,7,11! 1,5,6!
cNMyc! 6,7,10,11,12! 6,8,9,10,11,12,17! 5,6,14,18!
EgrN1! 3,4,6,7,10,14! 4,5,6,7! N!
ELF1_(SCN631)! 1,4,6,7,10,12! 3,4,5,6,7,8,9,11! 1,3,5,6!
ETS1! 6,7,10! 4,6! 3,5!
GABP! 4,6,7,10! 3,4,6,7,8,11! 1,3,5!
IRF3! 7! 7! N!
Max! 7! N! 9!
MEF2A! 4,7! N! N!
NFKB! 4! N! N!
Nrf1! 4,6,7,10,12! 4,6,9! 1,3,5!
OctN2! 4,6,7! 3,4,6,7,8,9,11! 1,5,7,9!
p300! 7! N! N!
PAX5NC20! 6,7,10! 6,7,10! 1,5!
Pbx3! 4,7! 7! N!
PU.1! 4! 4! N!
RFX5_(NN494)! 7! 7,8! N!
RXRA! 4,7! 6! N!
Sin3AkN20! 4,6,7,9,10,12! 3,4,5,6,7,8,9,11,17! 1,3,5,6!
SP1! 4,6,7,10,12,14! 3,5,6,7,8,9,11! 1,3,5,6!
SPT20! N! 7! N!
SRF! 4,6,7! 4,6,9! 1,3,5!
TAF1! 4,6,7! 3,4,6,7,10,11,13,17! 1,3,5!
TBP! 1,4,6,7! 3,4,6,7,8,9,13! 1,5!
TCF12! 7! 3,6,7,19! N!
TR4! 6! 6! N!
USFN1! 6,7,10! 6,8,11! 9!
USF2! 7,10! 6,8,11! 5!
YY1_(CN20)! 1,4,6,7,10! 3,4,6,7,8,9,12! 1,3,5,9!
ZBTB33! 7! N! 5!
ZEB1_(SCN25388)! 6! N! N!
Znf143_(16618N1NAP)! 6,7,10! 3,6! 5!
!
Comparing! results! from!3! different! datasets!we! found! that!many! enrichments! are!
replicated.! In! summary,! enrichments! for! 27! TFs! found! in! Yoruba! Yale! dataset! are!




expression! coNvariations! of! trans' target! genes! are! more! likely! originated! from!
biological!effects!rather!than!batch!effects.!We!also!observed!enrichments! in!trans!
target!genes!of!multiple!PCs.!For!example,!the!enrichments!of!bound!target!genes!of!
CHD2!were! found! in! trans! target! genes! of! PC4,! PC6,! PC7,! PC12! from! Yoruba! Yale!












of! gene! TSS,! respectively)! of! trans! target! genes.! We! observed! that! there! are!
enrichments! of! 16! individual! TFs! binding! to! 2! kbp,! 5! kbp! and! 10! kbp! promoter!
regions! of! trans! target! genes! identified! from! the! same! PCs.! The! enrichments! of!
remaining! 16! individual! TFs! were! observed! in! 2! kbp,! 5! kbp! and! 10! kbp! promoter!
regions!of!trans!target!genes!identified!from!similar!sets!of!PCs.!But!enrichments!of!
BCL3,! BCLAF1! and!MEF2C! were! only! observed! in! one! or! two! ranges! of! promoter!
regions!of!trans!target!genes.!!
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Table, 3.2, Summary, of, enrichment, tests, for, TFs, binding, to, different, ranges, of, promoter,
regions,
Bound!target!genes!of!individual!TFs!are!defined!based!on!2!kbp,!5!kbp!and!10!kbp!promoter!
regions! (±1! kbp,! ±2.5! kbp! and! ±5! kbp! of! gene! TSS,! respectively).! The! numbers! indicate!
different!groups!of!trans'target!genes!identified!from!Yoruba!Yale!data.!“N“!is!filled!when!no!
enrichment! is! found!from!its!corresponding!test.!“*”! indicates!the!enrichment!of! individual!
TFs!binding!to!3!promoter!regions!of!trans!target!genes!identified!from!the!same!PCs.!
!
ChIP7seq,antibody, Promoter.2.kbp, Promoter.5.kbp, Promoter.10.kbp,
ATF3! 6,10! 6,7,10! 6,7,10!
BCL3! 7! N! N!
BCLAF1_(M33NP5B11)! 6! N! 6!
CHD2_(NN1250)! 4,6,7,12! 4,7,12! 4,6,7,12!
cNMyc*! 6,7,10,11,12! 6,7,10,11,12! 6,7,10,11,12!
EgrN1! 3,4,6,7,10,14! 3,4,6,7,10! 3,4,6,7,10!
ELF1_(SCN631)! 1,4,6,7,10,12! 1,4,6,7,10,12! 1,4,6,7,10!
ETS1! 6,7,10! 6,7! 6,7!
GABP*! 4,6,7,10! 4,6,7,10! 4,6,7,10!
IRF3*! 7! 7! 7!
Max*! 7! 7! 7!
MEF2A! 4,7! 7! 7!
MEF2C_(SCN13268)! N! 7! 7!
NFKB! 4! 4,7! 4,7!
Nrf1*! 4,6,7,10,12! 4,6,7,10,12! 4,6,7,10,12!
OctN2! 4,6,7! 4,6,7! 4,7!
p300*! 7! 7! 7!
PAX5NC20*! 6,7,10! 6,7,10! 6,7,10!
Pbx3*! 4,7! 4,7! 4,7!
PU.1! 4! 4! 4,7!
RFX5_(NN494)! 7! 7,10! 7,10!
RXRA*! 4,7! 4,7! 4,7!
Sin3AkN20! 4,6,7,9,10,12! 4,6,7,9,10,12,18! 4,6,7,9,10,12!
SP1*! 4,6,7,10,12,14! 4,6,7,10,12,14! 4,6,7,10,12,14!
SRF! 4,6,7! 6,7! 6,7!
TAF1! 4,6,7! 4,7,11! 4,7,11!
TBP! 1,4,6,7! 1,4,6,7! 4,7!
TCF12*! 7! 7! 7!
TR4*! 6! 6! 6!
USFN1*! 6,7,10! 6,7,10! 6,7,10!
USF2*! 7,10! 7,10! 7,10!
YY1_(CN20)! 1,4,6,7,10! 1,4,6,7,10! 4,6,7,10!
ZBTB33*! 7! 7! 7!
ZEB1_(SCN25388)!*! 6! 6! 6!
Znf143_(16618N1NAP)! 6,7,10! 6,7,10,12,18! 6,7,10!
!









trans! target! genes! are! robust! with! respect! to! the! promoter! regions! we! used! to!
define!bound!target!genes!of!individual!TFs.!!
!
Figure, 3.13, Enrichment, tests, of, TF, bound, target, genes, defined, by, different, promoter,
regions,,














































































































































































In! this! section! we! observed! substantial! enrichments! for! bound! target! genes! of!
individual! TFs! in! trans' target! genes! from! three! different! datasets.! Moreover,! we!
realize!that!TFs!perform!their!regulatory!functions!by!cooperating!with!other!TFs!as!






TFs! usually! cooperatively! regulate! gene! expression.! Therefore,! besides! the!
enrichment!of!bindings!of! individual!TFs,!we!were!also! interested! in! the!combined!
effect! of!multiple! coNbinding! TFs.!We! proposed! the! hypothesis! that! if! bindings! of!
multiple! TFs! are! enriched! in! trans! target! genes,! they! are!more! likely! regulated! by!
trans&acting! effects! rather! than! batch! effects.! In! this! section! we! shall! test! this!
hypothesis!in!groups!of!trans'target!genes!identified!from!3!datasets.!!
The! number! of! all! possible! TF! combinations! composed! of! 50! different! TFs! will!
increase! exponentially! when! the! number! of! different! TFs! included! in! one!
combination! increases.!For!example,! there!are!1,225!different!combinations!of!TFs!
formed!by!2!out!of!50!TFs,!and!19,600!combinations!of!TFs!formed!by!3!out!of!50!TFs.!
It! would! not! be! practical! to! test! all! possible! combinations! of! 50! TFs! due! to! the!
stringent! P! values! required! under! multiple! testing! correction.! However,! we! can!
selectively! test!a!subset!of!TF!combinations!with!potential!transNacting! function.! In!
order!to!achieve!this!goal,!we!presumed!that!when!the!number!of!correlating!gene!
pairs! is!minimum!when! top!20!PCs!are! removed! in!Yoruba!Yale!data! (Figure!3.10),!
there! are! remaining! trans' effect! residues! that! are! sources! of! expression! coN
variations!in!the!gene!expression!data.!We!hypothesized!that!trans'effect!residues!in!
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PC21! may! originate! from! shared! bound! TFs! of! correlating! gene! pairs.! Then! the!
shared!bound!TFs! found!from!correlating!gene!pairs! in!PC21!may!have!the!highest!
functional! potential,! since! their! trans'effect! residues! can! still! be! observed! in! gene!
expression! data! of! PC21! where! most! trans' effects! are! removed.! Therefore,! we!













Results! from! Yoruba! Yale,! Yoruba! Argonne! and! Caucasian! dataset! are! shown! in! different!
columns.! The! numbers! indicate! different! groups! of! trans! target! genes.! Symbol! “N”! is! filled!
when!there!is!no!significant!enrichment!found.!
!
TF,combinations, N.TFs, Yoruba,Yale, Yoruba,Argonne, Caucasian,
CTCF,Sin3AkN20! 2! 6! 6! N!
EBF1,EgrN1! 2! 7! N! N!
EBF1,ELF1! 2! 7! 6! N!
EgrN1,Sin3AkN20! 2! 4,6,7,10! 4,5,6,7,8,9! 1,3,5!
ELF1,PAX5NC20! 2! 4,6,7,10! 4,6,7! 1,5!
ELF1,SP1! 2! 4,6,7,10,12! 3,6,7,8,9,11! 1,3,5,6!
ELF1,YY1! 2! 1,4,6,7,10! 3,4,6,7,8,9,11! 1,3,5,9!
ELF1,ZEB1! 2! 6! N! N!
Sin3AkN20,USF2! 2! 7,10! 6,8,11! 5!
Sin3AkN20,ZEB1! 2! 6,7! 6! N!
SP1,YY1! 2! 4,6,7,10,12! 3,6,7,9,11! 1,3,5,6,9!
YY1,ZEB1! 2! 6! 7! N!
EBF1,EgrN1,ELF1! 3! 7! N! N!
EBF1,ELF1,Sin3AkN20! 3! 7! 6! N!
EBF1,ELF1,YY1! 3! 7! 6! 5!
EgrN1,Sin3AkN20,YY1! 3! 4,6,7,10! 4,6,7,8! 1,3,5,9!
EgrN1,SP1,YY1! 3! 6,7,10,12,14! 6,7,8! 3,5!
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ELF1,Nrf1,YY1! 3! 4,6,7,10,12! 4,6,9! 3,5!
ELF1,OctN2,YY1! 3! 4,6,7! 3,4,6,7,8,9,11! 1,3,5,9!
ELF1,PAX5NC20,Sin3AkN20! 3! 4,6,7,10! 6,7,9! 1,3,5!
ELF1,PAX5NC20,TBP! 3! 7! 6,7,8! 1!
ELF1,Sin3AkN20,TBP! 3! 4,6,7! 3,4,6,7,8,9! 1,5!
ELF1,Sin3AkN20,Znf143! 3! 6,7,10,12,18! 6,9,11! 1,5!
ELF1,TAF1,TBP! 3! 4,6,7! 3,4,6,7,11! 1,5,10!
USFN1,USF2,YY1! 3! 6,7,10! 6,11! 5,9!
EBF1,EgrN1,ELF1,Nrf1! 4! 7! N! N!
EBF1,ELF1,YY1,Znf143! 4! 10! 3,6! N!
EgrN1,ELF1,Sin3AkN20,YY1! 4! 4,6,7,10! 4,6,7,8! 1,3,5,9!
ELF1,Nrf1,Sin3AkN20,SP1! 4! 4,6,7,10,12,14! 6,8,9,11! 5,6!
ELF1,OctN2,Sin3AkN20,SP1! 4! 6,7,12! 6,7,8,9,11! 1,5!
ELF1,OctN2,TAF1,YY1! 4! 4,7! 3,6,7,11! 1,3,5,10!
ELF1,PU.1,SP1,USF2! 4! 7! N! N!
ELF1,SP1,TAF1,YY1! 4! 4,6,7,11! 3,6,7,9,11,17! 1,3,5,10!
OctN2,RFX5,Sin3AkN20,SP1! 4! 7! 7,8,11! N!
CHD2,EgrN1,ELF1,SP1,TBP! 5! 7! 7,8! N!
EgrN1,ELF1,PU.1,Sin3AkN20,YY1! 5! 4! 4! 5!
ELF1,GABP,Sin3AkN20,TBP,YY1! 5! 4,7! 3,6,7,8,11! 1,5!
ELF1,Nrf1,Sin3AkN20,SP1,TCF12! 5! 7! 6,9! N!
ELF1,OctN2,RFX5,TBP,YY1! 5! 7! 7,8! 10!
ELF1,RFX5,Sin3AkN20,SP1,TAF1! 5! 7! N! N!
ELF1,RFX5,SP1,TAF1,YY1! 5! 7! 6! 10!
OctN2,PAX5NC20,Sin3AkN20,TCF12,USF2! 5! 7! N! 5!
OctN2,Pbx3,SP1,TAF1,TBP! 5! 7! 7! N!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 5! 7,8,14! 3,6,11! 1,10!
CHD2,EgrN1,ELF1,SP1,TAF1,TBP! 6! 7! 7! N!
EBF1,EgrN1,ELF1,SP1,YY1,Znf143! 6! 7,10! N! N!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 6! 7,14! 7,11! 1,10!
EgrN1,ELF1,PU.1,TAF1,TBP,YY1! 6! 7! N! N!
ELF1,Nrf1,OctN2,RFX5,Sin3AkN20,YY1! 6! 7! 8! 9!
ELF1,OctN2,Pbx3,SP1,TBP,TCF12! 6! 7! N! N!
CHD2,PAX5NC20,RFX5,Sin3AkN
20,SP1,TBP,Znf143! 7! 7! N! N!
EgrN1,ELF1,SP1,SRF,TAF1,USF2,YY1! 7! 7! 7! N!
EgrN1,OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1! 7! 7,8! 7,8! 1!
ELF1,OctN2,PAX5NC20,Sin3AkN
20,TBP,YY1,Znf143! 7! 7! 6,8! N!
OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1,Znf143! 7! 7! 11! 1,10!
CHD2,ELF1,GABP,OctN2,RFX5,Sin3AkN
20,SP1,TAF1! 8! 7! N! N!
cNMyc,ELF1,PAX5NC20,Sin3AkN
20,SRF,TBP,USF2,YY1! 8! 10! N! N!
EgrN1,ELF1,GABP,Nrf1,OctN2,Sin3AkN




genes! in! trans' target! genes! from! Yoruba! Argonne! and! Caucasian! data.! Comparing!
results! from! 3! datasets,! in! Table! 3.3! we! observed! that! there! are! replications! of!




Yale! data,! trans' target! genes! of! PC6! from! Yoruba! Argonne! data,! and! trans' target!
genes!of!PC5!from!Caucasian!data.!Bound!target!genes!of!31!TF!combinations,!such!
as! “EgrN1,Sin3AkN20”,! “ELF1,SP1”! and! “EgrN1,SP1,YY1”,! are! enriched! in! at! least! one!
group!of!trans'target!genes!from!all!3!datasets.!Moreover,!many!enrichments!were!
observed!in!trans!target!genes!of!multiple!PCs.!For!example,!the!enrichments!of!TF!
combination! “ELF1,YY1”! were! found! in! trans! target! genes! of! PC1,! PC4,! PC6,! PC7,!
PC10! from! Yoruba! Yale! data,! trans! target! genes! of! PC3,! PC4,! PC6,! PC7,! PC8,! PC9,!
PC11!from!Yoruba!Argonne!data,!and!trans!target!genes!of!PC1,!PC3,!PC5,!PC9!from!
Caucasian! data.! This!may! suggest! that! trans! effects! of! combinations! of! TFs! are! so!
strong! that! they! can!be! recognized!by!multiple!PCs! from!different!datasets.! These!
results!also!suggest!that!the!influence!of!TF!combinations!may!contribute!to!the!coN
variation!of!trans!target!genes!under!trans&regulation,!and!that!there!may!be!shared!
trans' effects! of! TF! combinations! between! datasets! from! Yoruba! and! Caucasian!
populations.!!
In! conclusion,! we! observed!multiple! enrichments! for! both! bound! target! genes! of!
individual! TFs! and! bound! target! genes! of! TF! combinations! in! trans! target! genes,!
which!suggest!that!the!expression!coNvariations!of!trans'target!genes!could!be!better!
explained!by!bound!TFs! in!their!promoter!regions!than!batch!effects.!However,!we!
recognized! that! GVs! affecting! a! particular! TF! may! not! have! influence! on! the!
expression!levels!of!all!bound!target!genes!of!that!TF!as!we!discussed!in!section!1.3.2.!
Therefore,! in! the! next! section! we! shall! test! the! enrichment! of! differentially!







trans! target! genes! are!enriched! for!DE!genes! from!TF! gene! knockdown,! it! is!more!
likely!that!they!are!under!the!regulation!of!the!same!TF!rather!than!batch!effects.!In!
this! section! we! will! test! whether! there! are! enrichments! of! DE! genes! from! the!
knockdown!of!individual!TF!genes!in!groups!of!trans'target!genes.!!








observed! that! the! expressions! of! DE! genes! are!more! variant! in! Yoruba! individuals!
(1.66!fold!change!on!average)!than!in!TF!knockdown!experiments!(1.09!fold!change!
on!average).!The!two!possible!reasons!could!be!the!large!genetic!difference!among!
68! Yoruba! individuals,! and! the! stronger! cumulative! trans! effects! of! multiple! TFs!
compared!to!the!effect!of!single!TF!gene!knockdown.!
Groups! of! DE! genes! from! the! knockdown! of! 55! individual! TF! genes! were! used! in!
following! analysis.! Enrichments! of! DE! genes! from! TF! knockdown! in! trans' target!
genes!were!tested!by!hypergeometric!test!at!the!significance!threshold!P!<!4.2!×!10N5!
corrected! for! 20!PCs! and!55! groups!of!DE! genes! for!both! Yoruba!Yale! and!Yoruba!
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target! genes! of! the! same! PCs! are! enriched! for! groups! of! DE! genes! from! the!





from!Yoruba!Yale!data!and!10!groups!of! trans' target!genes! (PC1,!PC3! to!PC10!and!
PC13)! from! Yoruba! Argonne! data! may! be! trans&regulated! genes.! And! such! trans&
regulation!may!be!caused!by!expression!variations!of!multiple!TFs.!!
!




TF,Knockdown, PC, N.genes, Freq.obs, Freq.exp, fold, pv, dataset,
EP300! 3! 334! 25%! 20.40%! 1.2! 6.30EN06! Yoruba,Yale,
IRF4*! 3! 450! 33.60%! 27.10%! 1.2! 1.20EN08! !
PAX5*! 3! 289! 21.60%! 17.40%! 1.2! 1.40EN05! !
RAD21*! 3! 320! 23.90%! 19.60%! 1.2! 1.30EN05! !
EP300! 4! 384! 24.80%! 20.40%! 1.2! 2.00EN06! !
EZH2! 4! 80! 5.17%! 3.35%! 1.5! 2.20EN05! !
IRF4*! 4! 486! 31.40%! 27.10%! 1.2! 2.70EN05! !
LCORL! 4! 128! 8.28%! 5.60%! 1.5! 1.20EN06! !
SP1*! 4! 487! 31.50%! 25.70%! 1.2! 2.00EN08! !
SP1*! 6! 392! 32.10%! 25.70%! 1.2! 5.20EN08! !
CREBBP! 7! 294! 23.40%! 18.70%! 1.2! 5.30EN06! !
IRF4*! 7! 402! 32%! 27.10%! 1.2! 2.60EN05! !
IRF5! 7! 118! 9.39%! 6.49%! 1.4! 1.10EN05! !
SP1*! 7! 383! 30.50%! 25.70%! 1.2! 2.70EN05! !
USF1! 8! 27! 8.77%! 3.73%! 2.4! 1.20EN05! !
TCF12*! 10! 33! 13.40%! 6.60%! 2! 3.50EN05! !
RAD21*! 1! 313! 23.90%! 19.20%! 1.2! 3.40EN06! Yoruba,Argonne,
IRF4*! 3! 455! 31.10%! 26.70%! 1.2! 2.60EN05! !
PAX5*! 3! 310! 21.20%! 17.20%! 1.2! 1.10EN05! !
CREBBP! 4! 387! 22.30%! 18.50%! 1.2! 5.40EN06! !
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EP300! 4! 439! 25.30%! 20.10%! 1.3! 3.00EN09! !
IRF4*! 4! 530! 30.60%! 26.70%! 1.1! 3.40EN05! !
RAD21*! 4! 397! 22.90%! 19.20%! 1.2! 1.30EN05! !
SP1*! 4! 532! 30.70%! 25.40%! 1.2! 2.50EN08! !
SP1*! 5! 316! 31.80%! 25.40%! 1.3! 7.70EN07! !
SP1*! 6! 403! 30.60%! 25.40%! 1.2! 2.70EN06! !
TCF12*! 7! 84! 9.82%! 6.45%! 1.5! 3.40EN05! !
IRF4*! 8! 113! 37%! 26.70%! 1.4! 2.20EN05! !
TFDP1! 9! 52! 14.20%! 8.07%! 1.8! 2.10EN05! !
SP1*! 10! 74! 37.90%! 25.40%! 1.5! 3.40EN05! !
TCF12*! 10! 29! 14.90%! 6.45%! 2.3! 7.40EN06! !
IRF4*! 4! 240! 45.90%! 31.50%! 1.5! 5.80EN13! Caucasian,
NR2F6! 4! 82! 15.70%! 9.70%! 1.6! 3.30EN06! !
PAX5*! 4! 153! 29.30%! 20.20%! 1.4! 1.30EN07! !
RAD21*! 4! 169! 32.30%! 22.50%! 1.4! 3.70EN08! !
SP1*! 4! 199! 38%! 29.80%! 1.3! 1.40EN05! !
TFDP1! 6! 71! 15.50%! 9.83%! 1.6! 3.30EN05! !
TCF12*! 9! 36! 16.60%! 7.57%! 2.2! 2.20EN06! !
RELA! 14! 12! 12.40%! 3.50%! 3.5! 3.10EN05! !
,
!
Table, 3.5, Summary, of, significant, enrichments, of, differentially, expressed, genes, from, TF,
gene,knockdown,
Numbers! in! the! cells! represent! different! groups! of! trans' target! genes.! Symbol! “N”! is! filled!
when!there!is!no!enrichment!found.!
!
TF.knockdown, Yoruba,Yale, Yoruba,Argonne, Caucasian,
CREBBP! 7! 4! N!
EP300! 3,4! 4! N!
EZH2! 4! N! N!
IRF4! 3,4,7! 3,4,8! 4!
IRF5! 7! N! N!
LCORL! 4! N! 4!
PAX5! 3! 3! 4!
RAD21! 3! 1,4! 4!
RELA! N! N! 14!
SP1! 4,6,7! 4,5,6,10! 4!
TCF12! 10! 7,10! 9!
TFDP1! N! 9! 6!







the! knockdown!of! IRF4,' PAX5,' RAD21,' SP1'and' TCF12! are! enriched! in! trans! target!
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genes!from!all!three!datasets!(Table!3.4!and!Table!3.5).!However,!DE!genes!from!the!
knockdown!of!4!TF!genes!(EZH2,' IRF5,'RELA'and'USF1)!are!enriched! in!trans! target!
genes!from!only!one!dataset.!For!example,!DE!genes!from!the!knockdown!of!EZH2!
are! enriched! in! trans' target! genes! of! PC4! from!Yoruba! Yale! data,! but! not! in! trans'
target!genes!from!either!Yoruba!Argonne!or!Caucasian!data.!!
In!conclusion,!we!identified!enrichments!for!13!out!of!55!groups!of!DE!genes!from!TF!
knockdown! in! at! least! one! group!of! trans' target! genes! from!either!dataset.! These!
enrichments! of! functional! targets! of! TFs! further! support! our! conclusion! that,! coN
variations! of! trans' target! genes! could! be! better! explained! by! trans' effects! rather!




In! this! chapter!we!aimed! to! identify!coNvarying!genes!under! trans&regulation!using!
combined!PCA!and!correlation!analysis.!In!order!to!achieve!this!goal!we!followed!the!
analysis!workflow!as!illustrated!in!Figure!3.3.!!









Thirdly,! we! aimed! to! test! whether! trans' target! genes! are! replicable! between!
datasets!with!the!same!LCL!samples,!and!also!between!datasets!with!samples!from!
different! populations.!We! found! significant! overlaps! for! 19! of! 20! groups! of! trans'
target! genes! from! either! Yoruba! Yale! or! Yoruba! Argonne! data,! suggesting! coN
variations! of! trans' target! genes! are! caused! by! shared! effects! between! these! two!
datasets,! which! are! more! likely! to! be! trans' effects! than! batch! effects.! Significant!
overlaps!were!also!observed!between!15!groups!of!trans'target!genes!from!Yoruba!












TF! expressions,! we! tested! whether! DE! genes! from! TF! knockdown! are! enriched! in!
trans' target!genes.!Substantial!enrichments!were! found! in! trans' target!genes! from!
Yoruba!Yale!data,!Yoruba!Argonne!data,!and!Caucasian!data,! suggesting! that! trans'





coNvariations! of! trans' target! genes! are!more! likely! caused! by! trans' effects! rather!
than!batch!effects.!In!the!next!chapter!we!will!identify!trans&regulated!genes!from!a!
different!approach,!which!is!based!on!the!assumption!that!trans'effects!can!also!be!
detected! from! correlating! gene! pairs! with! shared! bound! TFs! in! their! promoter!
regions.!!
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expression! levels! of! their! target! genes.! In! section! 1.3.3! we! introduced! that! TFs!
cooperatively! regulate! the! activity! of! RNA! polymerase! and! hence! regulate! gene!




Later! in! section! 3.8.2! we! selectively! tested! a! subset! of! TF! combinations! with! the!
strongest! potential! of! trans&acting! influence,! and! found! that! their! bound! target!
genes! are! overrepresented! in! multiple! groups! of! trans' target! genes.! These!
overrepresentations! are! also! replicated! in! Yoruba! Yale,! Yoruba! Argonne! and!
Caucasian! dataset.! However,! there! is! still! no! direct! evidence! supporting! the! trans'
effects!of!TF!combinations!on!gene!expression! levels.!Therefore,! it! is! imperative!to!
design!novel!approach!to!provide!direct!evidence!of!trans'effects!of!TF!combinations!
influencing!expression!levels!of!their!target!genes.!!
In! this! chapter! we! aimed! to! detect! trans' effects! of! TF! combinations! using! a!
combination! of! gene! expression! data! and! ChIPNseq! data.! We! designed! a! novel!
approach! based! on! the! hypothesis! that! if! trans' effects! of! TFs! target! genes! with!
shared!bound! TFs! in! their! promoter! regions,! and!batch! effects! affect! an! unknown!
large! number! of! genes,! we! can! perform! correlation! comparisons! to! differentiate!












expression!correlations! tend! to!have!a!shared!bound!TF! in! their!promoter! regions,!





expression! coNvariations! between! some! correlating! gene! pairs! in! PC21.! Such! trans'
effect!residues!may!originate!from!the!influence!of!individual!TFs!or!TF!combinations.!
The! signature! of! trans' effect! residues! should! be! the! shared! bound! TFs! in! the!
promoter! regions! of! correlating! gene! pairs.! Therefore,!we! hypothesized! that! such!
trans' effect! residues! may! be! detectable! by! identifying! shared! bound! TFs! and!
examining!their!trans'effects!on!the!expression!of!correlating!gene!pairs.!!
Assumption,2,
Based! on! the! positive! association! between! shared! bound! TFs! and! expression!
correlations! of! gene!pairs,!we! also! assumed! that! if! a! combination!of! bound! TFs! is!
functional,!expression!coNvariations!of!gene!pairs!with!this!combination!of!bound!TFs!
should! be! stronger! than! expression! coNvariations! of! gene! pairs! without! this!
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combination! of! bound! TFs.! The! reason! is! that! some! trans' effects! specifically!
influence! genes! with! shared! bound! TFs,! but! batch! effects! influence! genes!
irrespective!of!their!bound!TFs.!Therefore,! if!we!observe!that!coNvariations!of!gene!
pairs! with! a! shared! combination! of! bound! TFs! are! significantly! stronger! than! coN











In! PC21! Yoruba! Yale! data! most! largeNscale! trans' effects! are! removed! with! the!
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variations! of! gene! pairs! with! shared! bound! TFs! and! coNvariations! of! gene! pairs!
without!shared!bound!TFs.!We!may!recover!the!removed!trans'effects! if!some!PCs!
are!added!back!into!PC21!expression!data.!However,!the!problem!is!that!both!batch!
effects! and! trans'effects!will! be! added! back! to! the! expression! data! if!we! add! PCs!
back.! Therefore,!we!assumed! that! if! trans'effects! target! genes!with! shared!bound!
TFs,! the! adding! back! of! PCs! with! trans' effects! will! increase!more! coNvariations! of!
gene!pairs!with! the!shared!bound!TFs! than!coNvariations!of!gene!pairs!without! the!
shared!bound! TFs.! If! batch! effects! target! genes! regardless! of! their! bound! TFs,! the!
adding!back!of!PCs!with!batch!effects!will! increase!coNvariations!of!gene!pairs!with!
the!shared!bound!TFs!and!coNvariations!of!gene!pairs!without!the!shared!bound!TFs!






The! purpose! of! this! step! is! to! identify! all! pairs! of! "seed! genes",! and! their!
corresponding!“candidate!genes”!and!“background!genes”!from!each!dataset.!Gene!




Yale! data).! Bound! TFs! in! the! 2! kbp!promoter! region!of! each! expressed! gene!were!
identified! from!ENCODE!ChIPNseq! data! as! described! in! section! 3.2.! For! any! pair! of!
seed! genes! G1G2! with! the! shared! combination! of! bound! TFs! “TF1TF2…TFn”,! their!
corresponding! "candidate, genes"! are! defined! as! all! other! genes! with! the! same!
! 85!
combination! of! bound! TFs! “TF1TF2…TFn”! as! we! found! in! G1G2,! and! their!
corresponding!"background,genes"!are!defined!as!all! remaining!genes!without! the!
same! combination! of! bound! TFs.! By! this! definition,! genes! from! seed! genes! and!






coefficient! above! the! threshold! were! identified! and! highlighted.! B)! Correlating! gene! pairs!
with! shared! bound! TFs! in! their! promoter! regions! were! defined! as! “seed! genes”.! Then!
“candidate!genes”!and!“background!genes”!were!defined!based!on!whether!they!share!the!
same! combination! of! bound! TFs! as! seed! genes.! C)! Correlation! matrix! A! was! computed!
between!seed!genes!and!candidate!genes,!and!correlation!matrix!B!was!computed!between!





where! coNvariations!of! gene!pairs!with! shared!bound!TFs!are! significantly! stronger!
than! coNvariations! of! gene! pairs! without! shared! bound! TFs.! To! quantify! the! coN
variations! of! a! gene! pair,! we! will! calculate! the! absolute! Spearman’s! correlation!
coefficient!between!two!gene!expression!profiles.!Expression!correlations!between!




genes! and! seed! genes,! it! will! suggest! that! coNvariations! of! gene! pairs! with! a!
particular! shared! combination! of! bound! TFs! are! significantly! stronger! than! coN
variations! of! gene! pairs! without! the! combination! of! bound! TFs,! which! can! be!
interpreted!as! the!evidence!of!detectable! trans'effects!of! a! combination!of!bound!
TFs!on!gene!expression.!
Taking!Yoruba!Yale!data!as!an!example,!the!largest!difference!between!correlations!
between! candidate! genes! and! seed! genes! and! correlations! between! background!
genes! and! seed! genes! is! expected! to! be! observed! in! a! particular! PC! between!PC1!
(where! no! batch! effects! are! removed)! and! PC21! (where! most! batch! effects! are!








between! coNvariations! of! gene! pairs! with! shared! bound! TFs! and! coNvariations! of!
gene!pairs!without!shared!bound!TFs!is!the!largest,!and!also!where!trans'effects!of!a!





In! this! section!we! aimed! to! identify! seed! genes!with! shared! bound! TFs,! and! their!
corresponding!candidate!genes!and!background!genes!for!each!dataset.!To!identify!




examined! the! bound! TFs! in! the! 2! kbp! promoter! regions! of! these! correlating! gene!
pairs! to! identify!pairs!of! seed!genes!with! shared!bound!TFs.! For!each!pair!of! seed!
genes,! its!corresponding!candidate!genes!were!determined!as!all!other!genes!with!
the!same!bound!TFs!as!we!found!from!the!seed!genes.!We!determined!background!




104! pairs! of! seed! genes! with! 103! different! combinations! of! shared! bound! TFs.!
Meanwhile,!we!identified!137!pairs!of!seed!genes!with!132!combinations!of!shared!





genes! of! Yoruba! Yale! data! are! composed! of! 2! to! 21! different! TFs! with! their!








, Yoruba,Yale, Yoruba,Argonne, Caucasian!
Feature, All, Significant, All, Significant, All, Significant,
Pairs,of,seed,genes, 104! 61!(59%)! 137! 54!(39%)! 32! 20!(63%)!
Shared,TF,combinations, 103! 60!(58%)! 132! 51!(39%)! 32! 20!(63%)!
TFs,in,a,TF,combination, 2–20! 2–18! 2–19! 2–17! 2–18! 2–16!







TFs,! we! calculated! correlations! between! candidate! genes! and! seed! genes! and!
correlations!between!background!genes!and!seed!genes!for!each!pair!of!seed!genes,!
and! correlation! comparisons! were! performed! in! multiple! PCs! by! oneNtailed!
Wilcoxon’s! test.! These! tests! resulted! in! 21! P! values! from! correlation! comparisons!












genes.! The! numbers! of! their! corresponding! candidate! genes! range! from! the!
maximum! 5877! to! the!minimum! 3.! In! Figure! 4.3!we! showed! that! for! Yoruba! Yale!
data! the! best! PCs! are! most! frequent! in! PC1,! PC4! and! PC7! with! 16,! 9! and! 15!
significant!tests,!respectively.!The!less!frequent!PCs!are!PC2,!PC3,!PC6!and!PC8!with!































































































































































































































































For!Yoruba!Argonne!data! tests! for!55!pairs!of! seed!genes!with!52!combinations!of!
shared!bound!TFs!were! found!significant.! In!Figure!4.3!we!showed!that! for!Yoruba!
Argonne!data!the!best!PCs!are!most!frequent!in!PC1,!PC3!and!PC4!with!11,!9!and!18!
significant! tests,! respectively.! The! PCs!with! fewer! numbers! of! significant! tests! are!
PC5,! PC7! and! PC8! with! 4,! 3! and! 4! significant! tests,! respectively.! Comparing! with!
results!of!Yoruba!Yale!data,! the! same!PCs! (PC1,!PC4,!PC7!and!PC8)!were!observed!
with! many! significant! tests! from! either! dataset,! suggesting! that! trans' effects! of!




that! the! best! PCs! are! most! frequent! in! PC1! and! PC3! with! 11! and! 3! significant!




either! dataset,! suggesting! that! trans' effects! of! TF! combinations! are! detectable! in!
PC1!and!PC3!from!datasets!of!either!Yoruba!or!Caucasian!individuals.!
Comparing!results!of!correlation!comparisons!from!Yoruba!Yale!and!Yoruba!Argonne!
data,! we! observed! 11! combinations! of! bound! TFs! shared! between! these! two!
datasets!as!listed!in!Table!4.2.!We!suggest!that!these!11!TF!combinations!are!highly!
likely! to! be! functional! cooperative! TFs! from! gene! expression! data! of! Yoruba!
individuals.!We!also!observed!that!2!of!these!11!combinations!of!TFs!were!identified!
from! seed! genes! from! Caucasian! data,! and! the! combination! of! TFs!
"ELF1,SP1,TAF1,YY1"!is!significant!in!correlation!comparisons!from!all!three!datasets,!
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suggesting! that!shared! trans'effects!of! functional!cooperative!TFs!can!be!observed!
from!both! Yoruba! and!Caucasian! gene! expression! data.! These! results! also! suggest!
that! trans' effects! of! bound! TFs! can! be! detected! from! different! datasets! using!





marked!with! symbol! “*”.! “NA”! indicates! that! there! is! no! such! TF! combination! found! in! its!
corresponding!dataset.,
!
, Yoruba,Yale, Yoruba,Argonne, Caucasian,
TFs.combinations, Best.P.value, Best.PC, Best.P.value, Best.PC, Best.P.value, Best.PC,
ELF1,YY1! 2.30EN15! 7! 2.40EN60! 1! NA! NA!
IRF4,TBP! 3.90EN06! 2! 6.30EN06! 2! NA! NA!
YY1,ZEB1! 3.10EN07! 6! 3.20EN06! 3! 0.085! 15!
ELF1,Nrf1,YY1! 2.70EN38! 1! 3.40EN21! 3! NA! NA!
ELF1,PAX5NC20! 1.10EN16! 7! 2.60EN19! 3! NA! NA!
ELF1,SP1,TAF1,YY1*! 3.40EN21! 4! 3.10EN30! 4! 2.20EN25! 1!
ELF1,PU.1,SP1,USF2! 9.30EN07! 7! 1.30EN07! 5! NA! NA!
EBF1,ELF1,Sin3AkN20! 3.50EN15! 4! 8.00EN13! 4! NA! NA!
OctN2,Pbx3,SP1,TAF1,TBP! 2.50EN07! 8! 3.60EN06! 4! NA! NA!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 8.10EN27! 2! 1.40EN21! 4! NA! NA!
ELF1,GABP,MEF2A,PAX5NC20,!




pair!of! seed!genes!with! shared!bound!TFs,!we!did!not! rule!out! the!possibility! that!
trans'effects!of!shared!bound!TFs!can!be!observed! in!multiple!PCs.!To!characterize!
the! trans'effects!of!bound!TFs! in!multiple!PCs,! in! this! section!we!will! examine! the!
changes!of!P!values!from!correlation!comparisons!across!multiple!PCs.!!
We!expect! that!when! the!PCs!are!added!back! sequentially! to! the!gene!expression!
data,! the! P! values! will! be! lower! when! the! first! PCs! are! added! back,! and! then! be!
higher!after!the!best!PC! is!added!back!as!we!described!in!section!4.2.! In!Figure!4.4!
we! observed! that! this! expectation! is! right! considering! the! 11! replicated! TF!
combinations! (listed! in!Table!4.2)! identified! from!Yoruba!Yale!and!Yoruba!Argonne!
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data.!The!P!value!becomes!lower!and!lower!slowly!when!PCs!are!sequentially!added!
back,! and! reaches! their! best! P! value! between! PC2! and! PC8.! After! the! best! PC! is!
added!back!P! value!becomes!higher,! indicating! that!more!batch!effects!are! added!
back! into! the! gene! expression! data.! Moreover,! significant! tests! for! correlation!
comparisons! are! frequently! observed! in!multiple! consecutive! PCs.! For! example,! in!
Figure!4.4!we!observed!that! for!seed!genes!with!shared!combination!of!bound!TFs!
“ELF1,! YY1”,! P! values! from! correlation! comparisons! are! lower! than! the! threshold!
from!PC3! to!PC10.!Similar!observations!were!also! found! for!other! combinations!of!
TFs,! such! as! “ELF1,! PAX5”,! “ELF1,! SP1,! TAF1,! YY1”! and! “EBF1,! ELF1,! Sin3Ak”.!
Moreover,! in! some! particular! PCs,! such! as! PC6! and! PC7,! significant! tests! can! be!
observed!from!multiple!pairs!of!seed!genes!with!different!combinations!of!TFs.!For!
example,! in!Figure!4.4!we!observed! that!P!values! from!tests! for! shared!bound!TFs!
“ELF1,YY1”,! “ELF1,PAX5”,! “ELF1,SP1,TAF1,YY1”! and! “ELF1,PU.1,SP1,USF2”! are! all!




bound! TFs! are! better! correlated! than! gene! pairs! without! shared! bound! TFs,!
suggesting! that! stronger! coNvariations! between! a! pair! of! seed! genes! and! its!
candidate! genes! can! be! partly! explained! by! the! trans' effects! of! their! shared!
combination! of! bound! TFs.! Therefore,! it! would! be! interesting! to! test! whether!
candidate! genes! under! trans' effects! of! shared! TF! combinations! and! trans' target!
genes! under! the! influence! of! cumulative! trans'effects! are! the! same! genes.! In! the!


































































































































































































































































































































































In! chapter! 3! we! identified! groups! of! trans' target! genes! that! are! potential! transN
regulated! genes.! In! this! chapter! we! also! identified! multiple! groups! of! candidate!
genes!with! shared! combination! of! bound! TFs.! It! is! possible! that!we! identified! the!
same! trans&regulated!genes!using!different!approaches,!which!could!be!due!to! the!
same! detectable! trans' effects! in! our! gene! expression! datasets.! Therefore,! we!
hypothesized!that! if!trans'target!genes! identified! in!chapter!3!and!candidate!genes!
identified! in! this! chapter! are! due! to! the! same! trans' effects,! there! should! be!
significant! overlaps! between! these! two! gene! sets.! To! test! this! hypothesis,! in! this!







groups!of! trans' target!genes.!Groups!of! candidate!genes!defined!by! shared!bound!
TFs!are! frequently!overlapped!with! trans' target!genes!of!PC4,!PC6!and!PC7!due! to!
that! PC4,! PC6! and! PC7! are! the!most! frequent! best! PCs.! The! combinations! of! TFs!




6! different! TFs.! From! Caucasian! data! there! are! 12! out! of! 20! groups! of! candidate!






















“N.TF”! is!the!number!of!TFs! in!each!TF!combination,!“trans.PC”! is!the!group!of!trans'target!
genes.!“N.shared”! is!the!number!of!shared!genes!between!candiate!genes!and!trans'target!




TF,combination, N.TF, trans.PC, N.shared, Fold, P,value,
ELF1,!ZEB1! 2! 1! 470! 1.2! 0.00074!
ELF1,!SP1! 2! 4! 695! 1.3! 2.00EN07!
YY1,!ZEB1! 2! 6! 297! 1.5! 1.20EN07!
YY1,!ELF1! 2! 7! 773! 1.8! 2.50EN23!
ELF1,!PAX5NC20*! 2! 7! 518! 1.7! 2.10EN16!
USF2,!Sin3AkN20! 2! 7! 265! 1.7! 1.60EN11!
YY1,!Nrf1,!ELF1*! 3! 1! 449! 1.2! 0.00021!
TBP,!ELF1,!TAF1! 3! 4! 428! 1.4! 2.40EN09!
YY1,!EgrN1,!Sin3AkN20! 3! 4! 459! 1.3! 6.20EN07!
ELF1,!Znf143,!Sin3AkN20! 3! 6! 350! 1.5! 3.00EN09!
TBP,!ELF1,!Sin3AkN20! 3! 7! 467! 2! 1.30EN25!
ELF1,!Sin3AkN20,!PAX5NC20! 3! 7! 437! 1.8! 1.40EN19!
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YY1,!USF2,!USFN1! 3! 7! 211! 1.6! 8.80EN09!
YY1,!ELF1,!TAF1,!SP1*! 4! 4! 344! 1.3! 2.50EN05!
OctN2,!YY1,!ELF1,!TAF1! 4! 7! 364! 2! 1.00EN23!
OctN2,!ELF1,!Sin3AkN20,!SP1! 4! 7! 350! 1.9! 4.40EN21!
YY1,!ELF1,!EgrN1,!Sin3AkN20! 4! 7! 407! 1.7! 4.80EN15!
PU.1,!USF2,!ELF1,!SP1! 4! 7! 101! 1.9! 6.20EN08!
OctN2,!TBP,!TAF1,!Sin3AkN20,!SP1! 5! 7! 242! 2! 1.30EN17!
OctN2,!YY1,!TBP,!EgrN1,!TAF1,!Sin3AkN20,!SP1! 7! 7! 162! 2! 3.20EN13!
OctN2,!YY1,!TBP,!TAF1,!Znf143,!Sin3AkN20,!SP1! 7! 7! 124! 1.9! 3.00EN09!
OctN2,!YY1,!TBP,!ELF1,!EgrN1,!TAF1,!Pbx3,!
Sin3AkN20,!CHD2,!PAX5NC20! 10! 7! 35! 2.3! 6.40EN05!
,
Yoruba,Argonne!
TF,combination! N.TF! trans.PC! N.shared! Fold! Fisher.P!
ELF1,!PAX5NC20*! 2! 4! 604! 1.3! 1.10EN05!
ELF1,!Nrf1,!YY1*! 3! 3! 360! 1.3! 6.50EN05!
EgrN1,!Sin3AkN20,!SRF,!YY1! 4! 8! 47! 1.7! 0.00093!
ELF1,!PU.1,!Sin3AkN20,!TAF1,!TBP,!YY1! 6! 4! 147! 1.4! 0.00018!
CHD2,!ELF1,!GABP,!PAX5NC20,!SP1,!USF2! 6! 7! 33! 2.3! 7.30EN05!
EgrN1,!ELF1,!Nrf1,!OctN2,!Sin3AkN20,!SP1! 6! 8! 37! 2.5! 4.10EN06!
,
Caucasian,
TF,combination! N.TF! trans.PC! N.shared! Fold! Fisher.P!
ELF1,!GABP! 2! 1! 795! 1.5! 3.50EN13!
ELF1,!Znf143! 2! 5! 426! 1.5! 2.40EN10!
Sin3AkN20,!SP1,!PAX5NC20! 3! 1! 483! 1.3! 9.60EN07!
YY1,!TBP,!ELF1,!Sin3AkN20! 4! 1! 625! 1.7! 2.90EN20!
OctN2,!ELF1,!TAF1,!Sin3AkN20! 4! 1! 506! 1.6! 1.20EN13!
YY1,!ELF1,!TAF1,!SP1*! 4! 1! 510! 1.4! 5.50EN10!
YY1,!ELF1,!ZEB1,!PAX5NC20! 4! 1! 281! 1.3! 0.00022!
ELF1,!ETS1,!Sin3AkN20,!SP1! 4! 3! 151! 1.5! 5.30EN05!
YY1,!ELF1,!EgrN1,!PAX5NC20! 4! 3! 230! 1.3! 0.001!
Nrf1,!TBP,!ELF1,!Sin3AkN20,!SP1! 5! 1! 249! 1.5! 4.90EN07!
ELF1,!EgrN1,!cNMyc,!Sin3AkN20,!SP1! 5! 18! 18! 3.4! 3.40EN05!






contributing! to! expression! coNvariations! of! gene! pairs.! To! achieve! this! goal! we!
developed!a!novel!approach!combining!correlation!analysis!and!bound!TFs! in!gene!
promoter! regions! identified! from! ChIPNseq.! We! showed! that! definitions! of! seed!





effects! on! gene! expression.! We! also! observed! significant! overlaps! between!
candidate!genes!and!trans'target!genes,!suggesting!that!expression!coNvariations!of!
candidate!genes!and!trans'target!genes!could!be!attributed!to!the!same!trans'effects.!!
Candidate! genes! identified! in! this! chapter! and! trans' target! genes! identified! in!
chapter! 3! are! both! potential! trans&regulated! genes! identified! using! different!













variation! of! mRNA! levels.! Therefore,! we! asked! whether! there! is! an!
overrepresentation!of!genes!with!shared!functions!in!transNregulated!genes.!
In! this! chapter! we! aimed! to! study! the! functional! enrichments! of! trans&regulated!
genes!using!gene!annotations!from!KEGG!pathways.!There!are!two!reasons!for!doing!




consequences! in! multiple! individuals! due! to! the! expression! coNvariations! of! trans'
target!genes.!Therefore,!in!section!5.1!and!section!5.2!we!will!test!the!enrichments!
of! KEGG! pathway! terms! in! groups! of! trans' target! genes! and! candidate! genes,!
respectively.!Moreover,!pathway!annotations!are!not!the!only!route!to!infer!shared!









To!achieve! this! goal,!we! tested!whether! trans' target! genes! identified! in! this! study!
are!enriched!for!any!KEGG!pathway.!Enrichment!tests!for!genes!annotated!by!KEGG!
pathway!terms!(Kanehisa!et!al.!2010)!were!performed!in!each!group!of!trans'target!

















KEGG,pathway, PC, NG.observed, P,value,
Oxidative!phosphorylation! 5! 20! 5.00EN08!
Parkinson's!disease! 5! 19! 3.60EN07!
Huntington's!disease! 5! 22! 4.20EN06!
Alzheimer's!disease! 5! 19! 2.10EN05!
Spliceosome! 7! 32! 2.40EN10!
Proteasome! 7! 17! 7.00EN10!
Huntington's!disease! 7! 35! 3.90EN08!
DNA!replication! 7! 13! 7.10EN07!
Alzheimer's!disease! 7! 29! 1.80EN06!
Pyrimidine!metabolism! 7! 21! 5.10EN06!
Parkinson's!disease! 7! 23! 1.10EN05!
Ribosome! 8! 15! 2.80EN11!
Ribosome! 13! 9! 1.10EN08!
Protein!processing!in!endoplasmic!reticulum! 14! 7! 2.30EN06!




KEGG,Pathway, PC, NG.observed, P,value,
Fatty!acid!metabolism! 1! 13! 5.80EN07!
Peroxisome! 1! 17! 1.80EN05!
Metabolic!pathways! 1! 106! 2.20EN05!
Huntington's!disease! 5! 31! 6.40EN09!
Parkinson's!disease! 5! 21! 4.70EN07!
Alzheimer's!disease! 5! 25! 4.80EN07!
Oxidative!phosphorylation! 5! 21! 5.90EN07!
Nucleotide!excision!repair! 6! 14! 3.40EN06!
Spliceosome! 6! 24! 2.00EN05!
Protein!processing!in!endoplasmic!reticulum! 7! 25! 3.50EN06!
Renal!cell!carcinoma! 7! 14! 4.80EN06!
RNA!polymerase! 7! 8! 7.50EN06!
Proteasome! 7! 10! 1.40EN05!
Protein!processing!in!endoplasmic!reticulum! 8! 13! 9.70EN06!
Ribosome! 8! 9! 1.10EN05!
DNA!replication! 9! 11! 3.20EN11!
Cell!cycle! 9! 16! 1.60EN08!
Spliceosome! 10! 9! 2.80EN06!
Ribosome! 11! 11! 1.80EN10!
Ribosome! 14! 14! 1.30EN15!
Ribosome! 15! 6! 2.20EN06!
,
Caucasian,
KEGG,pathway, PC, NG.observed, P,value,
RNA!transport! 1! 44! 3.20EN06!
Citrate!cycle!(TCA!cycle)! 1! 13! 7.60EN06!
Oxidative!phosphorylation! 2! 26! 3.10EN07!
Parkinson's!disease! 2! 26! 3.10EN07!
Ribosome! 2! 20! 1.40EN05!
Huntington's!disease! 2! 30! 2.20EN05!
Huntington's!disease! 5! 33! 1.00EN06!
DNA!replication! 6! 11! 1.40EN09!
Cell!cycle! 6! 20! 1.70EN08!
Spliceosome! 6! 16! 1.40EN06!
Ribosome! 7! 13! 5.00EN10!
Cell!cycle! 7! 11! 4.80EN06!
Ribosome! 10! 10! 8.70EN12!
Glycolysis!/!Gluconeogenesis! 14! 6! 3.40EN08!
Protein!processing!in!endoplasmic!reticulum! 16! 6! 2.50EN06!




that! 9! enriched! pathways,! including! cellular! components! “Spliceosome”,!
“Proteasome”! and! “Ribosome”,! disease! pathways! “Parkinson's! disease”,!
“Huntington's! disease”,! “Alzheimer's! disease”! and! cellular! functions! “Oxidative!
phosphorylation”,! “DNA! replication”! and! “Protein! processing! in! endoplasmic!
reticulum”,! are! replicated! between! results! from! Yoruba! Yale! and! Yoruba! Argonne!
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data! that! are! datasets! from! the! same! Yoruba! individuals.! We! also! observed! that!
some!KEGG!pathway! terms!are!enriched! in! trans' target!genes!of!multiple!PCs.! For!




Argonne! data.! In! table! 5.2!we! observed! that! three! pathways! are! only! enriched! in!
trans' target! genes! from! Caucasian! data,! including! “Glycolysis/Gluconeogenesis”,!
“Citrate! cycle! (TCA! cycle)”! and! “RNA! transport”.! We! also! found! that! 7! KEGG!
pathways! “DNA! replication”,! "Ribosome",! “Spliceosome”,! “Protein! processing! in!







KEGG, Yoruba.Yale, Yoruba.Argonne, Caucasian,
Ribosome! 8,13! 8,11,14,15! 2,7,10,18!
Protein!processing!in!endoplasmic!reticulum! 14,18! 7,8! 16!
DNA!replication! 7! 9! 6!
Spliceosome! 7! 6,10! 6!
Proteasome! 7! 7! N!
Oxidative!phosphorylation! 5! 5! 2!
Alzheimer's!disease! 5,7! 5! N!
Parkinson's!disease! 5,7! 5! 2!
Huntington's!disease! 5,7! 5! 2,5!
Pyrimidine!metabolism! 7! N! N!
Cell!cycle! N! 9! 6,7!
Fatty!acid!metabolism! N! 1! N!
Metabolic!pathways! N! 1! N!
RNA!polymerase! N! 7! N!
Nucleotide!excision!repair! N! 6! N!
Peroxisome! N! 1! N!
Renal!cell!carcinoma! N! 7! N!
Glycolysis!/!Gluconeogenesis! N! N! 14!
Citrate!cycle!(TCA!cycle)! N! N! 1!
RNA!transport! N! N! 1!
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To! examine! whether! enrichments! of! KEGG! pathways! can! be! observed! in! random!
sets!of!genes,!enrichment!tests!for!KEGG!pathways!were!carried!out!in!control!genes!
using! hypergeometric! test.! We! defined! control! genes! as! the! expressed! genes!
without!any!TF!bound!in!their!promoter!regions,!and!identified!2119,!2260!and!1216!
control!genes! from!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data,! respectively.!
From! the! results! we! did! not! observe! any! enriched! KEGG! pathway! in! the! control!
genes!from!either!dataset!at! the!significance!threshold!2.4!×!10N4!corrected!for!the!
number! of! tests,! suggesting! that! enrichments! of! KEGG! pathways! in! trans! target!
genes!are!not!likely!due!to!random!chance.!
We! identified!158!genes!that!are!annotated!with!“Alzheimer's!disease”!from!KEGG!
pathway! database! with! 51%! of! them! encoding! proteins! with! mitochondrial!
localization!based!on! the! the! list! of! 1023!human!mitochondrial! genes!provided!by!
Pagliarini!et.al!(2008).!We!also!identified!127!“Parkinson's!disease”!genes!with!66%!
of! them! encoding! proteins!with!mitochondrial! localization,! and! 177! “Huntington's!
disease”!genes!with!50%!of!them!encoding!proteins!with!mitochondrial!localization.!
There! are! 89! genes! that! are! shared! among! these! 3! pathways! with! 84%! of! them!
encoding! proteins! with! mitochondrial! localization,! suggesting! that! proteins! with!
mitochondrial! localization! may! play! important! roles! in! Alzheimer's! disease,!
Parkinson's! disease! and!Huntington's! disease.! In! table! 5.2!we!observed! that! KEGG!
pathways! “Huntington's! disease”,! “Alzheimer's! disease”! and! “Parkinson's! disease”!










of! PC5! from!Yoruba!Argonne!data.!We! showed! in! table! 5.3! that! 8! genes! (ATP5F1,'
ATP5G2,' COX5A,' COX5B,' COX6C,' NDUFA2,' NDUFC1,' UQCRC1)! are! shared! between!
the!18!genes! from!Yoruba!Yale!data!and! the!19!genes! from!Yoruba!Argonne!data,!
which!are!all!genes!encoding!proteins!with!mitochondrial!localization.!We!observed!
that! some!of! these!genes!are!encoding! subunits!of!ATP! synthase! (ATP5A1,'ATP5B,'
ATP5E,' ATP5F1,' ATP5G2,' ATP5G3,' ATP5O),! subunits! of! cytochrome! c! oxidase!
(COX4I1,'COX5A,'COX5B,'COX6C,'COX7A2,'COX7B,'COX7C,'CYC1,'CYCS),! subunits!of!
NADH! dehydrogenase! (NDUFA2,' NDUFA4,' NDUFA8,' NDUFB3,' NDUFB5,' NDUFB6,'




×! 10N5)! or! Yoruba! Argonne! data! (84! genes,! P! =! 2.4! ×! 10N4),! suggesting! that!
mitochondrial! localization!may!have!an! important! role! in! the! functions!of!proteins!
encoded!by!trans'target!genes!from!datasets!of!Yoruba!individuals.!!
In! conclusion,!multiple! enrichments! of! KEGG! pathway! terms! in! trans' target! genes!






associated! with! trans&regulated! genes.! These! functional! enrichments! further!
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support! that! coNvariations! of! trans' target! genes! could! originate! from! trans&acting!
effects! rather! than! batch! effects.! They! also! suggest! possible! phenotypic!


























ATP5O! ATP!synthase,!H+!transporting,!mitochondrial!F1!complex,!O!subunit!! Y! N!
COX4I1! cytochrome!c!oxidase!subunit!IV!isoform!1!! N! A!
COX5A! cytochrome!c!oxidase!subunit!Va!! Y! A!
COX5B! cytochrome!c!oxidase!subunit!Vb!! Y! A!
COX6C! cytochrome!c!oxidase!subunit!VIc!! Y! A!
COX7A2! cytochrome!c!oxidase!subunit!VIIa!polypeptide!2!(liver)!! Y! N!
COX7B! cytochrome!c!oxidase!subunit!VIIb!! Y! N!
COX7C! cytochrome!c!oxidase!subunit!VIIc!! N! A!
CYC1! cytochrome!cN1!! N! A!
CYCS! cytochrome!c,!somatic!! N! A!
NDUFA2! NADH!dehydrogenase!(ubiquinone)!1!alpha!subcomplex,!2,!8kDa!! Y! A!
NDUFA4! NADH!dehydrogenase!(ubiquinone)!1!alpha!subcomplex,!4,!9kDa!! Y! N!
NDUFA8! NADH!dehydrogenase!(ubiquinone)!1!alpha!subcomplex,!8,!19kDa!! N! A!
NDUFB3! NADH!dehydrogenase!(ubiquinone)!1!beta!subcomplex,!3,!12kDa!! Y! N!
NDUFB5! NADH!dehydrogenase!(ubiquinone)!1!beta!subcomplex,!5,!16kDa!! Y! N!
NDUFB6! NADH!dehydrogenase!(ubiquinone)!1!beta!subcomplex,!6,!17kDa!! Y! N!
NDUFB7! NADH!dehydrogenase!(ubiquinone)!1!beta!subcomplex,!7,!18kDa!! N! A!










SDHA! succinate!dehydrogenase!complex,!subunit!A,!flavoprotein!(Fp)!! N! A!




identified! from! section! 4.3! and! trans' target! genes! identified! from! section! 3.6,!
suggesting! that! the! same! trans' effects! can! be! detected! using! two! different!
approaches.!Moreover,! In! section! 4.3.2! we! observed! that! the! group! of! candidate!
genes! with! shared! bound! TFs! "ELF1,SP1,TAF1,YY1"! are! significant! in! correlation!
comparisons! from! all! three! datasets,! suggesting! that! it! is! the! most! replicable!
combination! of! TFs! with! trans' effects! detected! from! three! different! datasets.!
However,!whether!do!these!candidate!genes!share!the!same!functional!enrichments!
with! trans' target! genes! is! still! unknown.! In! this! section! we! aimed! to! study! the!
functional! implications! of! candidate! genes.! We! proposed! the! hypothesis! that! if!
stronger! coNvariations! between! candidate! genes! and! seed! genes! are! caused! by!
trans&acting!effects! from!TFs,!some!biological!pathways!could!be!enriched! in! these!
candidate! genes.! If! trans' target! genes! and! candidate! genes! are! influenced! by! the!
same! trans' effects,! it! is! possible! that! enrichments! of! some! pathways! should! be!
shared!between!candidate!genes!and!trans'target!genes.!
We! performed! enrichment! tests! for! genes! annotated! by! KEGG! pathway! terms! by!
hypergeometric! test! in! the! group! of! candidate! genes! with! shared! bound! TFs!




the! 10! KEGG! pathways! that! are! significantly! enriched! in! candidate! genes! from!
Yoruba! Yale! data,! 10! enriched! KEGG! pathways! from! Yoruba! Argonne! data,! and! 7!
enriched! pathways! from! Caucasian! data.! Comparing! the! enriched! pathways! in!
candidate!genes!identified!in!each!dataset,!we!observed!that!the!same!10!enriched!
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pathways! “Ribosome”,! “Spliceosome”,! “RNA! transport”,! “Protein! processing! in!
endoplasmic! reticulum”,! “RNA! degradation”,! “Huntington! disease”,! “Terpenoid!
backbone! biosynthesis”,! “Basal! transcription! factors”,! “AminoacylNtRNA!
biosynthesis”,!and!“Proteasome”!are!shared!between!Yoruba!Yale!data!and!Yoruba!
Argonne!data,!and!the!same!7!enriched!pathways!“Ribosome”,!“Spliceosome”,!“RNA!
transport”,! “RNA! degradation”,! “Terpenoid! backbone! biosynthesis”,! “Protein!
processing! in!endoplasmic! reticulum”,! and! “Basal! transcription! factors”! are! shared!
among! all! datasets,! suggesting! that! trans&regulation! of! TFs! on! candidate! genes!
identified!from!different!populations!may!have!the!same!phenotypic!consequences.!
5! of! these! pathways! (“Ribosome”,! “Spliceosome”,! “Protein! processing! in!
endoplasmic! reticulum”,! “Huntington's! disease”! and! “Proteasome”)! enriched! in!




In! conclusion,! we! observed!multiple! enrichments! of! KEGG! pathways! in! candidate!
genes,! suggesting! that! coNvariations! of! candidate! genes! could! be! caused! by! trans'
effects! of! biological! origin.! Batch! effects! are! not! likely! the! cause! since! they! are!
expected! to! be! independent! of! any! functional! pathway.! These! functional!
















































genes!of! the!same!phenotype!or!disease! tend! to! interact.!Therefore,!we!proposed!
the!hypothesis!that!if!trans'target!genes!have!related!functions,!proteins!encoded!by!





We! used! the! DAPPLE! version! 2.0! (http://www.broadinstitute.org/mpg/dapple/!
dappleTMP.php)! to! test! whether! proteins! encoded! in! each! group! of! trans' target!
genes!are!more!connected!by!PPIs!than!chance!expectation.!Both!direct!and!indirect!
PPI! network!were!built! from!proteins! encoded!by! the! group!of! trans' target! genes!
under! test.! In! the!direct!PPI!network,!where! input!proteins! are!directly! connected!
with!each!other!by!PPIs,!“Direct.Edge”! (the!number!of!direct!connections!between!
input! proteins)! and! “Direct.Degree”! (the! average! direct! binding! degree! of! input!
proteins)! were! measured! to! quantify! its! network! connectivity.! In! the! indirect! PPI!
network,! where! two! input! proteins! can! be! indirectly! connected! by! a! common!






In! Table! 5.5! we! summarized! DAPPLE! results,! which! are! values! of! four! network!
statistics! “Direct.Edge”,! “Direct.Degree”,! “Indirect.Degree”! and! “CI.Degree”! from!
proteins! encoded! by! each! group! of! trans' target! genes,! and! their! corresponding! P!
values! estimated! by! 1000! permutations.! Significance! threshold! was! set! to! be! P! <!
0.0025!corrected!for!20!groups!of!trans'target!genes!from!each!dataset.!We!found!
that!proteins!encoded!by!17!of!20!groups!of!trans'target!genes!(PC2!to!PC16,!PC19!
and! PC20)! from! Yoruba! Yale! data! are! more! connected! by! PPIs! than! chance!
expectation! supported! by! at! least! one! significant! network! statistic.! For! Yoruba!
Argonne!data!we!observed!that!15!groups!of!trans'target!genes!(PC1,!PC3!to!PC14,!
PC16! and! PC17)! are! supported! by! at! least! one! significant! network! statistic.!
Comparing!results!from!Yoruba!Yale!and!Yoruba!Argonne!data!we!found!that!trans'
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target!genes!of!PC3! to!PC14!and!PC16!are! replicated,! suggesting! that! they!are! coN
varying! genes! due! to! biological! trans' effects! rather! than! batch! effects.! From!
Caucasian!data!proteins!encoded!by!14!groups!of!trans'target!genes! (PC2!to!PC12,!
PC14,! PC18! and! PC19)! are! more! connected! by! PPIs! than! chance! expectation!
supported! by! at! least! one! significant! network! statistic.! These! results! show! that!
proteins!encoded!by!most!groups!of!trans'target!genes!are!more!connected!by!PPIs!











Direct.Edge, Direct.Degree, Indirect.Degree, CI.Degree,
N, P, N, P, N, P, N, P,
1! 691! 1312, 0.004, 3.8, 0.016, 191.4, 0.066, 5.5, 0.004,
2! 472! 923, 0.033, 3.9, 0.009, 218.8, 0.001*, 5.2, 0.003,
3! 583! 1270, 0.001*, 4.4, 0.007, 231.8, 0.336, 5.5, 0.12,
4! 790! 2470, 0.001*, 6.3, 0.001*, 433.9, 0.001*, 7.2, 0.001*,
5! 260! 440, 0.047, 3.4, 0.019, 191.5, 0.001*, 4.6, 0.001*,
6! 551! 1291, 0.001*, 4.7, 0.011, 331, 0.001*, 6.1, 0.001*,
7! 727! 2895, 0.002*, 8, 0.002*, 642.9, 0.002*, 7.8, 0.002*,
8! 129! 340, 0.001*, 5.3, 0.001*, 376.4, 0.001*, 4.8, 0.001*,
9! 53! 56, 0.007, 2.1, 0.086, 97.25, 0.003, 3.3, 0.001*,
10! 116! 184, 0.001*, 3.2, 0.01, 200.6, 0.001*, 4, 0.001*,
11! 90! 139, 0.047, 3.1, 0.051, 233.6, 0.001*, 4, 0.001*,
12! 97! 147, 0.01, 3, 0.16, 205.3, 0.001*, 3.9, 0.003,
13! 51! 122, 0.001*, 4.8, 0.001*, 342.4, 0.001*, 4.4, 0.001*,
14! 30! 51, 0.001*, 3.4, 0.001*, 182.1, 0.001*, 3.4, 0.001*,
15! 19! 16, 0.019, 1.7, 0.066, 70.96, 0.001*, 2.9, 0.003,
16! 17! 15, 0.001*, 1.8, 0.051, 87.33, 0.001*, 2.8, 0.005,
17! 23! 20, 0.103, 1.7, 0.464, 86.2, 0.009, 2.7, 0.103,
18! 16! 11, 0.044, 1.4, 0.277, 36.62, 0.007, 2.4, 0.046,
19! 10! 7, 0.083, 1.4, 0.103, 62.28, 0.001*, 2.6, 0.003,




! ! Direct.Edge,,,,! Direct.Degree! Indirect.Degree! CI.Degree!
PC, N.gene, N, P, N, P, N, P, N, P,
1! 679! 768! 0.001*! 3.4! 0.049! 177.4! 0.045! 4.8! 0.002*!
2! 595! 419! 0.702! 2.7! 0.199! 115.4! 0.439! 4.2! 0.006!
3! 841! 1450! 0.002*! 4.5! 0.186! 257.8! 0.598! 5.8! 0.007!
4! 900! 3158! 0.001*! 7.0! 0.001*! 428.1! 0.109! 7.6! 0.001*!
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5! 625! 963! 0.001*! 4.6! 0.002*! 282.9! 0.001*! 5.6! 0.001*!
6! 801! 1783! 0.001*! 6! 0.001*! 383.9! 0.001*! 6.7! 0.001*!
7! 605! 1224! 0.001*! 5.6! 0.001*! 346.2! 0.001*! 5.9! 0.001*!
8! 214! 152! 0.024! 2.9! 0.037! 155.4! 0.001*! 4! 0.001*!
9! 259! 412! 0.001*! 4.9! 0.001*! 331.6! 0.001*! 5.3! 0.001*!
10! 140! 97! 0.007! 2.9! 0.019! 152.2! 0.001*! 3.6! 0.001*!
11! 125! 168! 0.001*! 4.9! 0.001*! 314.2! 0.001*! 4.6! 0.001*!
12! 107! 77! 0.027! 2.7! 0.107! 171.2! 0.001*! 3.6! 0.001*!
13! 64! 31! 0.001*! 2.2! 0.014! 94.53! 0.001*! 2.9! 0.013!
14! 67! 99! 0.001*! 6.8! 0.001*! 388.6! 0.001*! 4.6! 0.001*!
15! 37! 7! 0.31! 1.3! 0.537! 73.19! 0.003! 2.8! 0.008!
16! 55! 29! 0.001*! 2.4! 0.008! 99.48! 0.001*! 3! 0.001*!
17! 58! 35! 0.001*! 2.7! 0.004! 129.4! 0.001*! 3.4! 0.001*!
18! 42! 3! 0.628! 1.2! 0.347! 22.44! 0.035! 2.3! 0.13!
19! 67! 24! 0.005! 2.2! 0.013! 68.35! 0.007! 2.9! 0.015!
20! 22! 3! 0.5! 1.2! 0.561! 35.88! 0.003! 2.3! 0.041!
,
Caucasian,
! ! Direct.Edge,,,,! Direct.Degree! Indirect.Degree! CI.Degree!
PC, N.gene, N, P, N, P, N, P, N, P,
1! 1108! 4195! 0.006! 7.6! 0.006! 560.1! 0.006! 8.3! 0.006!
2! 445! 1149! 0.003! 5.2! 0.001*! 387.2! 0.001*! 6! 0.001*!
3! 476! 1213! 0.001*! 5.1! 0.001*! 348.8! 0.001*! 5.8! 0.001*!
4! 187! 314! 0.052! 3.4! 0.01! 178.9! 0.001*! 4.3! 0.002*!
5! 585! 1745! 0.001*! 6! 0.002*! 429.3! 0.001*! 6.6! 0.001*!
6! 234! 811! 0.001*! 6.9! 0.001*! 516.6! 0.001*! 6.1! 0.001*!
7! 90! 189! 0.001*! 4.2! 0.001*! 279.6! 0.001*! 4.4! 0.001*!
8! 36! 36! 0.117! 2! 0.058! 81.03! 0.002! 3.1! 0.001*!
9! 88! 149! 0.001*! 3.4! 0.001*! 180.6! 0.001*! 4! 0.001*!
10! 21! 56! 0.001*! 5.3! 0.001*! 279.9! 0.001*! 4.7! 0.001*!
11! 16! 23! 0.001*! 2.9! 0.001*! 128.5! 0.001*! 3.3! 0.001*!
12! 5! 4! 0.82! 1.6! 0.246! 67.93! 0.001*! 2.5! 0.016!
13! 11! 8! 0.22! 1.5! 0.34! 46.17! 0.098! 2.5! 0.236!
14! 40! 37! 0.109! 1.8! 0.32! 138.3! 0.001*! 3.1! 0.002*!
15! 4! 2! 0.608! 1! 0.881! 17.65! 0.032! 2.3! 0.079!
16! 13! 12! 0.236! 1.8! 0.169! 76.29! 0.026! 2.6! 0.141!
17! 6! 3! 0.375! 1! 0.909! 36.6! 0.072! 2.2! 0.519!
18! 23! 73! 0.001*! 6.3! 0.001*! 399.5! 0.001*! 4.3! 0.001*!
19! 12! 10! 0.012! 1.7! 0.054! 58.84! 0.001*! 2.5! 0.002*!
20! 2! 1! 0.517! 1! 0.517! 6.5! 0.56! 2! 0.693!
!
!
To! further! support! that! trans! target! genes! from! different! datasets! have! similar!
functions,!we! tested!whether! there! is! significant! amount! of! overlapped! PPIs! from!
proteins!encoded!by!trans!target!genes!from!two!datasets!using!Fisher’s!exact!test.!
In!Table!5.6!we!observed!that! there!are!22!significant!overlaps!between!PPIs! from!
proteins! encoded! by! trans! target! genes! from! Yoruba! Yale! data! and! PPIs! from!
proteins!encoded!by!trans!target!genes!from!Yoruba!Argonne!data.!The!numbers!of!
overlapped! PPIs! range! from! 2! to! 807! accounting! for! 1.4%! to! 32.7%! of! PPIs! from!
! 111!
proteins!encoded!by!trans!target!genes!from!Yoruba!Yale!data,!and!1.7%!to!34.9%!of!
PPIs! from! proteins! encoded! by! trans! target! genes! from! Yoruba! Argonne! data.!
Besides,!we!observed!17! significant!overlaps!between!PPIs! from!proteins! encoded!
by! trans! target! genes! from! Yoruba! Yale! data! and! PPIs! from! proteins! encoded! by!
trans! target! genes! from! Caucasian! data.! Among! these! overlaps! the! numbers! of!
overlapped! PPIs! range! from! 4! to! 218! accounting! for! 1.3%! to! 13.9%! of! PPIs! from!
proteins!encoded!by!trans!target!genes!from!Yoruba!Yale!data,!and!1%!to!17.9%!of!
PPIs!from!proteins!encoded!by!trans!target!genes!from!Caucasian!data.!These!results!
suggest! that! there! is! significant! amount!of! overlapped!PPIs! between!PPI! networks!
built! from! proteins! encoded! by! trans! target! genes! from! datasets! of! technical!






Groups! of! trans! target! genes! are! listed! in! the! “PC”! column.! “N”! is! the! number! of! PPIs!
observed! from! proteins! encoded! by! a! group! of! trans! target! genes.! “Percentage”! is! the!





PC, N, Percentage, PC, N, Percentage, N, P,value,
1! 1312! 13.30%! 1! 768! 22.70%! 174! 1.80EN235!
1! 1312! 5.40%! 3! 1450! 4.90%! 71! 5.20EN28!
2! 923! 2.40%! 1! 768! 2.90%! 22! 3.00EN06!
2! 923! 8.80%! 2! 419! 19.30%! 81! 1.20EN112!
2! 923! 3.10%! 3! 1450! 2%! 29! 8.20EN05!
3! 1270! 15.60%! 3! 1450! 13.70%! 198! 8.60EN211!
4! 2471! 32.70%! 4! 3159! 25.50%! 807! 1EN954!
5! 440! 13%! 5! 963! 5.90%! 57! 3.40EN62!
6! 1291! 19.10%! 6! 1783! 13.80%! 246! 2.70EN254!
7! 2898! 4.70%! 6! 1783! 7.60%! 135! 2.30EN31!
7! 2898! 14.80%! 7! 1226! 34.90%! 428! 1EN471!
7! 2898! 1.40%! 9! 412! 9.70%! 40! 5.60EN14!
8! 340! 6.20%! 7! 1226! 1.70%! 21! 5.20EN11!
8! 340! 2.10%! 8! 152! 4.60%! 7! 5.60EN08!
8! 340! 1.80%! 11! 168! 3.60%! 6! 8.20EN06!
10! 184! 6.50%! 9! 412! 2.90%! 12! 2.10EN14!
10! 184! 2.70%! 10! 97! 5.20%! 5! 4.20EN08!
11! 139! 4.30%! 14! 99! 6.10%! 6! 5.00EN10!
! 112!
12! 147! 4.80%! 9! 412! 1.70%! 7! 1.20EN07!
13! 122! 2.50%! 14! 99! 3%! 3! 3.20EN05!
14! 51! 3.90%! 17! 35! 5.70%! 2! 7.80EN05!




PC, N, Percentage, PC, N, Percentage, N, P,value,
1, 1312, 12%, 1, 4195, 3.70%, 157, 1.90EN52,
2, 923, 8.90%, 1, 4195, 2%, 82, 2.80EN12,
3, 1270, 9.50%, 1, 4195, 2.90%, 121, 1.60EN19,
4, 2471, 2.80%, 2, 1150, 6%, 69, 7.50EN11,
4, 2471, 1.30%, 4, 314, 9.90%, 31, 1.90EN11,
5, 440, 4.10%, 2, 1150, 1.60%, 18, 8.60EN06,
6, 1291, 4.10%, 3, 1213, 4.40%, 53, 1.80EN16,
7, 2898, 7.50%, 1, 4195, 5.20%, 218, 7.20EN09,
7, 2898, 5.90%, 5, 1745, 9.80%, 171, 9.40EN46,
7, 2898, 1.90%, 6, 811, 6.70%, 54, 2.00EN09,
8, 340, 2.90%, 10, 56, 17.90%, 10, 5.10EN18,
8, 340, 3.20%, 18, 73, 15.10%, 11, 1.20EN19,
10, 184, 2.20%, 9, 149, 2.70%, 4, 6.00EN05,
11, 139, 5.80%, 6, 811, 1%, 8, 1.50EN06,
12, 147, 7.50%, 6, 811, 1.40%, 11, 7.40EN09,
13, 122, 13.90%, 6, 811, 2.10%, 17, 2.70EN19,










38! out! of! 44! trans' target! genes! encoding! interacting! proteins! from! pathway!
“Oxidative! phosphorylation”,! and! 36! out! of! 49! trans' target! genes! encoding!
interacting! proteins! from! “Protein! processing! in! endoplasmic! reticulum”.! These!
results! support! our! claim! that! PPIs! may! contribute! to! the! potential! phenotypic!









ID, geneID, description, Yoruba,Yale,
Yoruba,
Argonne, Caucasian, PPI,
1! ALYREF! Aly/REF!export!factor!! N! N! C! N!
2! AQR! aquarius!intronNbinding!spliceosomal!factor!! N! A! N! N!
3! BCAS2! breast!carcinoma!amplified!sequence!2!! Y! N! N! P!
4! BUD31! BUD31!homolog!(S.!cerevisiae)!! N! A! N! P!
5! CCDC12! coiledNcoil!domain!containing!12!! Y! N! N! P!
6! CDC5L! cell!division!cycle!5Nlike!! Y! A! N! P!
7! CRNKL1! crooked!neck!preNmRNA!splicing!factor!1!! Y! N! N! P!
8! DDX23! DEAD!(AspNGluNAlaNAsp)!box!polypeptide!23!! N! A! C! P!
9! DDX46! DEAD!(AspNGluNAlaNAsp)!box!polypeptide!46!! Y! N! C! P!
10! DHX15! DEAH!(AspNGluNAlaNHis)!box!helicase!15!! N! N! C! P!
11! DHX38! DEAH!(AspNGluNAlaNHis)!box!polypeptide!38!! N! A! C! P!
12! EFTUD2! elongation!factor!Tu!GTP!binding!domain!
containing!2!!
N! N! C! P!
13! HNRNPC! heterogeneous!nuclear!ribonucleoprotein!C!
(C1/C2)!!
Y! A! N! P!
14! HNRNPK! heterogeneous!nuclear!ribonucleoprotein!K!! Y! N! N! P!
15! HNRNPM! heterogeneous!nuclear!ribonucleoprotein!M!! Y! N! C! P!
16! HNRNPU! heterogeneous!nuclear!ribonucleoprotein!U!
(scaffold!attachment!factor!A)!!
N! A! N! P!
17! HSPA8! heat!shock!70kDa!protein!8!! N! A! N! P!
18! LSM3! LSM3!homolog,!U6!small!nuclear!RNA!associated!
(S.!cerevisiae)!!
Y! N! N! P!
19! LSM4! LSM4!homolog,!U6!small!nuclear!RNA!associated!
(S.!cerevisiae)!!
Y! N! N! P!
20! LSM6! LSM6!homolog,!U6!small!nuclear!RNA!associated!
(S.!cerevisiae)!!
N! A! N! P!
21! MAGOH! magoNnashi!homolog,!proliferationNassociated!
(Drosophila)!!
Y! N! N! P!
22! MAGOHB! magoNnashi!homolog!B!(Drosophila)!! Y! N! N! P!
23! NHP2L1! NHP2!nonNhistone!chromosome!protein!2Nlike!1!
(S.!cerevisiae)!!
Y! A! N! P!
24! PCBP1! poly(rC)!binding!protein!1!! N! A! N! P!
25! PHF5A! PHD!finger!protein!5A!! Y! N! N! P!
26! PLRG1! pleiotropic!regulator!1!! Y! N! N! P!
27! PPIH! peptidylprolyl!isomerase!H!(cyclophilin!H)!! Y! A! N! N!
28! PRPF19! preNmRNA!processing!factor!19!! Y! N! C! P!
29! PRPF40A! PRP40!preNmRNA!processing!factor!40!homolog!
A!(S.!cerevisiae)!!
N! A! N! P!
30! PRPF40B! PRP40!preNmRNA!processing!factor!40!homolog!
B!(S.!cerevisiae)!!
N! A! N! P!
31! RBMX! RNA!binding!motif!protein,!XNlinked!! N! A! N! P!
32! SART1! squamous!cell!carcinoma!antigen!recognized!by!
T!cells!!
N! N! C! P!
33! SF3A2! splicing!factor!3a,!subunit!2,!66kDa!! Y! A! N! P!
34! SF3A3! splicing!factor!3a,!subunit!3,!60kDa!! Y! N! N! P!
35! SF3B1! splicing!factor!3b,!subunit!1,!155kDa!! Y! A! N! P!
36! SF3B2! splicing!factor!3b,!subunit!2,!145kDa!! N! N! C! P!
37! SF3B3! splicing!factor!3b,!subunit!3,!130kDa!! Y! N! C! P!
38! SF3B6! splicing!factor!3b,!subunit!6,!14kDa!! Y! A! N! N!
39! SMNDC1! survival!motor!neuron!domain!containing!1!! N! A! N! P!
40! SNRNP40! small!nuclear!ribonucleoprotein!40kDa!(U5)!! Y! N! N! P!
41! SNRNP70! small!nuclear!ribonucleoprotein!70kDa!(U1)!! N! A! C! P!
42! SNRPA! small!nuclear!ribonucleoprotein!polypeptide!A!! N! A! N! P!
43! SNRPA1! small!nuclear!ribonucleoprotein!polypeptide!A'!! N! A! N! P!
44! SNRPB! small!nuclear!ribonucleoprotein!polypeptides!B!
and!B1!!
Y! N! N! P!
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45! SNRPB2! small!nuclear!ribonucleoprotein!polypeptide!B!! N! A! N! P!
46! SNRPC! small!nuclear!ribonucleoprotein!polypeptide!C!! Y! N! N! P!
47! SNRPD1! small!nuclear!ribonucleoprotein!D1!polypeptide!
16kDa!!
Y! N! N! P!
48! SNRPD2! small!nuclear!ribonucleoprotein!D2!polypeptide!
16.5kDa!!
Y! A! N! P!
49! SNRPD3! small!nuclear!ribonucleoprotein!D3!polypeptide!
18kDa!!
Y! N! N! P!
50! SNRPE! small!nuclear!ribonucleoprotein!polypeptide!E!! N! A! N! P!
51! SRSF1! serine/arginineNrich!splicing!factor!1!! N! A! C! N!
52! SRSF5! serine/arginineNrich!splicing!factor!5!! N! A! N! N!
53! SRSF6! serine/arginineNrich!splicing!factor!6!! Y! A! N! N!
54! SRSF7! serine/arginineNrich!splicing!factor!7!! Y! N! C! N!
55! TCERG1! transcription!elongation!regulator!1!! N! A! N! P!
56! THOC1! THO!complex!1!! N! A! N! N!
57! TRA2B! transformer!2!beta!homolog!(Drosophila)!! Y! N! N! P!
58! U2AF1! U2!small!nuclear!RNA!auxiliary!factor!1!! N! N! C! P!
59! U2AF2! U2!small!nuclear!RNA!auxiliary!factor!2!! N! A! C! P!
60! U2SURP! U2!snRNPNassociated!SURP!domain!containing!! N! A! N! N!
61! USP39! ubiquitin!specific!peptidase!39!! Y! N! N! P!
62! WBP11! WW!domain!binding!protein!11!! N! A! N! P!
!
Oxidative,phosphorylation,







Y! N! N! P!
2! ATP5B! ATP!synthase,!H+!transporting,!mitochondrial!F1!
complex,!beta!polypeptide!!
N! A! C! P!
3! ATP5D! ATP!synthase,!H+!transporting,!mitochondrial!F1!
complex,!delta!subunit!!
N! N! C! P!
4! ATP5E! ATP!synthase,!H+!transporting,!mitochondrial!F1!
complex,!epsilon!subunit!!
N! A! N! P!
5! ATP5F1! ATP!synthase,!H+!transporting,!mitochondrial!Fo!
complex,!subunit!B1!!
Y! A! N! P!
6! ATP5G2! ATP!synthase,!H+!transporting,!mitochondrial!Fo!
complex,!subunit!C2!(subunit!9)!!
Y! A! C! P!
7! ATP5G3! ATP!synthase,!H+!transporting,!mitochondrial!Fo!
complex,!subunit!C3!(subunit!9)!!
Y! N! N! P!
8! ATP5I! ATP!synthase,!H+!transporting,!mitochondrial!Fo!
complex,!subunit!E!!
Y! N! C! P!
9! ATP5O! ATP!synthase,!H+!transporting,!mitochondrial!F1!
complex,!O!subunit!!
Y! N! C! P!
10! ATP6V0A1! ATPase,!H+!transporting,!lysosomal!V0!subunit!a1!! N! A! N! P!
11! ATP6V0A2! ATPase,!H+!transporting,!lysosomal!V0!subunit!a2!! Y! N! N! N!
12! ATP6V0B! ATPase,!H+!transporting,!lysosomal!21kDa,!V0!
subunit!b!!
N! N! C! N!
13! ATP6V1B2! ATPase,!H+!transporting,!lysosomal!56/58kDa,!V1!
subunit!B2!!
N! A! N! P!
14! ATP6V1D! ATPase,!H+!transporting,!lysosomal!34kDa,!V1!
subunit!D!!
N! N! C! P!
15! ATP6V1E1! ATPase,!H+!transporting,!lysosomal!31kDa,!V1!
subunit!E1!!
N! A! C! P!
16! COX11! COX11!cytochrome!c!oxidase!copper!chaperone!! N! N! C! N!
17! COX4I1! cytochrome!c!oxidase!subunit!IV!isoform!1!! N! A! C! P!
18! COX5A! cytochrome!c!oxidase!subunit!Va!! Y! A! C! P!
19! COX5B! cytochrome!c!oxidase!subunit!Vb!! Y! A! C! P!
20! COX6A1! cytochrome!c!oxidase!subunit!VIa!polypeptide!1!! N! N! C! P!
21! COX6B1! cytochrome!c!oxidase!subunit!VIb!polypeptide!1!
(ubiquitous)!!
N! N! C! P!
22! COX6C! cytochrome!c!oxidase!subunit!VIc!! Y! A! C! P!
23! COX7A2! cytochrome!c!oxidase!subunit!VIIa!polypeptide!2!
(liver)!!
Y! N! C! N!
24! COX7A2L! cytochrome!c!oxidase!subunit!VIIa!polypeptide!2!
like!!
N! N! C! P!
25! COX7B! cytochrome!c!oxidase!subunit!VIIb!! Y! N! N! P!
! 115!
26! COX7C! cytochrome!c!oxidase!subunit!VIIc!! N! A! C! P!
27! CYC1! cytochrome!cN1!! N! A! N! P!
28! NDUFA1! NADH!dehydrogenase!(ubiquinone)!1!alpha!
subcomplex,!1,!7.5kDa!!
N! N! C! P!
29! NDUFA2! NADH!dehydrogenase!(ubiquinone)!1!alpha!
subcomplex,!2,!8kDa!!
Y! A! C! P!
30! NDUFA4! NDUFA4,!mitochondrial!complex!associated!! Y! N! C! P!
31! NDUFA8! NADH!dehydrogenase!(ubiquinone)!1!alpha!
subcomplex,!8,!19kDa!!
N! A! N! P!
32! NDUFB11! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!11,!17.3kDa!!
N! N! C! P!
33! NDUFB3! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!3,!12kDa!!
Y! N! N! P!
34! NDUFB4! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!4,!15kDa!!
N! N! C! P!
35! NDUFB5! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!5,!16kDa!!
Y! N! C! P!
36! NDUFB6! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!6,!17kDa!!
Y! N! N! P!
37! NDUFB7! NADH!dehydrogenase!(ubiquinone)!1!beta!
subcomplex,!7,!18kDa!!
N! A! N! P!
38! NDUFC1! NADH!dehydrogenase!(ubiquinone)!1,!subcomplex!
unknown,!1,!6kDa!!
Y! A! N! P!
39! NDUFS3! NADH!dehydrogenase!(ubiquinone)!FeNS!protein!3,!
30kDa!(NADHNcoenzyme!Q!reductase)!!
N! A! N! P!
40! NDUFS4! NADH!dehydrogenase!(ubiquinone)!FeNS!protein!4,!
18kDa!(NADHNcoenzyme!Q!reductase)!!
Y! N! N! P!
41! NDUFS7! NADH!dehydrogenase!(ubiquinone)!FeNS!protein!7,!
20kDa!(NADHNcoenzyme!Q!reductase)!!
N! A! N! P!
42! PPA1! pyrophosphatase!(inorganic)!1!! N! N! C! N!
43! SDHA! succinate!dehydrogenase!complex,!subunit!A,!
flavoprotein!(Fp)!!
N! A! N! N!
44! UQCRC1! ubiquinolNcytochrome!c!reductase!core!protein!I!! Y! A! C! P!
,
Protein,processing,in,endoplasmic,reticulum,
ID! geneID! description! Yoruba,Yale!
Yoruba,
Argonne! Caucasian! PPI!
1! BAG2! BCL2Nassociated!athanogene!2!! N! A! N! P!
2! BCL2! BNcell!CLL/lymphoma!2!! N! A! N! N!
3! CALR! calreticulin!! N! A! N! P!
4! CANX! calnexin!! N! A! N! P!
5! DDOST! dolichylNdiphosphooligosaccharideNNprotein!
glycosyltransferase!subunit!(nonNcatalytic)!!
Y! N! C! P!
6! DNAJA1! DnaJ!(Hsp40)!homolog,!subfamily!A,!member!1!! Y! N! N! P!
7! DNAJB11! DnaJ!(Hsp40)!homolog,!subfamily!B,!member!11!! Y! N! N! N!
8! DNAJB12! DnaJ!(Hsp40)!homolog,!subfamily!B,!member!12!! N! A! N! N!
9! DNAJB2! DnaJ!(Hsp40)!homolog,!subfamily!B,!member!2!! N! A! N! N!
10! DNAJC3! DnaJ!(Hsp40)!homolog,!subfamily!C,!member!3!! N! A! N! P!
11! EDEM1! ER!degradation!enhancer,!mannosidase!alphaN
like!1!!
N! A! N! P!
12! EIF2AK3! eukaryotic!translation!initiation!factor!2Nalpha!
kinase!3!!
N! A! N! P!
13! EIF2S1! eukaryotic!translation!initiation!factor!2,!subunit!
1!alpha,!35kDa!!
N! A! N! P!
14! ERN1! endoplasmic!reticulum!to!nucleus!signaling!1!! N! A! N! P!
15! ERO1L! ERO1Nlike!(S.!cerevisiae)!! Y! A! N! P!
16! HSP90AB1! heat!shock!protein!90kDa!alpha!(cytosolic),!class!
B!member!1!!
Y! N! N! P!
17! HSP90B1! heat!shock!protein!90kDa!beta!(Grp94),!member!
1!!
Y! N! C! P!
18! HSPA5! heat!shock!70kDa!protein!5!(glucoseNregulated!
protein,!78kDa)!!
N! N! C! P!
19! HSPA8! heat!shock!70kDa!protein!8!! N! A! N! P!
20! HSPH1! heat!shock!105kDa/110kDa!protein!1!! Y! N! N! P!
21! LMAN1! lectin,!mannoseNbinding,!1!! Y! A! N! N!
22! MAN1B1! mannosidase,!alpha,!class!1B,!member!1!! N! A! N! N!




N! A! N! N!
25! NGLY1! NNglycanase!1!! N! A! N! P!
26! P4HB! prolyl!4Nhydroxylase,!beta!polypeptide!! Y! A! N! P!
27! PDIA3! protein!disulfide!isomerase!family!A,!member!3!! Y! N! N! P!
28! PDIA4! protein!disulfide!isomerase!family!A,!member!4!! N! A! N! P!
29! PPP1R15A! protein!phosphatase!1,!regulatory!subunit!15A!! N! A! N! P!
30! PREB! prolactin!regulatory!element!binding!! N! A! N! N!
31! RAD23B! RAD23!homolog!B!(S.!cerevisiae)!! N! A! N! P!
32! RPN1! ribophorin!I!! N! A! N! P!
33! SEC13! SEC13!homolog!(S.!cerevisiae)!! Y! A! N! P!
34! SEC23A! Sec23!homolog!A!(S.!cerevisiae)!! N! A! N! P!
35! SEC23B! Sec23!homolog!B!(S.!cerevisiae)!! N! A! N! P!
36! SEC24A! SEC24!family!member!A!! N! A! N! P!
37! SEC24C! SEC24!family!member!C!! N! A! N! P!
38! SEC24D! SEC24!family!member!D!! N! A! N! P!
39! SEC31A! SEC31!homolog!A!(S.!cerevisiae)!! Y! A! N! P!
40! SEC61A1! Sec61!alpha!1!subunit!(S.!cerevisiae)!! N! N! C! P!
41! SSR1! signal!sequence!receptor,!alpha!! N! A! N! P!
42! SSR2! signal!sequence!receptor,!beta!(transloconN
associated!protein!beta)!!
N! A! N! P!
43! SSR4! signal!sequence!receptor,!delta!! N! N! C! P!
44! STT3A! STT3A,!subunit!of!the!oligosaccharyltransferase!
complex!(catalytic)!!
Y! A! N! N!
45! TRAM1! translocation!associated!membrane!protein!1!! N! A! N! N!
46! UBE2G2! ubiquitinNconjugating!enzyme!E2G!2!! N! A! N! P!
47! UBE2J1! ubiquitinNconjugating!enzyme!E2,!J1!! N! A! N! N!
48! UFD1L! ubiquitin!fusion!degradation!1!like!(yeast)!! N! A! N! P!





In! this!chapter! to!characterize! the! functional! implications!of! trans' target!genes!we!
carried!out!enrichment!tests!for!KEGG!pathway!terms!in!groups!of!trans'target!genes.!
Enrichments! of! 9! functional! pathways! were! identified! from! Yoruba! Yale! data! and!
replicated! in! Yoruba! Argonne! data,! including! cellular! components! “Spliceosome”,!
“Proteasome”! and! “Ribosome”,! diseases! “Parkinson's! disease”,! “Huntington's!
disease”,! “Alzheimer's!disease”!and! cellular! functions! “Oxidative!phosphorylation”,!
“DNA! replication”! and! “Protein! processing! in! endoplasmic! reticulum”,! 7! of! which!





the! enrichment! of! KEGG! pathways! in! candidate! genes.! Enrichments! of! the! same!
pathways! were! found! in! both! trans' target! genes! and! candidate! genes,! including!




shared! trans' effects,! proteins! encoded! by! trans' target! genes! should! be! more!
physically! interacted!than!chance!expectation.!We!used!DAPPLE!online!tool! to! test!
whether!proteins!encoded!by! trans' target!genes!are!more!connected!by!PPIs! than!
chance! expectation.! Results! showed! that! most! groups! of! trans' target! genes! are!









gene! expression! data.! We! calculated! the! steadyNstate! gene! expression! levels! in!
human!LCLs!from!Yoruba!and!Caucasian!individuals!using!RNANseq!data!from!Pickrell!
et! al.! (2010)! and!Montgomery! et! al.! (2010).!We! identified! groups! of! trans' target!
genes!using!a!combination!of!PCA!and!correlation!analysis.! !We!provided!7!lines!of!
evidence!to!support! that!coNvariations!of!trans'target!genes!are!more! likely!due!to!
trans' effects! of! biological! origin! than! batch! effects.! We! also! identified! and!
characterized! groups! of! candidate! genes! from! a! novel! approach! using! correlation!
analysis!and!the!bindings!of!TFs!identified!from!ChIPNseq!data.!!!
In! this! chapter,!we!will! summarize! our! key! findings! and! their! contributions! to! the!







from!Yoruba!Yale! /!Yoruba!Argonne! /!Caucasian!dataset.!We! then!determined! the!
correlation! threshold! for! the! identification! of! correlating! gene! pairs! using! a!
permutation!process.!!We!removed!PCs!sequentially!from!gene!expression!data,!and!
identified!all!correlating!gene!pairs!with!correlations!above!the!threshold!for!each!PC.!
We! defined! trans' target! genes! as! genes! belonging! to! gene! pairs!with! correlations!
above! the! threshold! in!one!PC,!but!are!not!any!gene!belonging! to!gene!pairs!with!
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correlations! above! the! threshold! in! the! subsequent! PC,! which! are! groups! of! coN
varying!genes!that!are!most!affected!by!the!removal!of!individual!PCs.!In!total,!8,723!
/! 8,582! /! 5,846! trans' target! genes! were! identified! from! Yoruba! Yale! /! Yoruba!
Argonne!/!Caucasian!dataset.!We!recognized!that!expression!coNvariations!of! trans'
target! genes! could! be! due! to! the! influence! of! either! trans&acting! effects! or! batch!
effects.!Therefore,!we!performed!multiple!analyses!and!provided!7!lines!of!evidence!
to!support! that!expression!coNvariations!of! trans' target!genes!could!be!more! likely!
due! to! biological! origin! effects! rather! than! batch! effects.!We! summarized! these! 7!
lines!of!evidence!in!Table!6.1.!
1. In!section!3.7,!we!observed!significant!overlaps!between!trans'target!genes!
of! 19! PCs! from! Yoruba! Yale! data! and! trans' target! genes! of! 19! PCs! from!
Yoruba!Argonne!data,!which!are! two!datasets! from! technical! replicates.! In!
Figure! 6.1,!we! showed! that! 6! to! 967! trans' target! genes! from! Yoruba! Yale!
data!are!shared!with!trans'target!genes!from!Yoruba!Argonne!data,!and!6!to!
815! trans' target! genes! from! Yoruba! Argonne! data! are! shared! with! trans'
target!genes!from!Yoruba!Yale!data.!!





target!genes! from!Caucasian!data!are! shared!with! trans' target!genes! from!
Yoruba!Yale!data.!






dataset.!Enrichments!of!bound! target!genes!of!18!out!of!50!TFs! in!at! least!
one! group! of! trans' target! genes! were! found! in! all! three! datasets.! The!
enrichments! of! bound! target! genes! of! individual! TFs! can! be! observed! in!
trans'target!genes!of!11!/!13!/!8!PCs!from!Yoruba!Yale!/!Yoruba!Argonne!/!
Caucasian!data,!respectively.!!
4. In! section! 3.8.2,! the! enrichments! of! bindings! of! combinations! of! TFs! in!
promoter! regions! of! trans' target! genes! were! also! observed,! further!
supporting!the!claim!that!shared!bound!TFs!could!be!one!possible!source!of!
trans&acting!influence!contributing!to!the!coNvariations!of!trans'target!genes.!




5. In! section! 3.9,! we! observed! enrichments! of! differentially! expressed! genes!
from!the!knockdown!of!individual!TF!genes!in!trans'target!genes,!suggesting!
that!trans'target!genes!could!be!functional!targets!of!TFs,!and!coNvariations!
of! trans' target! genes! might! be! attributed! to! cumulative! trans' effects! of!
multiple!TFs.!We!identified!enrichments!for!13!out!of!55!groups!of!DE!genes!
from!TF!knockdown!in!at! least!one!group!of' trans'target!genes!from!either!




genes! should!have! a! biological! origin.!We!expect! that! genes! influenced!by!
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batch! effects! should! not! be! enriched! for! any! biological! function.! We!
observed!the!enrichments!of!20!KEGG!pathways!in!trans'target!genes!of!6!/!
10!/!9!PCs!from!Yoruba!Yale!/!Yoruba!Argonne!/!Caucasian!data,!respectively.!!
7. In! section! 5.3,! we! found! that! proteins! encoded! by! trans' target! genes! are!
more! frequently! physically! interacted! than! chance! expectation.! Genes!
influenced!by!batch!effects!are!not!expected!to!encode!proteins!with!more!
physical! interactions! than! chance! expectation.!We! observed! that! proteins!
encoded!by!trans'target!genes!of!17!/!15!/!14!PCs!from!Yoruba!Yale!/!Yoruba!





Groups!of! trans! target!genes!of!different!PCs! from!3!different!datasets!are! represented!by!
white!circles!and!listed!in!3!rows.!The!numbers!of!overlapped!genes,!which!were! identified!
between!groups!of! trans' target!genes! from!2!different!datasets,! are! listed!above!or!below!
their!corresponding!circles.!When!there!are!oneNtoNmany!overlaps!(one!group!of!trans!target!
genes!from!one!dataset!is!significantly!overlapped!with!multiple!groups!of!trans'target!genes!
from! another! dataset),! the! numbers! of! overlapped! genes! are! summed.! Circles! for!




Letters! “Y”,! “A”! and! “C”! indicate! that! there! is! at! least! one! significant! test! from! its!
corresponding! analysis! listed! in! different! columns! for! Yoruba! Yale! ,Yoruba! Argonne! and!



















1! YA! YA! Y! Y! A! A! A!
2! YA! Y! N! N! N! N! Y!
3! YA! YA! YA! A! YA! N! YA!
4! YA! YA! YA! YA! YA! N! YA!
5! YA! YA! A! A! A! YA! YA!
6! YA! YA! YA! YA! A! A! YA!
7! YA! YA! YA! YA! YA! YA! YA!
8! YA! YA! YA! YA! YA! YA! YA!
9! YA! A! YA! A! YA! A! YA!
10! YA! YA! YA! Y! YA! A! YA!
11! YA! YA! YA! YA! N! A! YA!
12! YA! YA! YA! Y! Y! N! YA!
13! YA! YA! A! N! A! Y! YA!
14! YA! YA! Y! Y! N! YA! YA!
15! YA! N! N! N! N! A! Y!
16! YA! YA! N! N! N! N! YA!
17! YA! N! A! A! N! N! A!
18! YA! Y! N! N! N! Y! N!
19! YA! A! A! N! N! N! Y!


















1! C! C! C! C! N! C! N!
2! C! C! N! N! N! C! C!
3! C! C! C! C! N! N! C!
4! C! N! N! N! C! N! C!
5! C! C! C! C! N! C! C!
6! C! C! C! C! C! C! C!
7! C! C! C! N! N! C! C!
8! C! C! N! N! N! N! C!
9! C! C! C! C! C! N! C!
10! C! C! N! C! N! C! C!
11! N! N! N! N! N! N! C!
12! N! N! N! N! N! N! C!
13! N! C! N! N! N! N! N!
14! C! C! C! N! C! C! C!
15! C! N! N! N! N! N! N!
16! N! N! N! N! N! C! N!
17! N! N! N! N! N! N! N!
18! C! C! C! N! N! C! C!
19! N! N! N! C! N! N! C!





bound! TFs.!We! removed! PCs! sequentially! until! a!minimum! number! of! correlating!
gene! pairs!were! detected,! and!we! assumed! that! these! gene! pairs!might! originate!
from!trans'effect!residues.!We!then!identified!shared!combination!of!TFs!bound!to!
promoter!regions!of!each!correlating!gene!pair,!and!then!identified!all!genes!bound!




than! gene! pairs! without.! In! total,! we! identified! 11! TF! combinations! with! better!
correlations! in! both! Yoruba! Yale! and! Yoruba! Argonne! dataset,! and! one! TF!
combination! in! all! three! datasets! as! shown! in! Table! 4.2.! Moreover,! significant!
overlaps!were! observed!when! comparing! candidate! genes! and! trans' target! genes,!
suggesting!that!the!same!trans'effects!can!be!detected!by!two!different!approaches.!!
To! understand! the! functional! consequences! in! human! individuals! with! expression!
coNvariations!of!trans&regulated!genes,!we!tested!the!enrichment!of!KEGG!pathways!
in!both!trans'target!genes!and!candidate!genes.!We!found!multiple!enriched!KEGG!
pathways! in! both! trans' target! genes! and! candidate! genes,! such! as! “Ribosome”,!
“Spliceosome”,! “Huntington's! disease”! and! “Parkinson's! disease”,! suggesting! the!
functional! importance! of! trans&regulation! in! mRNA! translation,! RNA! splicing! and!








In! Table! 6.1,! we! observed! that! trans! target! genes! can! be! supported! by! 7! lines! of!
evidence!at!one!extreme,!or!not!supported!by!any!evidence!other!than!coNvariation.!
This! observation! does! not! suggest! that! trans! target! genes! supported! by! more!




promoter! regions,! or! they! do! not! all! have! to! be! significantly! modulated! by! the!
knockdown!of!individual!TFs.!Our!argument!is!based!entirely!on!the!proposition!that!
trans!target!genes!are!indeed!the!product!of!shared!trans!influences,!because!many!
trans! target!genes!have!biological!characteristics! that!are!unlikely! to!be!associated!
with!batch!effects,!which!is!the!alternative!explanation!for!the!coNvariation!of!gene!
expression!levels.!
In! conclusion,! in! this! study! we! identified! trans' target! genes! and! candidate! genes!
from! RNANseq! data! of! human! LCLs! from! Yoruba! and! Caucasian! individuals! by! two!
novel! approaches,! suggesting! detectable! cumulative! trans' effects! on! human! gene!
expression.! Shared! trans' effects! can! be! observed! in! RNANseq! data! from! Yoruba!










Our! approach! to! identify! trans! target! genes! relies! on! the! assessment! of! large!
covariance! matrices.! But! Shaffer! and! Strimmer! (2005)! pointed! out! that! the!
maximum! likelihood! estimates! of! covariance! are! not! accurate! when! applied! to!
expression!data!with!small!sample!size.!To!solve!this!technical!issue!they!constructed!
a! novel! shrinkage! covariance! estimator! to! improve! the! estimation! of! gene!
expression!covariance.!!
To!evaluate! the! impact!of! this! issue!on!our!approach,!we!calculated! the! shrinkage!
correlation!using!R! package! corpcor! as! suggested!by! Shaffer! and! Strimmer! (2005).!
Comparing! the! distribution! of! shrinkage! correlations! with! the! distribution! of!
Spearman’s! correlations! calculated!using!Caucasian!data! (Figure!6.2),!we!observed!
that! the! shrinkage! correlation! simply! shrink! all! correlation! values! calculated! by!
Spearman’s! correlation.! We! argue! that! using! the! shrinkage! correlation! will! likely!
shrink! both! correlations! caused! by! biological! effects! and! correlations! caused! by!
random! noise,! but! the! fundamental! problem! still! remains.! We! will! still! need! a!
correlation!threshold!in!order!to!differentiate!them.!!
On!the!other!hand!one!of!the!main!goals!of!our!study!is!to!differentiate!between!coN
variations! caused!by!biological! effect! and!by!noise.!Our!permutation!procedure! to!










retrieved! the!RNANseq!dataset!with!462!human! individuals! from!Lappalainen!et!al.!
(2013),! and! generated! another! two! datasets!with! 62! and! 262! individuals! that! are!
randomly!selected!from!the!same!462!individuals.!We!applied!the!same!permutation!
procedure! on! each! gene! expression! dataset,! and! observed! that! sample! size! has!
strong! influence!on!the!correlation!threshold! (Figure!6.3).!At! the!same!significance!
level,! the! larger! the! sample! size! the! smaller! the! correlation! threshold! will! be.! In!
Figure! 6.4! we! compared! the! correlation! distributions! of! these! 3! datasets,! and!
observed! that! datasets! with! different! sample! size! have! different! correlation!
structures.! Then! to! examine! the! detection! power! of! correlating! gene! pairs,! we!
calculated!the!number!of!gene!pairs!with!correlations!above!the!threshold!for!each!
dataset!(|ρ|>!0.725!for!data!with!62!samples,!|ρ|>!0.387!for!data!with!262!samples,!
|ρ|>! 0.293! for! data!with! 462! samples).!We! observed! 2739! gene! pairs! (with! 1482!
unique!genes)!for!data!with!62!samples,!179125!gene!pairs!(with!7824!unique!genes)!
for!data!with!262! samples,! 683246!gene!pairs! (with!10287!unique!genes)! for!data!




































































































































































































































































The! investigation! of! the! collective! behavior! of! trans' target! genes! improves! our!
understanding!of!genetic! trans' influences!on!gene!expression.!We! found! that!over!
5000! expressed! genes! could! be! potentially! influenced! by! trans' effects,! which!
challenged! previous! studies! wherein! the! number! of! genes! under! trans&regulation!
has!been!greatly!underestimated.!
Contribution, 2.!We! developed! a! novel! approach! to! identify! coNvarying! genes! that!
are! potential! target! genes! of! trans' influences,!which!were! defined! as! trans! target!
genes.!The!key! feature!of! this!approach! is! the!combination!of!PCA!and!correlation!
analysis.!We!used!PCA! to! sequentially! remove!a!proportion!of!expression!variance!
from!gene!expression!data,!and!used!correlation!analysis!to!identify!the!genes!that!
are!most!affected!by!the!removal!of!individual!PCs.!!
We! compared!our! approach!with! the!approach! from! the! study!by!Goldinger!et! al.!
(2013),! who! investigated! that! whether! principal! components! of! gene! expression!
data!can!be!explained!by!genetic!variations!or!batch!effects.!The!similarity!is!that!we!
both! applied! PCA! to! identify! genes! that! are! highly! correlated!with! individual! PCs.!
Moreover,!they!observed!multiple!enriched!KEGG!pathways!in!genes!correlated!with!
the! first! 50! PCs,! such! as! “oxidative! phosphorylation”,! “Parkinson’s! disease”,!
“Huntington’s! disease”,! “Alzheimer’s! disease”,! “ribosome”,! and! “proteasome”,!
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which!are!the!same!pathways!that!are!enriched!in!trans!target!genes!from!our!study.!
The!difference! is! that! they!acknowledged! that! linear! regression! is!not!able! to!deal!
with!datasets!with!unknown!batch!effects,!while!using!our!approach!the!application!
of! statistical! tests! for! 7! different! biological! properties! is! able! to! differentiate! coN
variations!of!trans!target!genes!due!to!biological!effects!or!unknown!batch!effects.!!




the!overlapping!of! trans' target!genes!between! replicates,! the!overlapping!of! trans'
target!genes!between!populations,!the!enrichment!of!bindings!of!individual!TFs,!the!
enrichment! of! bindings! of! combinations! of! TFs,! the! enrichment! of! differentially!
expressed!genes!from!TF!gene!knockdown,!the!enrichment!of!KEGG!pathways,!and!
the! connectivity! of! PPI! network.! The! results! of! these! analyses! suggest! that! batch!
effects!are!not!likely!to!be!the!source!of!coNvariations!of!trans'target!genes.!These!7!
lines!of!evidence!are!also!summarized!in!Table!6.1.!
Contribution, 4.! We! designed! a! novel! approach! to! identify! trans' effects! from!
combinations!of!bound!TFs.!
This! novel! approach! was! designed! based! on! the! assumption! that! if! a! particular!
combination! of! TFs! is! functional,! its! trans' effects! should! contribute! to! the! coN
variations! of! gene! pairs! with! such! combination! of! bound! TFs.! Therefore,! we!
compared! the! correlation! levels! of! gene! pairs! with! and! without! a! particular!
combination! of! bound! TFs! to! search! for! functional! combinations! of! TFs! with!
evidence!of!trans!effects.!No!previous!study!combined!ChIPNseq!data!together!with!
gene! expression! data! to! detect! trans' effects! of! combinations! of! bound! TFs! while!
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considering! batch! effects.! One! possible! limitation! of! this! approach! is! that! the!





Enrichment! test! of! KEGG! pathways! is! a! useful! method! to! explore! functional!




frequently! physically! interacted! than! chance! expectation.! Therefore,! we! tested!







data! and! replicated! in! Yoruba! Argonne! data,! including! cellular! components!
“Spliceosome”,! “Proteasome”! and! “Ribosome”,! disease! pathways! “Parkinson's!
disease”,! “Huntington's! disease”,! “Alzheimer's! disease”! and! cellular! functions!
“Oxidative! phosphorylation”,! “DNA! replication”! and! “Protein! processing! in!




Although! we! considered! these! enriched! KEGG! pathways! as! potential! functions! of!
trans' target! genes,! we! did! not! ignore! the! functions! that! are! abundant! but! not!
enriched! in! trans' target! genes.! To! find! the! most! abundant! pathways,! we!
summarized!all!KEGG!pathway!annotations! for!5,038!genes!that!are!shared!among!
trans' target! genes! from!Yoruba!Yale,! Yoruba!Argonne!and!Caucasian!data.!Among!
the! top! 10! abundant! pathways! we! observed! that! 334! genes! are! annotated! in!
“Metabolic! pathways”,! 100! genes! in! “Pathways! in! cancer”,! 91! genes! in! "RNA!
transport",!79!genes!in!“MAPK!signaling!pathway”,!82!genes!in!"Cell!cycle",!72!genes!
in! "Ubiquitin! mediated! proteolysis".! We! also! found! pathways! that! are! both!
abundant!and!significantly!enriched!in!trans'target!genes.!For!example,!there!are!95!
genes! in! "Huntington's! disease",! 86! genes! in! "Protein! processing! in! endoplasmic!
reticulum",!76!genes!in!"Alzheimer's!disease"!and!82!genes!in!“Spliceosome”.!These!







included! in! each!pathway,! and! the!numbers! of! trans' target! genes! that! are! shared!
among!three!datasets.!In!this!section!to!stress!the!importance!of!trans'target!genes!














Alzheimer's!disease! 97! 97! 83! 90! 76!
Parkinson's!disease! 84! 78! 71! 77! 66!
Huntington's!disease! 115! 115! 99! 110! 95!
Spliceosome! 93! 94! 83! 93! 82!
Proteasome! 32! 33! 31! 32! 30!
Ribosome! 70! 68! 66! 68! 65!
Protein!processing!in!endoplasmic!
reticulum!
131! 120! 96! 119! 86!
Oxidative!phosphorylation! 81! 81! 72! 79! 70!





Figure! 6.5! shows! the! roles! of! 95! trans' target! genes! out! of! 177! genes! that! are!
involved!in!the!KEGG!pathway!“Huntington's!disease”.!These!trans'target!genes!are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!
of! selected! proteins! or! protein! complexes! encoded! by! trans' target! genes!
(highlighted!in!red)!are!briefly!discussed!below.,
The!mutant!protein!HTT!(huntingtin)!encoded!by!trans'target!gene!HTT!is!the!major!
cause! of! Huntington’s! disease! (HD).! In! neurons,! the! mutant! HTT! fails! to! form! a!
protein! complex! with! clathrin,! HIP1! (huntingtin! interacting! protein! 1)! and! AP2!






et! al.! 2005).! Trans' target! genes! encode! the! 5! major! enzymes! in! oxidative!
phosphorylation! from!mitochondrial!complex, I! to!complex,V.!The!mutant!HTT! can!






Shared! trans' target! genes! among! Yoruba! Yale,! Yoruba!Argonne! and!Caucasian!dataset! are!






Figure! 6.6! shows! the! roles! of! 66! trans' target! genes! out! of! 127! genes! that! are!
involved! in! the!KEGG!pathway! “Parkinson's! disease”.! These! trans' target! genes! are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!
of! selected! proteins! or! protein! complexes! encoded! by! trans' target! genes!
(highlighted!in!red)!are!briefly!discussed!below.,
The! mutation! of! DJ71! encoded! by! PARK7! (parkinson! protein! 7)! induces! oxidative!
stress! in! Parkinson’s! disease! (PD).! The! ubiquitin! mediated! proteolysis! process! is!
carried! out! by! three! enzymes,! ubiquitinNactivating! enzyme! (E1),! ubiquitinN
conjugating!enzyme!(E2)!and!ubiquitin!ligase!(E3).!Parkin!cooperates!with!ubiquitinN
activating!enzyme!E1!(UBA1)!and!E2!ubiquitinNconjugating!enzymes!UBCH7,!UBCH8!
and! UBC6! or! UBC7! to! ubiquitinate! their! target! proteins! (Moore! et! al.! 2003).! In!
dopaminergic! neurons,! 1NmethylN4Nphenylpyridinium! (MPP+)! is! sequestrated! into!
synaptic!vesicles!via!the!vesicular!monoamine!transporter!(VMAT).!MPP+!also!blocks!
the! transfer! of! electrons! from! complex! I! to! ubiquinone! in! the! mitochondria! and!
causes! complex! I! deficiency! (Dauer! &! Przedborski! 2003).! Both! high! temperature!







Shared! trans' target! genes! among! Yoruba! Yale,! Yoruba!Argonne! and!Caucasian!dataset! are!





Figure! 6.7! shows! the! roles! of! 76! trans' target! genes! out! of! 158! genes! that! are!
involved! in! the!KEGG!pathway!“Alzheimer's!disease”.!These! trans' target!genes!are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!




apolipoprotein! E! (APOE)! (Kanehisa! et! al.! 2010).! The!mutant!PS1! encoded! by! gene!
PSEN! inhibits!the!activation!of!ER!(endoplasmic!reticulum)!stress!transducers!ERN1!




Aβ! (βNamyloid)! interacts! with! ABAD! (AβNbinding! alcohol! dehydrogenase)! and!
reduces!the!activity!of!complex,IV!in!the!mitochondria!of!AD,!which!leads!to!higher!
levels!of!oxidative!stress!and!apoptosis!(Lustbader!et!al.!2004;!Bosetti!2002).!!
From! the! published! GWAS! by! (Sherva! et! al.! 2014)! we! observed! that! trans! target!
gene!CYCS! (cytochrome!c,! somatic),!which! transfers!electrons!between!complex! III!
and! complex! IV,! is! associated! with! human! disease! “Alzheimer’s! disease”.! The!
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Figure! 6.8! shows! the! roles! of! 70! trans' target! genes! out! of! 128! genes! that! are!
involved! in! the! KEGG! pathway! “Oxidative! phosphorylation”.! These! trans' target!
genes! are! replicated! in! Yoruba! Yale,! Yoruba! Argonne! and! Caucasian! data.! The!
biological! roles!of! selected!proteins!or!protein! complexes! encoded!by! trans' target!
genes!(highlighted!in!red)!are!briefly!discussed!below.,
The! oxidative! phosphorylation! pathway! is! connected! by! 5! protein! complexes!
including!complex, I! (NADH!dehydrogenase),!complex, II! (succinate!dehydrogenase),!
complex, III! (cytochrome! c! reductase),! complex, IV! (cytochrome! c! oxidase)! and!
complex, V! (ATP! synthase).! ! The!FNtype!and!VNtype!ATPases!have!distinct! structure!
features! and! subcellular! locations.! The! FNtype! ATPases! can! be! found! in! the!
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Figure! 6.9! shows! the! roles! of! 82! trans' target! genes! out! of! 113! genes! that! are!
involved! in! the! KEGG! pathway! “Spliceosome”.! These! trans' target! genes! are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!
of! selected! proteins! or! protein! complexes! encoded! by! trans' target! genes!
(highlighted!in!red)!are!briefly!discussed!below.,
A!typical!spliceosome!is!composed!of!five!small!nuclear!ribonucleoproteins!(snRNPs)!
including!U1,, U2,, U4/U6,, U5! snRNPs! and! several! spliceosomeNassociated! proteins!
(SAPs)! (Wahl!et!al.!2009).!The!beginning!of!preNmRNA!splicing! is! the!binding!of!U1!
snRNP! with! the! 5’! splice! site! (SS)! of! the! intron! to! be! excised.! Complex! A! is! then!
formed!with! the! association! of!U2! snRNP.! To! form! complex! B!U4/U6! and!U5! triN
snRNPs! are! recruited! to! complex! A.! When!U1! and!U4! snRNPs! are! released! from!
complex! B,! the! spliceosome! is! activated! (complex! B*).! The! first! step! of! splicing! is!
performed!by!the!activated!spliceosome,!which!results!in!the!formation!of!complex!
C.! After! the! second! splicing! step! the! spliceosome! releases! the! messenger!
ribonucleoprotein! (mRNP)! and! U2,, U5, and, U6! snRNPs,! and! generates! the! postN
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Figure! 6.10! shows! the! roles! of! 30! trans' target! genes! out! of! 40! genes! that! are!
involved! in! the! KEGG! pathway! “Proteasome”.! These! trans' target! genes! are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!
of! selected! proteins! or! protein! complexes! encoded! by! trans' target! genes!
(highlighted!in!red)!are!briefly!discussed!below.,
The! 26S! proteasome! consists! of! one! 20S! core! particle! and! two! 19S! regulatory!
particles.! For! the! 20S! core! particle! of! proteasome,! 10! out! of! 14! types! of! subunits!
(proteasome!subunit!α3!to!α5,!β1!to,β7)!are!encoded!by!trans'target!genes.!For!the!
19S! regulatory! particle,! all! 10! subunits! of! its! lid! subcomplex! (proteasome! 26S!
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subunit!RPM3,!RPM5! to!RPM12! and!RPM15)! are! encoded! by! trans' target! genes,!
while!6!out!of!9!subunits!of!its!base!subcomplex!(RPM2,,RPT2!to!RPT6)!are!encoded!
by! trans' target! genes.! Immunoproteasome! is! another! form! of! proteasome!
containing! two! 11S! regulatory! particles! PA28α! and! PA28β.! PI31! (proteasome!
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The! ribosome! is! a! large!protein! complex! composed!of! a! small! subunit! and! a! large!
subunit.!The!small!subunit!binds!to!mRNA,!while!the!large!subunit!binds!to!tRNA!and!
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Figure! 6.12! shows! the! roles! of! 26! trans' target! genes! out! of! 33! genes! that! are!
involved! in! the! KEGG! pathway! “DNA! replication”.! These! trans' target! genes! are!
replicated! in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!The!biological!roles!
of! selected! proteins! or! protein! complexes! encoded! by! trans' target! genes!
(highlighted!in!red)!are!briefly!discussed!below.,
Trans' target! genes! encode! components! of! the! DNA! replication! pathway! including!
three! DNA, polymerases! (alpha,, delta,, and, epsilon)! and! miniNchromosome!
maintenance! (MCM)! complex.!Proliferating! cell!nuclear!antigen! (PCNA)! is! the!DNA!
polymerase!clamp,!and!replication!factor!C!(RFC)!functions!as!a!clamp!loader!(Waga!
&!Stillman!1998).!The!RNA!primer!is!removed!from!Okazaki!fragments!by!FEN1!(flap!




Figure! 6.13! shows! the! roles! of! 86! trans' target! genes! out! of! 157! genes! that! are!
involved!in!the!KEGG!pathway!“Protein!processing!in!endoplasmic!reticulum”.!These!
trans'target!genes!are!replicated!in!Yoruba!Yale,!Yoruba!Argonne!and!Caucasian!data.!
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The! three! sensors! of! the! unfolded! protein! response! (UPR),! including! inositol!
requiring! elementN1! (IRE71),! PKRNlike! ER! kinase! (PERK)! and! activating! transcription!
factor! 6! (ATF6)! at! the! ER! membrane,! remain! inactive! when! binding! to! BIP!
(immunoglobulin!binding!protein).!On!the!accumulation!of!misfolded!proteins!bound!
BIP! is! released! from! them,! and! these! three! sensors! are! activated! (Naidoo! 2009).!
When! PERK! is! activated,! it! phosphorylates! the! translation! initiation! factor! EIF2α!
leading!to!a!general!decrease!of!protein!synthesis.!But!the!translation!of!ATF4!(cyclic!
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AMPNdependent! transcription! factor)! is! increased! by! EIF2α.! Activated! ATF6! is!
translocated!to!the!Golgi!body!and!cleaved!by!S1P!(siteN1!protease)!and!S2P!(siteN2!
protease)!endopeptidase!(Naidoo!2009).!The!integral!membrane!protein!BAP31! (BN
cell! receptorNassociated! protein! 31)! physically! interacts! with! SEC61! (protein!
transport!protein!SEC61),!TRAM, (translocating!chainNassociated!membrane!protein!
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in! individuals!with! expression! coNvariations! of! trans' target! genes.! In! chapter! 5!we!
found!multiple!enriched! functional!pathways! in! trans' target! genes,! and!we!expect!
that! phenotypic! outcomes! due! to! expression! coNvariations! of! trans' target! genes!
should! be! related! to! these! enriched! pathways.! For! example,! ATP! synthase,!
cytochrome! c! oxidase! and! NADH! dehydrogenase! are! important! components! of!
mitochondrial! electron! transport! chain! in! oxidative! phosphorylation.! NADH!
dehydrogenase!catalyzes!the!oxidation!of!NADH!(nicotinamide!adenine!dinucleotide,!
reduced! form)!by!ubiquinone! (Hirst!2005).!Evidence!suggests! that! the! inhibition!of!
NADH!dehydrogenase!is!one!of!the!major!causes!of!Parkinson’s!disease!(Moore!et!al.!
2003).! Cytochrome! c! oxidase! catalyzes! the! oxidation! of! cytochrome! c! and! the!
reduction!of!oxygen,!and!also!translocates!protons!across!the!membrane!(Yoshikawa!
et! al.! 2006).! ATP! synthase! is! the! mitochondrial! enzyme! that! synthesizes! ATP!
(adenosine! triphosphate)! from! ADP! (adenosine! diphosphate)! and! inorganic!
phosphate! (Yoshida! et! al.! 2001).! Panov! et! al.! (2003)! demonstrated! that! the!
abnormal!mitochondrial! calcium!handling! in!Huntington’s! disease!might!be!due! to!
the! negative! effects! of! mutant! huntingtin! protein! on! mitochondria,! and! the!
dysfunction! of! mitochondria! could! be! related! to! many! human! neurodegenerative!
diseases.!Therefore,!divergent!susceptibility!of!diseases!may!be!expected!in!multiple!
individuals!when!there!are!expression!coNvariations!of! trans' target!genes!encoding!
components! of! mitochondria.! RNA! splicing! is! the! process! removing! noncoding!
introns!from!precursor!messenger!RNAs,!which!is!carried!out!by!the!protein!complex!
spliceosome.! From! alternative! splicing!multiple! protein! isoforms! can! be! produced!
from!a! single! gene! (Black!2003).! Therefore,!we!expect! that!patterns!of! alternative!
splicing!may!be!different! in!multiple! individuals!when!mRNA! levels! of! trans' target!
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genes! involved! in! KEGG! pathway! “Spliceosome”! are! variant.! Proteasome! is! the!
protein! complex! that! degrades! intracellular! proteins.! Proteins! to! be! degraded! are!
usually!attached!with!a!chain!of!ubiquitins,!and!then!degraded!to!small!peptides!by!
the!proteasome!(Almond!&!Cohen!2002).!McNaught!et!al.!(2006)!suggested!that!the!
aggregation! and! Lewy! body! formation! in! Parkinson's! disease! can! be! attributed! to!
decreased!proteasome!activity,!and!the!aggregation!of!misfolded!proteins!is!shared!
as! a! common! feature! between! Parkinson's! disease! and! Alzheimer's! disease.! The!
process!of!translating!the!mRNA!sequence!into!a!polypeptide!chain!is!carried!out!by!
ribosome,! a! large! ribonucleoprotein! complex.! Ding! et! al.! (2005)! reported! that! the!
dysfunction!of! ribosome! is!associated!with!decreased!protein! synthesis,!decreased!
ribosomal!RNA!and!tRNA!levels,!and!increased!RNA!oxidation!in!Alzheimer's!disease.!






In! this! study!we! identified!multiple!groups!of! coNvarying!genes!and!many!enriched!
pathways! from! these! genes.! We! hypothesized! that! if! there! are! expression! coN
variations! of! genes! from! a! single! pathway! across! multiple! individuals,! we! may!
observe!different!phenotypic!consequences.!Therefore,! there!are! two!questions! to!
be! answered:! 1.! How! to! quantify! expression! variations! of! a! group! of! coNvarying!
genes?! 2.! How! to! determine! and! measure! the! possible! phenotypic! outcomes! in!
multiple! individuals?! One! straightforward! strategy! could! be! looking! for! the! two!











correlation! network! by! calculating! pairNwise! correlations! among! these! genes.! We!
will! then! connect! gene! pairs!with! correlations! above! the! correlation! threshold.! In!
this!way!the!connectivity! for!each!gene!will!be!counted.!The!gene!with! the! largest!
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connectivity,! whose! expression! profile! is! correlated! with! the! largest! number! of!
genes,!could!be!considered!as!the!key!node!in!this!correlation!network.!!Therefore,!
we! will! choose! the! gene! with! the! largest! connectivity! representing! the! average!
expression!profile!of!a!group!of!coNvarying!genes.!!!!
RNA!splicing!pattern!is!a!detectable!trait!from!RNANseq!experiments.!Therefore,!we!
will! study! trans' target! genes! involved! in! “Spliceosome”! and! test!whether! there! is!
association!between!the!expression!coNvariation!of!spliceosome!genes!and!the!RNA!
splicing! pattern.! Kwan! et! al.! (2008)! used! exonNtiling!microarray! to! investigate! the!
genomeNwide! variations! of! gene! splicing! using! LCLs! from! 57! unrelated! Caucasian!
individuals.! Pickrell! et! al.! (2010)!used!RNANseq! to! study! the! transcriptome!of! LCLs,!
and!treated!the!fraction!of!reads!mapped!to!one!exon!among!reads!mapped!to!the!
whole! gene! containing! the! exon! as! a! quantitative! trait.! They! identified! 187! genes!
whose! splicing! trait! is! significantly! associated! with! genotypes! from! a! cis&SNP! that!
was! defined! as! splicing! quantitative! trait! locus! (sQTL).! These! studies! suggest! that!




In! section! 3.7,! we! observed! significant! overlaps! between! trans' target! genes!
identified! in! RNANseq! data! of! LCLs! from!Yoruba! individuals! and! trans' target! genes!
from! Caucasian! individuals,! suggesting! shared! trans' effects! between! two!
populations.! It! would! be! interesting! to! test! whether! trans' target! genes! can! be!
replicated!in!more!populations!with!larger!sample!size.!In!a!recent!study!Lappalainen!
et! al.! (2013)! performed! RNANseq! for! LCLs! from! 462! individuals! from! the! 1000!
Genomes!Project!including!5!populations!Caucasian!(CEU),!Finns!(FIN),!British!(GBR),!
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Toscani! (TSI)! and! Yoruba! (YRI)! with! 89! to! 95! individuals! in! each! population.! The!
availability! of! this! largeNscale! RNANseq! data! from! 5! populations! provides! us! an!
opportunity! to! compare! trans' target! genes! among! populations! to! look! for! shared!
and!population!specific!trans'effects!due!to!the!diversity!of!their!genetic!background.!
Future!experiments!will!be!carried!out!as!below.!




of! PCs! removed.! PairNwise! gene! expression! correlations! will! be! calculated! in! each!
gene! expression! matrix.! Correlating! gene! pairs! with! correlation! level! above! the!
threshold!will!be!identified.!We!expect!to!identify!more!groups!of!trans'target!genes!
due! to! the! large! sample! size! of! this! RNANseq! data,!which!may! enable! us! to! study!
trans'effects!with!higher!statistical!power.!!
3.! To! support!whether! trans' target! genes! identified! from! these! 5! populations! are!
due! to! biological! effects,! we! will! perform! crossNcomparisons! to! test! whether! the!




Genetic! information! is! transformed! to! phenotype! through! mRNA! and! protein!
expressions.! Since!mature!mRNAs!need! to!be! transcribed! into!proteins! to!perform!
their!functions,!it!would!be!reasonable!to!assume!that!genetic!variations!influencing!
mRNA! levels! may! also! have! an! impact! on! proteins! levels,! i.e.! eQTLs! may! also! be!
! 150!
protein! quantitative! trait! loci! (pQTLs).! Although!Melzer! et! al.! (2008)! reported! the!
discovery! of! both! cis&! and! trans&pQTLs! in! human! tissues,! the! detection! of! trans&
pQTLs! is! still! challenging! due! to! small! sample! size! and! the! same! multiple! testing!
problem!as!in!trans&eQTL!studies.!!
Recently!Wu!et! al.! (2013)! reported! the! protein! levels! of! 5,953! genes! expressed! in!
human! LCLs! from! 95! HapMap! individuals! measured! by! mass! spectrometry! with!
genotype! data.!We!will! apply! the! same!workflow! as!we!described! in! chapter! 3! to!
identify!trans'target!genes!from!this!proteome!data.! It!would!be!interesting!to!test!
whether! the! same! genes! are! shared! between! trans' target! genes! identified! from!
protein!level!data!and!trans'target!genes!identified!from!mRNA!level!data.!It!would!
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which! are! followed! by! the! “Proportion”! of! mapped! reads.! Excluded! lanes! are! marked! by!
“excluded”!in!the!“Status”!column.!
Set, ID, Sample, Total, Mapped, Proportion, Status,
Yoruba!Yale! SRR031917! NA18486! 5930518! 4019161! 67.80%! IN!
Yoruba!Yale! SRR031821! NA18498! 9739474! 6563861! 67.40%! IN!
Yoruba!Yale! SRR031898! NA18498! 9971094! 6572276! 65.90%! IN!
Yoruba!Yale! SRR031822! NA18499! 5782532! 3851853! 66.60%! IN!
Yoruba!Yale! SRR031850! NA18501! 6422000! 4461038! 69.50%! IN!
Yoruba!Yale! SRR031950! NA18501! 8097072! 5669925! 70%! IN!
Yoruba!Yale! SRR031873! NA18502! 8909231! 5724409! 64.30%! IN!
Yoruba!Yale! SRR031953! NA18502! 8277356! 5570915! 67.30%! IN!
Yoruba!Yale! SRR031862! NA18504! 7113128! 4746070! 66.70%! IN!
Yoruba!Yale! SRR031876! NA18504! 8729513! 5722365! 65.60%! IN!
Yoruba!Yale! SRR031871! NA18505! 8849477! 5879077! 66.40%! IN!
Yoruba!Yale! SRR031952! NA18505! 7677809! 5289935! 68.90%! IN!
Yoruba!Yale! SRR031875! NA18507! 10329429! 6744760! 65.30%! IN!
Yoruba!Yale! SRR031868! NA18508! 8701858! 5753138! 66.10%! IN!
Yoruba!Yale! SRR031915! NA18510! 6248122! 4095167! 65.50%! IN!
Yoruba!Yale! SRR031819! NA18511! 10547619! 7021463! 66.60%! IN!
Yoruba!Yale! SRR031863! NA18516! 7818182! 5275687! 67.50%! IN!
Yoruba!Yale! SRR031878! NA18516! 7602729! 5079237! 66.80%! IN!
Yoruba!Yale! SRR031857! NA18517! 9367811! 6503341! 69.40%! IN!
Yoruba!Yale! SRR031897! NA18517! 10007597! 6776452! 67.70%! IN!
Yoruba!Yale! SRR031869! NA18519! 8838591! 5758077! 65.10%! IN!
Yoruba!Yale! SRR031823! NA18520! 7695310! 5290941! 68.80%! IN!
Yoruba!Yale! SRR031864! NA18522! 7691810! 5232282! 68%! IN!
Yoruba!Yale! SRR031959! NA18523! 4528349! 2670106! 59%! IN!
Yoruba!Yale! SRR031955! NA18852! 9606138! 6470371! 67.40%! IN!
Yoruba!Yale! SRR031845! NA18853! 9717230! 6430834! 66.20%! IN!
Yoruba!Yale! SRR031954! NA18855! 7930075! 5203024! 65.60%! IN!
Yoruba!Yale! SRR031851! NA18856! 5267997! 3468637! 65.80%! IN!
Yoruba!Yale! SRR031951! NA18856! 8946747! 6150853! 68.70%! IN!
Yoruba!Yale! SRR031956! NA18858! 8800059! 5869475! 66.70%! IN!
Yoruba!Yale! SRR031838! NA18861! 4642527! 3106026! 66.90%! IN!
Yoruba!Yale! SRR031846! NA18862! 8619671! 5777590! 67%! IN!
Yoruba!Yale! SRR031918! NA18870! 6833330! 4584347! 67.10%! IN!
Yoruba!Yale! SRR031916! NA18871! 6261611! 4054025! 64.70%! IN!
Yoruba!Yale! SRR031817! NA18909! 9130603! 5961544! 65.30%! IN!
Yoruba!Yale! SRR031852! NA18912! 4211405! 2674398! 63.50%! IN!
Yoruba!Yale! SRR031949! NA18912! 9081942! 5715201! 62.90%! IN!
Yoruba!Yale! SRR031844! NA18913! 9006101! 5904328! 65.60%! IN!
Yoruba!Yale! SRR031841! NA18916! 7559177! 5038401! 66.70%! IN!
Yoruba!Yale! SRR031865! NA19093! 6997219! 4820686! 68.90%! IN!
Yoruba!Yale! SRR031813! NA19098! 10280860! 7079982! 68.90%! IN!
Yoruba!Yale! SRR031896! NA19099! 9955015! 6760303! 67.90%! IN!
Yoruba!Yale! SRR031894! NA19101! 9320429! 6236225! 66.90%! IN!
Yoruba!Yale! SRR031853! NA19102! 4025513! 2519749! 62.60%! IN!
Yoruba!Yale! SRR031820! NA19108! 10627854! 7093007! 66.70%! IN!
Yoruba!Yale! SRR031874! NA19114! 8969212! 5350281! 59.70%! IN!
Yoruba!Yale! SRR031895! NA19116! 9693662! 6548661! 67.60%! IN!
Yoruba!Yale! SRR031854! NA19119! 3816178! 2463481! 64.60%! excluded!
Yoruba!Yale! SRR031870! NA19127! 9353324! 6047493! 64.70%! IN!
Yoruba!Yale! SRR031858! NA19128! 9498521! 6178229! 65%! IN!
Yoruba!Yale! SRR031859! NA19130! 8914041! 5988788! 67.20%! IN!
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Yoruba!Yale! SRR031839! NA19131! 8414765! 5712985! 67.90%! IN!
Yoruba!Yale! SRR031958! NA19137! 6574947! 4403533! 67%! IN!
Yoruba!Yale! SRR031872! NA19138! 9041280! 6053943! 67%! IN!
Yoruba!Yale! SRR031867! NA19140! 8970177! 5753046! 64.10%! IN!
Yoruba!Yale! SRR031848! NA19143! 8381930! 5635645! 67.20%! IN!
Yoruba!Yale! SRR031816! NA19144! 8327861! 5773966! 69.30%! IN!
Yoruba!Yale! SRR031847! NA19147! 7578019! 4855242! 64.10%! IN!
Yoruba!Yale! SRR031818! NA19152! 10247210! 6851281! 66.90%! IN!
Yoruba!Yale! SRR031815! NA19153! 8474542! 5656362! 66.70%! IN!
Yoruba!Yale! SRR031919! NA19159! 6382899! 4366546! 68.40%! IN!
Yoruba!Yale! SRR031899! NA19160! 9662020! 6509819! 67.40%! IN!
Yoruba!Yale! SRR031920! NA19160! 6515037! 4298913! 66%! IN!
Yoruba!Yale! SRR031855! NA19171! 6154300! 4140463! 67.30%! IN!
Yoruba!Yale! SRR031957! NA19171! 6077346! 4014877! 66.10%! IN!
Yoruba!Yale! SRR031866! NA19172! 7086910! 4690225! 66.20%! IN!
Yoruba!Yale! SRR031849! NA19190! 6729781! 4265784! 63.40%! IN!
Yoruba!Yale! SRR031840! NA19192! 8552871! 5599358! 65.50%! IN!
Yoruba!Yale! SRR031877! NA19193! 9370200! 5710371! 60.90%! IN!
Yoruba!Yale! SRR031856! NA19200! 6213671! 4107279! 66.10%! IN!
Yoruba!Yale! SRR031948! NA19200! 9279557! 6174783! 66.50%! IN!
Yoruba!Yale! SRR031814! NA19201! 9408711! 6271029! 66.70%! IN!
Yoruba!Yale! SRR031893! NA19203! 9630700! 6088193! 63.20%! IN!
Yoruba!Yale! SRR031914! NA19204! 6353169! 4276872! 67.30%! IN!
Yoruba!Yale! SRR031812! NA19209! 10301610! 6960736! 67.60%! IN!
Yoruba!Yale! SRR031811! NA19210! 9956027! 6786391! 68.20%! IN!
Yoruba!Yale! SRR031842! NA19222! 4567036! 3041198! 66.60%! IN!
Yoruba!Yale! SRR031843! NA19225! 8249884! 5005359! 60.70%! IN!
Yoruba!Yale! SRR031860! NA19238! 8406706! 5559497! 66.10%! IN!
Yoruba!Yale! SRR031861! NA19239! 9085407! 6160822! 67.80%! IN!
Yoruba!Yale! SRR031837! NA19257! 7469692! 4677960! 62.60%! IN!
Yoruba!Argonne! SRR031938! NA18486! 7749699! 5335469! 68.80%! IN!
Yoruba!Argonne! SRR031881! NA18498! 8699228! 5640216! 64.80%! IN!
Yoruba!Argonne! SRR031933! NA18498! 11630601! 7889631! 67.80%! IN!
Yoruba!Argonne! SRR031834! NA18499! 10614370! 7219675! 68%! IN!
Yoruba!Argonne! SRR031965! NA18501! 3545671! 2031744! 57.30%! IN!
Yoruba!Argonne! SRR031903! NA18502! 8344912! 5231829! 62.70%! IN!
Yoruba!Argonne! SRR031962! NA18502! 6988357! 4769783! 68.30%! IN!
Yoruba!Argonne! SRR031909! NA18504! 8197125! 5508080! 67.20%! IN!
Yoruba!Argonne! SRR031928! NA18504! 5363063! 2352536! 43.90%! excluded!
Yoruba!Argonne! SRR031902! NA18505! 7132811! 4742478! 66.50%! IN!
Yoruba!Argonne! SRR031964! NA18505! 7950616! 5561170! 69.90%! IN!
Yoruba!Argonne! SRR031911! NA18507! 8330364! 5344483! 64.20%! IN!
Yoruba!Argonne! SRR031904! NA18508! 8454404! 5564196! 65.80%! IN!
Yoruba!Argonne! SRR031947! NA18510! 6373677! 4294849! 67.40%! IN!
Yoruba!Argonne! SRR031879! NA18511! 8968585! 6080419! 67.80%! IN!
Yoruba!Argonne! SRR031913! NA18516! 9088080! 6218607! 68.40%! IN!
Yoruba!Argonne! SRR031929! NA18516! 5528980! 1072563! 19.40%! excluded!
Yoruba!Argonne! SRR031925! NA18517! 10116924! 7076349! 69.90%! IN!
Yoruba!Argonne! SRR031926! NA18517! 9127309! 6292437! 68.90%! IN!
Yoruba!Argonne! SRR031906! NA18519! 8634607! 5589486! 64.70%! IN!
Yoruba!Argonne! SRR031880! NA18520! 9176125! 6291316! 68.60%! IN!
Yoruba!Argonne! SRR031930! NA18522! 9185184! 5890323! 64.10%! IN!
Yoruba!Argonne! SRR031941! NA18523! 5919358! 3794557! 64.10%! IN!
Yoruba!Argonne! SRR031944! NA18852! 5649346! 3804796! 67.30%! IN!
Yoruba!Argonne! SRR031891! NA18853! 9648196! 6553362! 67.90%! IN!
Yoruba!Argonne! SRR031945! NA18855! 6928515! 4356408! 62.90%! IN!
Yoruba!Argonne! SRR031963! NA18856! 6087872! 4249703! 69.80%! IN!
Yoruba!Argonne! SRR031966! NA18856! 1256211! 601597! 47.90%! excluded!
Yoruba!Argonne! SRR031907! NA18858! 7917503! 5245534! 66.30%! IN!
Yoruba!Argonne! SRR031885! NA18861! 8705183! 6058867! 69.60%! IN!
Yoruba!Argonne! SRR031890! NA18862! 9436367! 6523022! 69.10%! IN!
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Yoruba!Argonne! SRR031946! NA18870! 6042345! 4111104! 68%! IN!
Yoruba!Argonne! SRR031935! NA18871! 7201594! 4808881! 66.80%! IN!
Yoruba!Argonne! SRR031831! NA18909! 9798209! 6581875! 67.20%! IN!
Yoruba!Argonne! SRR031940! NA18912! 6848584! 4377071! 63.90%! IN!
Yoruba!Argonne! SRR031967! NA18912! 3996364! 2361875! 59.10%! IN!
Yoruba!Argonne! SRR031892! NA18913! 8291212! 5453895! 65.80%! IN!
Yoruba!Argonne! SRR031889! NA18916! 8167882! 5442251! 66.60%! IN!
Yoruba!Argonne! SRR031931! NA19093! 11714315! 8057167! 68.80%! IN!
Yoruba!Argonne! SRR031826! NA19098! 8128155! 5625073! 69.20%! IN!
Yoruba!Argonne! SRR031927! NA19099! 9474797! 6585702! 69.50%! IN!
Yoruba!Argonne! SRR031921! NA19101! 8870597! 6019952! 67.90%! IN!
Yoruba!Argonne! SRR031968! NA19102! 3989379! 2330831! 58.40%! IN!
Yoruba!Argonne! SRR031883! NA19108! 9033582! 6154095! 68.10%! IN!
Yoruba!Argonne! SRR031912! NA19114! 8677053! 5355292! 61.70%! IN!
Yoruba!Argonne! SRR031934! NA19116! 10528137! 7406579! 70.40%! IN!
Yoruba!Argonne! SRR031969! NA19119! 2326743! 1189076! 51.10%! excluded!
Yoruba!Argonne! SRR031901! NA19127! 8570023! 5693535! 66.40%! IN!
Yoruba!Argonne! SRR031922! NA19128! 9988733! 6840327! 68.50%! IN!
Yoruba!Argonne! SRR031923! NA19130! 10349515! 6983847! 67.50%! IN!
Yoruba!Argonne! SRR031882! NA19131! 9200019! 6405225! 69.60%! IN!
Yoruba!Argonne! SRR031960! NA19137! 8012428! 5215027! 65.10%! IN!
Yoruba!Argonne! SRR031905! NA19138! 8690202! 5466079! 62.90%! IN!
Yoruba!Argonne! SRR031900! NA19140! 8067824! 5270394! 65.30%! IN!
Yoruba!Argonne! SRR031836! NA19143! 10115208! 6967086! 68.90%! IN!
Yoruba!Argonne! SRR031827! NA19144! 8476906! 5920004! 69.80%! IN!
Yoruba!Argonne! SRR031832! NA19147! 10054713! 6678830! 66.40%! IN!
Yoruba!Argonne! SRR031833! NA19152! 10618007! 7254143! 68.30%! IN!
Yoruba!Argonne! SRR031830! NA19153! 7125012! 4823581! 67.70%! IN!
Yoruba!Argonne! SRR031937! NA19159! 6511480! 4517462! 69.40%! IN!
Yoruba!Argonne! SRR031910! NA19160! 9208450! 6072801! 65.90%! IN!
Yoruba!Argonne! SRR031943! NA19160! 5152078! 3354856! 65.10%! IN!
Yoruba!Argonne! SRR031939! NA19171! 7677962! 5115558! 66.60%! IN!
Yoruba!Argonne! SRR031970! NA19171! 2021638! 1014343! 50.20%! excluded!
Yoruba!Argonne! SRR031932! NA19172! 11662307! 7877883! 67.50%! IN!
Yoruba!Argonne! SRR031884! NA19190! 8965588! 5887818! 65.70%! IN!
Yoruba!Argonne! SRR031887! NA19192! 7650417! 5089494! 66.50%! IN!
Yoruba!Argonne! SRR031942! NA19193! 6340598! 3932956! 62%! IN!
Yoruba!Argonne! SRR031961! NA19200! 7227700! 4285837! 59.30%! IN!
Yoruba!Argonne! SRR031971! NA19200! 2091947! 1002855! 47.90%! excluded!
Yoruba!Argonne! SRR031828! NA19201! 8540954! 5783346! 67.70%! IN!
Yoruba!Argonne! SRR031924! NA19203! 9338220! 5950430! 63.70%! IN!
Yoruba!Argonne! SRR031936! NA19204! 8512123! 5893486! 69.20%! IN!
Yoruba!Argonne! SRR031835! NA19209! 10706267! 7355386! 68.70%! IN!
Yoruba!Argonne! SRR031829! NA19210! 8432368! 5854205! 69.40%! IN!
Yoruba!Argonne! SRR031888! NA19222! 8249437! 5500223! 66.70%! IN!
Yoruba!Argonne! SRR031908! NA19225! 8448726! 5180194! 61.30%! IN!
Yoruba!Argonne! SRR031824! NA19238! 7218325! 4836506! 67%! IN!
Yoruba!Argonne! SRR031825! NA19239! 7738999! 5322807! 68.80%! IN!
Yoruba!Argonne! SRR031886! NA19257! 8287438! 5360260! 64.70%! IN!
Caucasian! 2036_6! NA06985! 13479396! 7549440! 56%! IN!
Caucasian! 2036_7! NA06986! 12809262! 7441754! 58.10%! IN!
Caucasian! 2036_1! NA06994! 10888958! 5962178! 54.80%! IN!
Caucasian! 2036_2! NA07000! 11936598! 6754796! 56.60%! IN!
Caucasian! 1974_8! NA07037! 14686982! 7215560! 49.10%! IN!
Caucasian! 1974_1! NA07051! 15638594! 7499894! 48%! IN!
Caucasian! 2036_3! NA07346! 9756248! 5650087! 57.90%! IN!
Caucasian! 2036_5! NA07347! 11559190! 6682130! 57.80%! IN!
Caucasian! 1974_2! NA07357! 15880352! 8110508! 51.10%! IN!
Caucasian! 1974_3! NA10847! 12657358! 6287259! 49.70%! IN!
Caucasian! 1974_5! NA10851! 15399590! 7939448! 51.60%! IN!
Caucasian! 1974_6! NA11829! 14454072! 7735581! 53.50%! IN!
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Caucasian! 1974_7! NA11830! 15289724! 7285065! 47.60%! IN!
Caucasian! 2208_2! NA11831! 17580000! 9099653! 51.80%! IN!
Caucasian! 2208_6! NA11832! 20068578! 11132285! 55.50%! IN!
Caucasian! 2208_7! NA11840! 21168756! 12082294! 57.10%! IN!
Caucasian! 1982_8! NA11881! 16139102! 8430551! 52.20%! IN!
Caucasian! 2011_5! NA11894! 15562930! 8683697! 55.80%! IN!
Caucasian! 1671_5! NA11918! 9712674! 3612632! 37.20%! excluded!
Caucasian! 2005_1! NA11920! 20140148! 12082065! 60%! IN!
Caucasian! 2005_2! NA11931! 23293758! 13432794! 57.70%! IN!
Caucasian! 2005_5! NA11992! 21571510! 13349288! 61.90%! IN!
Caucasian! 2005_6! NA11993! 17465186! 9863626! 56.50%! IN!
Caucasian! 2872_6! NA11994! 21455824! 12178547! 56.80%! IN!
Caucasian! 2992_6! NA11995! 21220328! 11562248! 54.50%! IN!
Caucasian! 2872_2! NA12003! 17916816! 10413983! 58.10%! IN!
Caucasian! 2963_6! NA12004! 26281342! 3938459! 15%! excluded!
Caucasian! 2992_7! NA12005! 24829534! 12554445! 50.60%! IN!
Caucasian! 2992_5! NA12006! 31791830! 15975549! 50.30%! IN!
Caucasian! 2781_3! NA12043! 27166590! 14748122! 54.30%! IN!
Caucasian! 2787_2! NA12044! 27913944! 14583856! 52.20%! IN!
Caucasian! 3125_7! NA12045! 32022736! 18703475! 58.40%! IN!
Caucasian! 2208_5! NA12144! 10715162! 5311542! 49.60%! IN!
Caucasian! 3125_3! NA12154! 30511396! 16910641! 55.40%! IN!
Caucasian! 2003_6! NA12155! 16679396! 8943470! 53.60%! IN!
Caucasian! 2003_7! NA12156! 12671618! 7013325! 55.30%! IN!
Caucasian! 2005_7! NA12234! 17024072! 10012230! 58.80%! IN!
Caucasian! 2208_8! NA12249! 18386014! 9971295! 54.20%! IN!
Caucasian! 2005_8! NA12287! 18254010! 10225250! 56%! IN!
Caucasian! 2011_6! NA12414! 15642266! 8481075! 54.20%! IN!
Caucasian! 3125_1! NA12489! 18366650! 9836353! 53.60%! IN!
Caucasian! 3122_8! NA12716! 23539746! 12419424! 52.80%! IN!
Caucasian! 2208_1! NA12717! 17523658! 6654599! 38%! excluded!
Caucasian! 2420_1! NA12750! 14623120! 7332642! 50.10%! IN!
Caucasian! 2354_1! NA12751! 18187384! 8985905! 49.40%! IN!
Caucasian! 2250_2! NA12760! 22164688! 12685253! 57.20%! IN!
Caucasian! 2257_8! NA12761! 15637198! 8874794! 56.80%! IN!
Caucasian! 2262_8! NA12762! 16644894! 6046568! 36.30%! excluded!
Caucasian! 2420_2! NA12763! 14969998! 8868224! 59.20%! IN!
Caucasian! 2631_1! NA12776! 27144840! 14849951! 54.70%! IN!
Caucasian! 3122_7! NA12812! 30599136! 17050452! 55.70%! IN!
Caucasian! 2527_7! NA12813! 13423212! 6719136! 50.10%! IN!
Caucasian! 3125_6! NA12814! 29674410! 17214011! 58%! IN!
Caucasian! 2420_3! NA12815! 18690544! 8994827! 48.10%! IN!
Caucasian! 2421_5! NA12828! 22814152! 11229124! 49.20%! IN!
Caucasian! 3125_2! NA12872! 27931288! 15000061! 53.70%! IN!
Caucasian! 2589_8! NA12873! 34755800! 13133838! 37.80%! excluded!
Caucasian! 3125_5! NA12874! 27933676! 14539644! 52.10%! excluded!
Caucasian! 2872_8! NA12891! 18993390! 11614014! 61.10%! IN!










ChIP7seq,antibody, PC, N.obs, Freq.obs, Freq.expect, Fold, P,value,
ELF1_(SCN631)! 1! 1333! 71.60%! 65.50%! 1.1! 4.60EN10!
TBP! 1! 736! 39.50%! 34.60%! 1.1! 6.00EN07!
YY1_(CN20)! 1! 1106! 59.40%! 53.80%! 1.1! 6.10EN08!
EgrN1! 3! 663! 49.60%! 44.40%! 1.1! 3.00EN05!
CHD2_(NN1250)! 4! 393! 25.40%! 21%! 1.2! 3.30EN06!
EgrN1! 4! 765! 49.50%! 44.40%! 1.1! 8.80EN06!
ELF1_(SCN631)! 4! 1151! 74.50%! 65.50%! 1.1! 2.70EN16!
GABP! 4! 569! 36.80%! 31%! 1.2! 1.00EN07!
MEF2A! 4! 254! 16.40%! 13.20%! 1.2! 3.00EN05!
NFKB! 4! 193! 12.50%! 9.05%! 1.4! 5.50EN07!
Nrf1! 4! 557! 36%! 30.70%! 1.2! 6.90EN07!
OctN2! 4! 589! 38.10%! 32.70%! 1.2! 7.20EN07!
Pbx3! 4! 313! 20.20%! 16.50%! 1.2! 1.80EN05!
PU.1! 4! 459! 29.70%! 25.10%! 1.2! 4.00EN06!
RXRA! 4! 156! 10.10%! 7.42%! 1.4! 1.50EN05!
Sin3AkN20! 4! 914! 59.10%! 50.90%! 1.2! 1.40EN12!
SP1! 4! 746! 48.30%! 43.10%! 1.1! 6.60EN06!
SRF! 4! 398! 25.70%! 21.80%! 1.2! 3.10EN05!
TAF1! 4! 604! 39.10%! 31.40%! 1.2! 3.80EN12!
TBP! 4! 661! 42.80%! 34.60%! 1.2! 4.50EN13!
YY1_(CN20)! 4! 939! 60.70%! 53.80%! 1.1! 2.20EN09!
ATF3! 6! 173! 14.20%! 10.30%! 1.4! 2.00EN06!
BCLAF1_(M33NP5B11)! 6! 200! 16.40%! 12.80%! 1.3! 4.50EN05!
CHD2_(NN1250)! 6! 310! 25.40%! 21%! 1.2! 4.10EN05!
cNMyc! 6! 220! 18%! 13.80%! 1.3! 4.90EN06!
EgrN1! 6! 617! 50.60%! 44.40%! 1.1! 2.50EN06!
ELF1_(SCN631)! 6! 931! 76.30%! 65.50%! 1.2! 3.30EN18!
ETS1! 6! 250! 20.50%! 16.40%! 1.3! 3.00EN05!
GABP! 6! 514! 42.10%! 31%! 1.4! 2.60EN18!
Nrf1! 6! 451! 37%! 30.70%! 1.2! 3.50EN07!
OctN2! 6! 465! 38.10%! 32.70%! 1.2! 1.10EN05!
PAX5NC20! 6! 487! 39.90%! 34.10%! 1.2! 3.50EN06!
Sin3AkN20! 6! 772! 63.30%! 50.90%! 1.2! 1.50EN20!
SP1! 6! 642! 52.60%! 43.10%! 1.2! 9.40EN13!
SRF! 6! 327! 26.80%! 21.80%! 1.2! 4.90EN06!
TAF1! 6! 445! 36.50%! 31.40%! 1.2! 3.30EN05!
TBP! 6! 492! 40.30%! 34.60%! 1.2! 5.00EN06!
TR4! 6! 85! 6.97%! 4.26%! 1.6! 1.60EN06!
USFN1! 6! 312! 25.60%! 20.70%! 1.2! 6.90EN06!
YY1_(CN20)! 6! 793! 65%! 53.80%! 1.2! 3.70EN17!
ZEB1_(SCN25388)! 6! 378! 31%! 25.20%! 1.2! 6.10EN07!
Znf143_(16618N1NAP)! 6! 471! 38.60%! 31.70%! 1.2! 3.20EN08!
BCL3! 7! 86! 6.84%! 4.57%! 1.5! 4.40EN05!
CHD2_(NN1250)! 7! 428! 34%! 21%! 1.6! 1.90EN30!
cNMyc! 7! 260! 20.70%! 13.80%! 1.5! 4.40EN13!
EgrN1! 7! 702! 55.80%! 44.40%! 1.3! 4.00EN18!
ELF1_(SCN631)! 7! 996! 79.20%! 65.50%! 1.2! 1.20EN29!
ETS1! 7! 269! 21.40%! 16.40%! 1.3! 3.70EN07!
GABP! 7! 500! 39.80%! 31%! 1.3! 1.70EN12!
IRF3! 7! 107! 8.51%! 4.84%! 1.8! 1.20EN09!
Max! 7! 121! 9.63%! 6.60%! 1.5! 5.60EN06!
MEF2A! 7! 213! 16.90%! 13.20%! 1.3! 1.90EN05!
Nrf1! 7! 506! 40.30%! 30.70%! 1.3! 1.20EN14!
OctN2! 7! 574! 45.70%! 32.70%! 1.4! 1.80EN24!
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p300! 7! 98! 7.80%! 4.85%! 1.6! 5.70EN07!
PAX5NC20! 7! 546! 43.40%! 34.10%! 1.3! 1.70EN13!
Pbx3! 7! 290! 23.10%! 16.50%! 1.4! 1.00EN10!
RFX5_(NN494)! 7! 247! 19.60%! 13.30%! 1.5! 1.20EN11!
RXRA! 7! 130! 10.30%! 7.42%! 1.4! 2.60EN05!
Sin3AkN20! 7! 846! 67.30%! 50.90%! 1.3! 6.20EN36!
SP1! 7! 707! 56.20%! 43.10%! 1.3! 2.50EN23!
SRF! 7! 354! 28.20%! 21.80%! 1.3! 7.10EN09!
TAF1! 7! 603! 48%! 31.40%! 1.5! 8.40EN39!
TBP! 7! 593! 47.20%! 34.60%! 1.4! 1.10EN22!
TCF12! 7! 423! 33.70%! 25.60%! 1.3! 8.20EN12!
USFN1! 7! 350! 27.80%! 20.70%! 1.3! 7.30EN11!
USF2! 7! 331! 26.30%! 19.10%! 1.4! 9.60EN12!
YY1_(CN20)! 7! 840! 66.80%! 53.80%! 1.2! 2.40EN23!
ZBTB33! 7! 181! 14.40%! 9.79%! 1.5! 1.30EN08!
Znf143_(16618N1NAP)! 7! 504! 40.10%! 31.70%! 1.3! 1.40EN11!
Sin3AkN20! 9! 108! 68.40%! 50.90%! 1.3! 2.60EN06!
ATF3! 10! 45! 18.20%! 10.30%! 1.8! 4.30EN05!
cNMyc! 10! 71! 28.70%! 13.80%! 2.1! 1.80EN10!
EgrN1! 10! 141! 57.10%! 44.40%! 1.3! 2.10EN05!
ELF1_(SCN631)! 10! 200! 81%! 65.50%! 1.2! 2.10EN08!
ETS1! 10! 64! 25.90%! 16.40%! 1.6! 4.30EN05!
GABP! 10! 110! 44.50%! 31%! 1.4! 2.50EN06!
Nrf1! 10! 121! 49%! 30.70%! 1.6! 4.50EN10!
PAX5NC20! 10! 118! 47.80%! 34.10%! 1.4! 2.80EN06!
Sin3AkN20! 10! 180! 72.90%! 50.90%! 1.4! 3.20EN13!
SP1! 10! 156! 63.20%! 43.10%! 1.5! 5.50EN11!
USFN1! 10! 86! 34.80%! 20.70%! 1.7! 7.10EN08!
USF2! 10! 81! 32.80%! 19.10%! 1.7! 7.30EN08!
YY1_(CN20)! 10! 191! 77.30%! 53.80%! 1.4! 3.20EN15!
Znf143_(16618N1NAP)! 10! 122! 49.40%! 31.70%! 1.6! 1.90EN09!
cNMyc! 11! 55! 23.80%! 13.80%! 1.7! 1.20EN05!
CHD2_(NN1250)! 12! 69! 32.90%! 21%! 1.6! 1.90EN05!
cNMyc! 12! 50! 23.80%! 13.80%! 1.7! 2.80EN05!
ELF1_(SCN631)! 12! 165! 78.60%! 65.50%! 1.2! 1.10EN05!
Nrf1! 12! 93! 44.30%! 30.70%! 1.4! 1.10EN05!
Sin3AkN20! 12! 141! 67.10%! 50.90%! 1.3! 5.30EN07!
SP1! 12! 134! 63.80%! 43.10%! 1.5! 4.00EN10!
EgrN1! 14! 50! 66.70%! 44.40%! 1.5! 3.10EN05!
SP1! 14! 49! 65.30%! 43.10%! 1.5! 3.20EN05!
!
Yoruba,Argonne,data,
ChIP7seq,antibody, PC, N.obs, Freq.obs, Freq.expect, Fold, P,value,
ELF1_(SCN631)! 3! 1042! 71.20%! 64.70%! 1.1! 9.20EN09!
GABP! 3! 552! 37.70%! 30.70%! 1.2! 3.60EN10!
OctN2! 3! 557! 38%! 32.30%! 1.2! 3.30EN07!
Sin3AkN20! 3! 835! 57%! 50.30%! 1.1! 1.70EN08!
SP1! 3! 710! 48.50%! 42.50%! 1.1! 4.30EN07!
TAF1! 3! 568! 38.80%! 31%! 1.3! 7.00EN12!
TBP! 3! 635! 43.40%! 34.30%! 1.3! 4.70EN15!
TCF12! 3! 437! 29.80%! 25.40%! 1.2! 2.00EN05!
YY1_(CN20)! 3! 915! 62.50%! 53.20%! 1.2! 1.20EN14!
Znf143_(16618N1NAP)! 3! 539! 36.80%! 31.50%! 1.2! 1.70EN06!
EgrN1! 4! 849! 49%! 43.70%! 1.1! 8.40EN07!
ELF1_(SCN631)! 4! 1285! 74.20%! 64.70%! 1.1! 3.40EN20!
ETS1! 4! 349! 20.20%! 16.10%! 1.2! 7.70EN07!
GABP! 4! 634! 36.60%! 30.70%! 1.2! 4.70EN09!
Nrf1! 4! 597! 34.50%! 30.20%! 1.1! 1.50EN05!
OctN2! 4! 640! 37%! 32.30%! 1.1! 4.40EN06!
PU.1! 4! 507! 29.30%! 24.80%! 1.2! 1.90EN06!
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Sin3AkN20! 4! 990! 57.20%! 50.30%! 1.1! 3.00EN10!
SRF! 4! 439! 25.30%! 21.50%! 1.2! 1.80EN05!
TAF1! 4! 645! 37.20%! 31%! 1.2! 1.20EN09!
TBP! 4! 686! 39.60%! 34.30%! 1.2! 2.20EN07!
YY1_(CN20)! 4! 1045! 60.30%! 53.20%! 1.1! 6.70EN11!
EgrN1! 5! 505! 50.90%! 43.70%! 1.2! 1.10EN06!
ELF1_(SCN631)! 5! 721! 72.60%! 64.70%! 1.1! 1.30EN08!
Sin3AkN20! 5! 577! 58.10%! 50.30%! 1.2! 1.20EN07!
SP1! 5! 481! 48.40%! 42.50%! 1.1! 4.10EN05!
ATF3! 6! 181! 13.70%! 10.10%! 1.4! 4.00EN06!
BCLAF1_(M33NP5B11)! 6! 214! 16.20%! 12.60%! 1.3! 1.50EN05!
CHD2_(NN1250)! 6! 346! 26.30%! 20.80%! 1.3! 1.60EN07!
cNMyc! 6! 255! 19.30%! 13.60%! 1.4! 2.40EN10!
EgrN1! 6! 680! 51.60%! 43.70%! 1.2! 5.80EN10!
ELF1_(SCN631)! 6! 994! 75.40%! 64.70%! 1.2! 3.80EN19!
ETS1! 6! 297! 22.50%! 16.10%! 1.4! 5.50EN11!
GABP! 6! 550! 41.70%! 30.70%! 1.4! 8.00EN20!
Nrf1! 6! 515! 39.10%! 30.20%! 1.3! 1.30EN13!
OctN2! 6! 544! 41.30%! 32.30%! 1.3! 1.80EN13!
PAX5NC20! 6! 561! 42.60%! 33.70%! 1.3! 4.00EN13!
RXRA! 6! 140! 10.60%! 7.35%! 1.4! 1.80EN06!
Sin3AkN20! 6! 846! 64.20%! 50.30%! 1.3! 2.60EN27!
SP1! 6! 720! 54.60%! 42.50%! 1.3! 3.80EN21!
SRF! 6! 377! 28.60%! 21.50%! 1.3! 5.80EN11!
TAF1! 6! 501! 38%! 31%! 1.2! 4.80EN09!
TBP! 6! 524! 39.80%! 34.30%! 1.2! 4.40EN06!
TCF12! 6! 406! 30.80%! 25.40%! 1.2! 1.30EN06!
TR4! 6! 84! 6.37%! 4.15%! 1.5! 2.10EN05!
USFN1! 6! 328! 24.90%! 20.40%! 1.2! 1.50EN05!
USF2! 6! 302! 22.90%! 18.80%! 1.2! 2.70EN05!
YY1_(CN20)! 6! 850! 64.50%! 53.20%! 1.2! 1.00EN18!
Znf143_(16618N1NAP)! 6! 532! 40.40%! 31.50%! 1.3! 2.50EN13!
CHD2_(NN1250)! 7! 265! 31%! 20.80%! 1.5! 9.60EN14!
EgrN1! 7! 450! 52.60%! 43.70%! 1.2! 2.60EN08!
ELF1_(SCN631)! 7! 655! 76.60%! 64.70%! 1.2! 2.60EN15!
GABP! 7! 325! 38%! 30.70%! 1.2! 8.40EN07!
IRF3! 7! 73! 8.54%! 4.81%! 1.8! 4.60EN07!
OctN2! 7! 361! 42.20%! 32.30%! 1.3! 1.20EN10!
PAX5NC20! 7! 356! 41.60%! 33.70%! 1.2! 1.90EN07!
Pbx3! 7! 189! 22.10%! 16.30%! 1.4! 2.10EN06!
RFX5_(NN494)! 7! 157! 18.40%! 13.30%! 1.4! 5.00EN06!
Sin3AkN20! 7! 534! 62.50%! 50.30%! 1.2! 5.00EN14!
SP1! 7! 461! 53.90%! 42.50%! 1.3! 1.60EN12!
SPT20! 7! 5! 0.59%! 0.09%! 6.6! 3.60EN05!
TAF1! 7! 362! 42.30%! 31%! 1.4! 1.80EN13!
TBP! 7! 402! 47%! 34.30%! 1.4! 5.20EN16!
TCF12! 7! 270! 31.60%! 25.40%! 1.2! 1.20EN05!
YY1_(CN20)! 7! 558! 65.30%! 53.20%! 1.2! 6.70EN14!
cNMyc! 8! 70! 23%! 13.60%! 1.7! 2.40EN06!
ELF1_(SCN631)! 8! 231! 75.70%! 64.70%! 1.2! 1.00EN05!
GABP! 8! 130! 42.60%! 30.70%! 1.4! 3.00EN06!
OctN2! 8! 133! 43.60%! 32.30%! 1.3! 1.10EN05!
RFX5_(NN494)! 8! 67! 22%! 13.30%! 1.7! 8.30EN06!
Sin3AkN20! 8! 199! 65.20%! 50.30%! 1.3! 3.60EN08!
SP1! 8! 163! 53.40%! 42.50%! 1.3! 4.20EN05!
TBP! 8! 138! 45.20%! 34.30%! 1.3! 2.20EN05!
USFN1! 8! 94! 30.80%! 20.40%! 1.5! 5.40EN06!
USF2! 8! 87! 28.50%! 18.80%! 1.5! 9.70EN06!
YY1_(CN20)! 8! 196! 64.30%! 53.20%! 1.2! 3.20EN05!
cNMyc! 9! 92! 25.10%! 13.60%! 1.9! 6.30EN10!
ELF1_(SCN631)! 9! 274! 74.90%! 64.70%! 1.2! 8.80EN06!
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Nrf1! 9! 159! 43.40%! 30.20%! 1.4! 2.00EN08!
OctN2! 9! 155! 42.30%! 32.30%! 1.3! 1.70EN05!
Sin3AkN20! 9! 256! 69.90%! 50.30%! 1.4! 3.30EN15!
SP1! 9! 219! 59.80%! 42.50%! 1.4! 5.10EN12!
SRF! 9! 110! 30.10%! 21.50%! 1.4! 4.10EN05!
TBP! 9! 162! 44.30%! 34.30%! 1.3! 2.20EN05!
YY1_(CN20)! 9! 239! 65.30%! 53.20%! 1.2! 8.30EN07!
cNMyc! 10! 53! 27.20%! 13.60%! 2! 1.30EN07!
PAX5NC20! 10! 93! 47.70%! 33.70%! 1.4! 1.60EN05!
TAF1! 10! 87! 44.60%! 31%! 1.4! 2.20EN05!
CHD2_(NN1250)! 11! 55! 33.50%! 20.80%! 1.6! 4.20EN05!
cNMyc! 11! 50! 30.50%! 13.60%! 2.2! 4.50EN09!
ELF1_(SCN631)! 11! 137! 83.50%! 64.70%! 1.3! 2.10EN08!
GABP! 11! 78! 47.60%! 30.70%! 1.6! 1.70EN06!
OctN2! 11! 80! 48.80%! 32.30%! 1.5! 3.60EN06!
Sin3AkN20! 11! 116! 70.70%! 50.30%! 1.4! 2.80EN08!
SP1! 11! 101! 61.60%! 42.50%! 1.4! 2.70EN07!
TAF1! 11! 84! 51.20%! 31%! 1.7! 2.00EN08!
USFN1! 11! 64! 39%! 20.40%! 1.9! 1.20EN08!
USF2! 11! 55! 33.50%! 18.80%! 1.8! 1.80EN06!
cNMyc! 12! 40! 25.30%! 13.60%! 1.9! 2.30EN05!
YY1_(CN20)! 12! 108! 68.40%! 53.20%! 1.3! 3.70EN05!
TAF1! 13! 49! 50%! 31%! 1.6! 2.80EN05!
TBP! 13! 53! 54.10%! 34.30%! 1.6! 1.70EN05!
cNMyc! 17! 30! 35.30%! 13.60%! 2.6! 8.80EN08!
Sin3AkN20! 17! 62! 72.90%! 50.30%! 1.5! 5.90EN06!
TAF1! 17! 45! 52.90%! 31%! 1.7! 7.80EN06!
TCF12! 19! 41! 44.60%! 25.40%! 1.8! 2.00EN05!
!
Caucasian,data,
ChIP7seq,antibody! PC! N.obs! Freq.obs! Freq.expect! Fold! P,value!
CHD2_(NN1250)! 1! 528! 26.80%! 23.40%! 1.1! 2.90EN05!
ELF1_(SCN631)! 1! 1527! 77.60%! 70.90%! 1.1! 4.40EN14!
GABP! 1! 800! 40.60%! 33.90%! 1.2! 1.20EN12!
Nrf1! 1! 732! 37.20%! 33.40%! 1.1! 3.90EN05!
OctN2! 1! 856! 43.50%! 36.20%! 1.2! 3.70EN14!
PAX5NC20! 1! 808! 41%! 37.20%! 1.1! 3.20EN05!
Sin3AkN20! 1! 1261! 64%! 56.20%! 1.1! 7.00EN16!
SP1! 1! 1023! 52%! 47.10%! 1.1! 6.10EN07!
SRF! 1! 563! 28.60%! 24.20%! 1.2! 1.50EN07!
TAF1! 1! 846! 43%! 35.40%! 1.2! 2.40EN15!
TBP! 1! 940! 47.70%! 38.20%! 1.2! 1.40EN22!
YY1_(CN20)! 1! 1286! 65.30%! 58.70%! 1.1! 8.80EN12!
ELF1_(SCN631)! 3! 814! 78.50%! 70.90%! 1.1! 2.00EN09!
ETS1! 3! 237! 22.90%! 18%! 1.3! 1.00EN05!
GABP! 3! 443! 42.70%! 33.90%! 1.3! 1.80EN10!
Nrf1! 3! 412! 39.70%! 33.40%! 1.2! 3.00EN06!
Sin3AkN20! 3! 663! 63.90%! 56.20%! 1.1! 3.20EN08!
SP1! 3! 561! 54.10%! 47.10%! 1.1! 8.00EN07!
SRF! 3! 303! 29.20%! 24.20%! 1.2! 3.20EN05!
TAF1! 3! 439! 42.30%! 35.40%! 1.2! 4.30EN07!
YY1_(CN20)! 3! 716! 69%! 58.70%! 1.2! 1.70EN13!
ATF3! 5! 172! 16.10%! 11.40%! 1.4! 2.70EN07!
CHD2_(NN1250)! 5! 333! 31.20%! 23.40%! 1.3! 1.70EN10!
cNMyc! 5! 217! 20.40%! 15.70%! 1.3! 5.70EN06!
ELF1_(SCN631)! 5! 857! 80.40%! 70.90%! 1.1! 2.70EN14!
ETS1! 5! 244! 22.90%! 18%! 1.3! 6.80EN06!
GABP! 5! 466! 43.70%! 33.90%! 1.3! 7.30EN13!
Nrf1! 5! 418! 39.20%! 33.40%! 1.2! 1.20EN05!
OctN2! 5! 456! 42.80%! 36.20%! 1.2! 1.20EN06!
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PAX5NC20! 5! 475! 44.60%! 37.20%! 1.2! 6.40EN08!
Sin3AkN20! 5! 716! 67.20%! 56.20%! 1.2! 3.00EN15!
SP1! 5! 598! 56.10%! 47.10%! 1.2! 1.90EN10!
SRF! 5! 316! 29.60%! 24.20%! 1.2! 5.70EN06!
TAF1! 5! 471! 44.20%! 35.40%! 1.2! 1.40EN10!
TBP! 5! 470! 44.10%! 38.20%! 1.2! 1.40EN05!
USF2! 5! 286! 26.80%! 21.10%! 1.3! 7.30EN07!
YY1_(CN20)! 5! 775! 72.70%! 58.70%! 1.2! 3.50EN24!
ZBTB33! 5! 159! 14.90%! 10.70%! 1.4! 2.80EN06!
Znf143_(16618N1NAP)! 5! 447! 41.90%! 34.20%! 1.2! 1.10EN08!
CHD2_(NN1250)! 6! 158! 34.50%! 23.40%! 1.5! 1.20EN08!
cNMyc! 6! 115! 25.10%! 15.70%! 1.6! 2.90EN08!
ELF1_(SCN631)! 6! 365! 79.70%! 70.90%! 1.1! 4.60EN06!
Sin3AkN20! 6! 314! 68.60%! 56.20%! 1.2! 1.00EN08!
SP1! 6! 269! 58.70%! 47.10%! 1.2! 1.30EN07!
OctN2! 7! 109! 49.30%! 36.20%! 1.4! 2.10EN05!
Max! 9! 32! 14.70%! 7.18%! 2.1! 2.90EN05!
OctN2! 9! 107! 49.30%! 36.20%! 1.4! 2.50EN05!
USFN1! 9! 75! 34.60%! 22.90%! 1.5! 2.90EN05!
YY1_(CN20)! 9! 155! 71.40%! 58.70%! 1.2! 3.30EN05!
cNMyc! 14! 30! 30.90%! 15.70%! 2! 4.50EN05!








, , 2,kbp,region, 5,kbp,region, 10,kbp,region,
ChIP7seq,antibody, PC, N.gene, P, N.gene, P, N.gene, P,
ATF3! 6! 173! 2.00EN06! 182! 4.30EN06! 191! 6.70EN06!
ATF3! 10! 45! 4.30EN05! 50! 6.40EN06! 50! 3.70EN05!
BCL3! 7! 86! 4.40EN05! 108! 7.60EN05! 137! 5.80EN05!
BCLAF1_(M33NP5B11)! 6! 200! 4.50EN05! 214! 2.00EN04! 240! 1.80EN05!
CHD2_(NN1250)! 4! 393! 3.30EN06! 417! 6.40EN06! 439! 1.00EN05!
CHD2_(NN1250)! 6! 310! 4.10EN05! 330! 5.00EN05! 356! 5.90EN06!
CHD2_(NN1250)! 7! 428! 1.90EN30! 453! 6.50EN31! 472! 3.40EN30!
CHD2_(NN1250)! 12! 69! 1.90EN05! 73! 1.80EN05! 76! 2.50EN05!
cNMyc! 6! 220! 4.90EN06! 236! 1.40EN05! 254! 2.40EN06!
cNMyc! 7! 260! 4.40EN13! 281! 3.60EN13! 300! 2.60EN14!
cNMyc! 10! 71! 1.80EN10! 83! 8.90EN14! 83! 2.90EN12!
cNMyc! 11! 55! 1.20EN05! 67! 2.10EN08! 72! 3.20EN09!
cNMyc! 12! 50! 2.80EN05! 55! 1.10EN05! 56! 3.20EN05!
EgrN1! 3! 663! 3.00EN05! 717! 6.40EN06! 750! 1.90EN05!
EgrN1! 4! 765! 8.80EN06! 820! 9.70EN06! 868! 2.70EN06!
EgrN1! 6! 617! 2.50EN06! 659! 4.00EN06! 690! 9.00EN06!
EgrN1! 7! 702! 4.00EN18! 752! 2.70EN19! 792! 1.30EN20!
EgrN1! 10! 141! 2.10EN05! 149! 3.30EN05! 156! 2.90EN05!
EgrN1! 14! 50! 3.10EN05! 51! 0.00015! 53! 0.00014!
ELF1_(SCN631)! 1! 1333! 4.60EN10! 1378! 3.10EN08! 1415! 7.80EN07!
ELF1_(SCN631)! 4! 1151! 2.70EN16! 1190! 1.10EN14! 1222! 2.10EN13!
ELF1_(SCN631)! 6! 931! 3.30EN18! 962! 5.90EN17! 997! 1.50EN18!
ELF1_(SCN631)! 7! 996! 1.20EN29! 1027! 4.10EN28! 1065! 1.60EN31!
ELF1_(SCN631)! 10! 200! 2.10EN08! 211! 3.40EN10! 214! 3.40EN09!
ELF1_(SCN631)! 12! 165! 1.10EN05! 169! 4.50EN05! 170! 0.00056!
ETS1! 6! 250! 3.00EN05! 271! 4.30EN06! 287! 3.90EN06!
ETS1! 7! 269! 3.70EN07! 286! 2.50EN07! 301! 4.10EN07!
ETS1! 10! 64! 4.30EN05! 67! 5.40EN05! 69! 0.00013!
GABP! 4! 569! 1.00EN07! 599! 1.10EN07! 615! 7.90EN07!
GABP! 6! 514! 2.60EN18! 544! 1.40EN19! 561! 3.00EN19!
GABP! 7! 500! 1.70EN12! 535! 1.90EN14! 561! 5.90EN16!
GABP! 10! 110! 2.50EN06! 119! 1.90EN07! 122! 3.20EN07!
GCN5! 8! 4! 2.40EN05! 4! 3.50EN05! 4! 6.60EN05!
IRF3! 7! 107! 1.20EN09! 111! 1.10EN09! 113! 1.10EN08!
Max! 7! 121! 5.60EN06! 136! 1.30EN05! 158! 6.30EN07!
MEF2A! 4! 254! 3.00EN05! 312! 0.00014! 379! 0.00034!
MEF2A! 7! 213! 1.90EN05! 265! 2.10EN05! 322! 3.10EN05!
NFKB! 4! 193! 5.50EN07! 239! 1.10EN06! 288! 6.00EN06!
Nrf1! 4! 557! 6.90EN07! 586! 7.90EN07! 614! 4.40EN07!
Nrf1! 6! 451! 3.50EN07! 483! 1.90EN08! 498! 1.30EN07!
Nrf1! 7! 506! 1.20EN14! 532! 6.40EN15! 558! 7.50EN16!
Nrf1! 10! 121! 4.50EN10! 128! 8.50EN11! 135! 8.60EN12!
Nrf1! 12! 93! 1.10EN05! 97! 1.20EN05! 103! 2.70EN06!
OctN2! 4! 589! 7.20EN07! 644! 9.70EN07! 697! 4.50EN07!
OctN2! 6! 465! 1.10EN05! 505! 3.50EN05! 541! 8.80EN05!
OctN2! 7! 574! 1.80EN24! 622! 1.00EN24! 660! 1.00EN23!
p300! 7! 98! 5.70EN07! 114! 3.80EN07! 131! 2.70EN06!
PAX5NC20! 6! 487! 3.50EN06! 545! 1.10EN05! 605! 5.40EN06!
PAX5NC20! 7! 546! 1.70EN13! 620! 2.60EN15! 671! 1.30EN13!
PAX5NC20! 10! 118! 2.80EN06! 135! 2.00EN07! 144! 1.20EN06!
Pbx3! 4! 313! 1.80EN05! 365! 4.30EN06! 412! 1.00EN06!
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Pbx3! 7! 290! 1.00EN10! 338! 2.60EN12! 373! 4.20EN12!
PU.1! 4! 459! 4.00EN06! 590! 8.20EN06! 700! 2.80EN05!
RFX5_(NN494)! 7! 247! 1.20EN11! 271! 1.20EN12! 291! 1.50EN12!
RXRA! 4! 156! 1.50EN05! 174! 3.00EN05! 198! 3.30EN05!
RXRA! 7! 130! 2.60EN05! 145! 4.30EN05! 168! 1.30EN05!
Sin3AkN20! 4! 914! 1.40EN12! 955! 3.60EN12! 980! 3.90EN11!
Sin3AkN20! 6! 772! 1.50EN20! 806! 1.30EN20! 841! 1.70EN23!
Sin3AkN20! 7! 846! 6.20EN36! 891! 9.80EN40! 914! 2.60EN39!
Sin3AkN20! 9! 108! 2.60EN06! 112! 3.10EN06! 114! 7.00EN06!
Sin3AkN20! 10! 180! 3.20EN13! 194! 7.20EN17! 197! 3.90EN16!
Sin3AkN20! 12! 141! 5.30EN07! 145! 1.80EN06! 146! 1.40EN05!
SP1! 4! 746! 6.60EN06! 798! 4.20EN06! 840! 9.60EN06!
SP1! 6! 642! 9.40EN13! 678! 4.50EN12! 713! 5.90EN12!
SP1! 7! 707! 2.50EN23! 752! 2.00EN24! 793! 1.10EN25!
SP1! 10! 156! 5.50EN11! 165! 2.10EN11! 170! 1.20EN10!
SP1! 12! 134! 4.00EN10! 138! 4.20EN09! 143! 9.20EN09!
SP1! 14! 49! 3.20EN05! 52! 1.70EN05! 54! 1.80EN05!
SRF! 4! 398! 3.10EN05! 438! 0.00035! 488! 0.00014!
SRF! 6! 327! 4.90EN06! 370! 1.90EN06! 407! 1.90EN06!
SRF! 7! 354! 7.10EN09! 406! 1.20EN10! 443! 2.60EN10!
TAF1! 4! 604! 3.80EN12! 628! 1.10EN11! 649! 2.40EN11!
TAF1! 6! 445! 3.30EN05! 462! 8.70EN05! 482! 5.10EN05!
TAF1! 7! 603! 8.40EN39! 621! 3.20EN37! 644! 1.90EN38!
TBP! 1! 736! 6.00EN07! 789! 3.70EN06! 822! 7.60EN05!
TBP! 4! 661! 4.50EN13! 709! 1.40EN12! 747! 2.10EN12!
TBP! 6! 492! 5.00EN06! 527! 1.80EN05! 551! 9.70EN05!
TBP! 7! 593! 1.10EN22! 636! 5.30EN23! 681! 1.90EN26!
TCF12! 7! 423! 8.20EN12! 475! 5.50EN12! 517! 2.60EN10!
TR4! 6! 85! 1.60EN06! 88! 8.20EN06! 91! 2.80EN05!
USFN1! 6! 312! 6.90EN06! 345! 1.20EN05! 393! 5.40EN08!
USFN1! 7! 350! 7.30EN11! 384! 2.50EN10! 420! 8.50EN11!
USFN1! 10! 86! 7.10EN08! 94! 6.00EN08! 101! 6.00EN08!
USF2! 7! 331! 9.60EN12! 370! 1.60EN11! 413! 8.50EN13!
USF2! 10! 81! 7.30EN08! 87! 4.50EN07! 96! 1.70EN07!
YY1_(CN20)! 1! 1106! 6.10EN08! 1161! 1.60EN05! 1210! 0.00068!
YY1_(CN20)! 4! 939! 2.20EN09! 1001! 3.60EN09! 1046! 9.80EN08!
YY1_(CN20)! 6! 793! 3.70EN17! 841! 6.40EN17! 885! 2.50EN17!
YY1_(CN20)! 7! 840! 2.40EN23! 882! 3.20EN21! 920! 7.10EN20!
YY1_(CN20)! 10! 191! 3.20EN15! 205! 5.80EN18! 209! 4.20EN16!
ZBTB33! 7! 181! 1.30EN08! 193! 9.60EN09! 208! 6.30EN09!
ZEB1_(SCN25388)! 6! 378! 6.10EN07! 415! 9.00EN07! 455! 2.00EN07!
Znf143_(16618N1NAP)! 6! 471! 3.20EN08! 515! 1.20EN06! 572! 7.50EN07!
Znf143_(16618N1NAP)! 7! 504! 1.40EN11! 569! 4.80EN13! 623! 2.40EN12!
















ELF1,YY1! 1! 1009! 54.20%! 48.30%! 1.1! 1.30EN08!
SP1,YY1! 4! 584! 37.80%! 32.50%! 1.2! 1.40EN06!
ELF1,YY1! 4! 872! 56.40%! 48.30%! 1.2! 3.70EN12!
ELF1,SP1! 4! 695! 45%! 39%! 1.2! 1.50EN07!
ELF1,TAF1,TBP! 4! 428! 27.70%! 21.80%! 1.3! 1.70EN09!
ELF1,Nrf1,YY1! 4! 411! 26.60%! 21%! 1.3! 7.00EN09!
ELF1,PAX5NC20! 4! 548! 35.40%! 30.90%! 1.1! 1.90EN05!
ELF1,OctN2,YY1! 4! 461! 29.80%! 25.40%! 1.2! 1.30EN05!
EgrN1,Sin3AkN20! 4! 555! 35.90%! 30.90%! 1.2! 3.00EN06!
ELF1,SP1,TAF1,YY1! 4! 344! 22.30%! 18.40%! 1.2! 1.90EN05!
ELF1,Sin3AkN20,TBP! 4! 487! 31.50%! 24.70%! 1.3! 2.70EN11!
EgrN1,Sin3AkN20,YY1! 4! 459! 29.70%! 24.60%! 1.2! 4.50EN07!
ELF1,OctN2,TAF1,YY1! 4! 338! 21.90%! 18.10%! 1.2! 2.30EN05!
ELF1,PAX5NC20,Sin3AkN20! 4! 445! 28.80%! 24.10%! 1.2! 2.50EN06!
ELF1,Nrf1,Sin3AkN20,SP1! 4! 272! 17.60%! 14.10%! 1.3! 1.40EN05!
EgrN1,ELF1,Sin3AkN20,YY1! 4! 439! 28.40%! 23.30%! 1.2! 2.80EN07!
ELF1,GABP,Sin3AkN20,TBP,YY1! 4! 247! 16%! 12.60%! 1.3! 1.10EN05!
EgrN1,ELF1,PU.1,Sin3AkN20,YY1! 4! 181! 11.70%! 8.50%! 1.4! 1.40EN06!
SP1,YY1! 6! 505! 41.40%! 32.50%! 1.3! 3.10EN12!
ELF1,YY1! 6! 727! 59.60%! 48.30%! 1.2! 3.10EN17!
ELF1,SP1! 6! 591! 48.40%! 39%! 1.2! 7.10EN13!
YY1,ZEB1! 6! 297! 24.30%! 18.70%! 1.3! 8.20EN08!
ELF1,ZEB1! 6! 347! 28.40%! 22.40%! 1.3! 6.90EN08!
EgrN1,SP1,YY1! 6! 331! 27.10%! 21.10%! 1.3! 4.40EN08!
ELF1,Nrf1,YY1! 6! 328! 26.90%! 21%! 1.3! 8.70EN08!
ELF1,PAX5NC20! 6! 454! 37.20%! 30.90%! 1.2! 3.10EN07!
ELF1,TAF1,TBP! 6! 332! 27.20%! 21.80%! 1.2! 8.80EN07!
Sin3AkN20,ZEB1! 6! 294! 24.10%! 17.60%! 1.4! 6.30EN10!
ELF1,OctN2,YY1! 6! 388! 31.80%! 25.40%! 1.3! 5.70EN08!
CTCF,Sin3AkN20! 6! 265! 21.70%! 16.60%! 1.3! 3.30EN07!
USFN1,USF2,YY1! 6! 190! 15.60%! 11.70%! 1.3! 6.90EN06!
EgrN1,Sin3AkN20! 6! 475! 38.90%! 30.90%! 1.3! 1.40EN10!
ELF1,SP1,TAF1,YY1! 6! 279! 22.90%! 18.40%! 1.2! 1.50EN05!
ELF1,Sin3AkN20,TBP! 6! 367! 30.10%! 24.70%! 1.2! 2.30EN06!
EgrN1,Sin3AkN20,YY1! 6! 394! 32.30%! 24.60%! 1.3! 6.20EN11!
ELF1,Sin3AkN20,Znf143! 6! 350! 28.70%! 21.90%! 1.3! 2.00EN09!
ELF1,PAX5NC20,Sin3AkN20! 6! 367! 30.10%! 24.10%! 1.2! 1.90EN07!
ELF1,Nrf1,Sin3AkN20,SP1! 6! 222! 18.20%! 14.10%! 1.3! 9.60EN06!
EgrN1,ELF1,Sin3AkN20,YY1! 6! 382! 31.30%! 23.30%! 1.3! 5.00EN12!
ELF1,OctN2,Sin3AkN20,SP1! 6! 280! 23%! 17.70%! 1.3! 4.60EN07!
SP1,YY1! 7! 558! 44.40%! 32.50%! 1.4! 6.90EN21!
ELF1,YY1! 7! 773! 61.50%! 48.30%! 1.3! 1.40EN23!
ELF1,SP1! 7! 654! 52%! 39%! 1.3! 2.00EN23!
EBF1,ELF1! 7! 361! 28.70%! 23.40%! 1.2! 1.80EN06!
EBF1,EgrN1! 7! 273! 21.70%! 16.80%! 1.3! 7.90EN07!
ELF1,TAF1,TBP! 7! 423! 33.70%! 21.80%! 1.5! 2.70EN25!
ELF1,PAX5NC20! 7! 518! 41.20%! 30.90%! 1.3! 1.30EN16!
EgrN1,SP1,YY1! 7! 379! 30.20%! 21.10%! 1.4! 4.30EN16!
ELF1,Nrf1,YY1! 7! 364! 29%! 21%! 1.4! 5.80EN13!
EBF1,ELF1,YY1! 7! 275! 21.90%! 16.90%! 1.3! 6.00EN07!
ELF1,OctN2,YY1! 7! 461! 36.70%! 25.40%! 1.4! 3.80EN21!
Sin3AkN20,USF2! 7! 265! 21.10%! 14.50%! 1.5! 9.70EN12!
USFN1,USF2,YY1! 7! 211! 16.80%! 11.70%! 1.4! 5.40EN09!
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Sin3AkN20,ZEB1! 7! 280! 22.30%! 17.60%! 1.3! 3.60EN06!
EgrN1,Sin3AkN20! 7! 533! 42.40%! 30.90%! 1.4! 3.70EN20!
EBF1,EgrN1,ELF1! 7! 249! 19.80%! 14.80%! 1.3! 1.70EN07!
ELF1,SP1,TAF1,YY1! 7! 366! 29.10%! 18.40%! 1.6! 3.70EN23!
ELF1,PAX5NC20,TBP! 7! 334! 26.60%! 17.60%! 1.5! 1.30EN17!
ELF1,Sin3AkN20,TBP! 7! 467! 37.20%! 24.70%! 1.5! 6.40EN26!
ELF1,PU.1,SP1,USF2! 7! 101! 8.04%! 4.76%! 1.7! 3.20EN08!
ELF1,OctN2,TAF1,YY1! 7! 364! 29%! 18.10%! 1.6! 5.10EN24!
EgrN1,Sin3AkN20,YY1! 7! 430! 34.20%! 24.60%! 1.4! 2.40EN16!
EBF1,ELF1,Sin3AkN20! 7! 272! 21.60%! 16.40%! 1.3! 1.40EN07!
EBF1,EgrN1,ELF1,Nrf1! 7! 119! 9.47%! 6.24%! 1.5! 9.50EN07!
ELF1,Sin3AkN20,Znf143! 7! 385! 30.60%! 21.90%! 1.4! 1.10EN14!
ELF1,RFX5,SP1,TAF1,YY1! 7! 122! 9.71%! 5.48%! 1.8! 5.40EN11!
ELF1,PAX5NC20,Sin3AkN20! 7! 437! 34.80%! 24.10%! 1.4! 7.90EN20!
CHD2,EgrN1,ELF1,SP1,TBP! 7! 155! 12.30%! 6.68%! 1.8! 2.90EN15!
ELF1,OctN2,RFX5,TBP,YY1! 7! 117! 9.31%! 4.81%! 1.9! 3.30EN13!
ELF1,Nrf1,Sin3AkN20,SP1! 7! 259! 20.60%! 14.10%! 1.5! 7.70EN12!
OctN2,Pbx3,SP1,TAF1,TBP! 7! 100! 7.96%! 4.52%! 1.8! 4.10EN09!
ELF1,OctN2,Sin3AkN20,SP1! 7! 350! 27.80%! 17.70%! 1.6! 2.20EN21!
EgrN1,ELF1,Sin3AkN20,YY1! 7! 407! 32.40%! 23.30%! 1.4! 2.90EN15!
OctN2,RFX5,Sin3AkN20,SP1! 7! 124! 9.86%! 5.29%! 1.9! 9.70EN13!
ELF1,GABP,Sin3AkN20,TBP,YY1! 7! 246! 19.60%! 12.60%! 1.6! 3.00EN14!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 7! 242! 19.30%! 11.50%! 1.7! 6.40EN18!
CHD2,EgrN1,ELF1,SP1,TAF1,TBP! 7! 123! 9.79%! 5.13%! 1.9! 2.10EN13!
ELF1,RFX5,Sin3AkN20,SP1,TAF1! 7! 120! 9.55%! 5.25%! 1.8! 1.30EN11!
EgrN1,ELF1,PU.1,TAF1,TBP,YY1! 7! 98! 7.80%! 5.21%! 1.5! 1.40EN05!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 7! 195! 15.50%! 9.55%! 1.6! 4.00EN13!
ELF1,OctN2,Pbx3,SP1,TBP,TCF12! 7! 74! 5.89%! 3.34%! 1.8! 3.80EN07!
ELF1,Nrf1,Sin3AkN20,SP1,TCF12! 7! 116! 9.23%! 6.26%! 1.5! 5.30EN06!
EBF1,EgrN1,ELF1,SP1,YY1,Znf143! 7! 83! 6.60%! 4.28%! 1.5! 2.00EN05!
EgrN1,ELF1,SP1,SRF,TAF1,USF2,YY1! 7! 45! 3.58%! 1.87%! 1.9! 6.10EN06!
ELF1,Nrf1,OctN2,RFX5,Sin3AkN20,YY1! 7! 55! 4.38%! 2.54%! 1.7! 1.90EN05!
OctN2,PAX5NC20,Sin3AkN20,TCF12,USF2! 7! 62! 4.93%! 2.79%! 1.8! 2.40EN06!
EgrN1,OctN2,Sin3AkN
20,SP1,TAF1,TBP,YY1! 7! 162! 12.90%! 7.41%! 1.7! 1.60EN13!
OctN2,Sin3AkN
20,SP1,TAF1,TBP,YY1,Znf143! 7! 124! 9.86%! 5.89%! 1.7! 1.50EN09!
CHD2,PAX5NC20,RFX5,Sin3AkN
20,SP1,TBP,Znf143! 7! 37! 2.94%! 1.46%! 2! 1.00EN05!
ELF1,OctN2,PAX5NC20,Sin3AkN
20,TBP,YY1,Znf143! 7! 135! 10.70%! 6.17%! 1.7! 1.80EN11!
CHD2,ELF1,GABP,OctN2,RFX5,Sin3AkN
20,SP1,TAF1! 7! 43! 3.42%! 1.54%! 2.2! 1.40EN07!
EgrN1,ELF1,GABP,Nrf1,OctN2,Sin3AkN
20,TAF1,TBP,YY1! 7! 55! 4.38%! 2.32%! 1.9! 1.00EN06!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 8! 61! 19.80%! 11.50%! 1.7! 6.40EN06!
EgrN1,OctN2,Sin3AkN
20,SP1,TAF1,TBP,YY1! 8! 43! 14%! 7.41%! 1.9! 1.80EN05!
SP1,YY1! 10! 134! 54.30%! 32.50%! 1.7! 3.90EN13!
ELF1,YY1! 10! 172! 69.60%! 48.30%! 1.4! 2.30EN12!
ELF1,SP1! 10! 142! 57.50%! 39%! 1.5! 1.10EN09!
ELF1,Nrf1,YY1! 10! 95! 38.50%! 21%! 1.8! 7.40EN11!
EgrN1,SP1,YY1! 10! 89! 36%! 21.10%! 1.7! 1.60EN08!
ELF1,PAX5NC20! 10! 108! 43.70%! 30.90%! 1.4! 6.90EN06!
Sin3AkN20,USF2! 10! 68! 27.50%! 14.50%! 1.9! 2.60EN08!
USFN1,USF2,YY1! 10! 57! 23.10%! 11.70%! 2! 1.10EN07!
EgrN1,Sin3AkN20! 10! 115! 46.60%! 30.90%! 1.5! 6.90EN08!
EgrN1,Sin3AkN20,YY1! 10! 101! 40.90%! 24.60%! 1.7! 4.30EN09!
EBF1,ELF1,YY1,Znf143! 10! 42! 17%! 8.64%! 2! 6.50EN06!
ELF1,Sin3AkN20,Znf143! 10! 98! 39.70%! 21.90%! 1.8! 6.40EN11!
ELF1,Nrf1,Sin3AkN20,SP1! 10! 72! 29.10%! 14.10%! 2.1! 1.70EN10!
ELF1,PAX5NC20,Sin3AkN20! 10! 91! 36.80%! 24.10%! 1.5! 2.20EN06!
EgrN1,ELF1,Sin3AkN20,YY1! 10! 93! 37.70%! 23.30%! 1.6! 1.10EN07!
! 174!
EBF1,EgrN1,ELF1,SP1,YY1,Znf143! 10! 25! 10.10%! 4.28%! 2.4! 2.10EN05!
cNMyc,ELF1,PAX5NC20,Sin3AkN
20,SRF,TBP,USF2,YY1! 10! 11! 4.45%! 1.11%! 4! 1.90EN05!
ELF1,SP1,TAF1,YY1! 11! 70! 30.30%! 18.40%! 1.6! 3.40EN06!
SP1,YY1! 12! 103! 49%! 32.50%! 1.5! 2.00EN07!
ELF1,SP1! 12! 124! 59%! 39%! 1.5! 1.10EN09!
EgrN1,SP1,YY1! 12! 75! 35.70%! 21.10%! 1.7! 2.80EN07!
ELF1,Nrf1,YY1! 12! 72! 34.30%! 21%! 1.6! 2.30EN06!
ELF1,Sin3AkN20,Znf143! 12! 74! 35.20%! 21.90%! 1.6! 2.90EN06!
ELF1,Nrf1,Sin3AkN20,SP1! 12! 60! 28.60%! 14.10%! 2! 1.10EN08!
ELF1,OctN2,Sin3AkN20,SP1! 12! 62! 29.50%! 17.70%! 1.7! 8.30EN06!
EgrN1,SP1,YY1! 14! 31! 41.30%! 21.10%! 2! 1.90EN05!
ELF1,Nrf1,Sin3AkN20,SP1! 14! 24! 32%! 14.10%! 2.3! 1.90EN05!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 14! 22! 29.30%! 11.50%! 2.6! 6.50EN06!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 14! 20! 26.70%! 9.55%! 2.8! 4.30EN06!










SP1,YY1! 3! 551! 37.60%! 32.10%! 1.2! 7.80EN07!
ELF1,YY1! 3! 813! 55.50%! 47.70%! 1.2! 8.10EN11!
ELF1,SP1! 3! 639! 43.60%! 38.50%! 1.1! 8.50EN06!
ELF1,TAF1,TBP! 3! 400! 27.30%! 21.50%! 1.3! 8.50EN09!
ELF1,OctN2,YY1! 3! 445! 30.40%! 25.10%! 1.2! 4.70EN07!
ELF1,SP1,TAF1,YY1! 3! 337! 23%! 18.20%! 1.3! 2.80EN07!
ELF1,Sin3AkN20,TBP! 3! 454! 31%! 24.40%! 1.3! 3.60EN10!
ELF1,OctN2,TAF1,YY1! 3! 345! 23.60%! 17.90%! 1.3! 1.60EN09!
EBF1,ELF1,YY1,Znf143! 3! 167! 11.40%! 8.53%! 1.3! 2.10EN05!
ELF1,GABP,Sin3AkN20,TBP,YY1! 3! 240! 16.40%! 12.40%! 1.3! 9.30EN07!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 3! 216! 14.80%! 11.40%! 1.3! 1.10EN05!
ELF1,YY1! 4! 978! 56.50%! 47.70%! 1.2! 1.70EN15!
ELF1,TAF1,TBP! 4! 456! 26.30%! 21.50%! 1.2! 1.20EN07!
ELF1,Nrf1,YY1! 4! 438! 25.30%! 20.70%! 1.2! 2.50EN07!
ELF1,PAX5NC20! 4! 604! 34.90%! 30.50%! 1.1! 8.90EN06!
ELF1,OctN2,YY1! 4! 508! 29.30%! 25.10%! 1.2! 7.50EN06!
EgrN1,Sin3AkN20! 4! 609! 35.20%! 30.50%! 1.2! 2.70EN06!
ELF1,Sin3AkN20,TBP! 4! 516! 29.80%! 24.40%! 1.2! 1.30EN08!
EgrN1,Sin3AkN20,YY1! 4! 494! 28.50%! 24.30%! 1.2! 5.50EN06!
EgrN1,ELF1,Sin3AkN20,YY1! 4! 473! 27.30%! 23%! 1.2! 2.70EN06!
EgrN1,ELF1,PU.1,Sin3AkN20,YY1! 4! 200! 11.50%! 8.41%! 1.4! 4.20EN07!
EgrN1,Sin3AkN20! 5! 371! 37.40%! 30.50%! 1.2! 5.50EN07!
SP1,YY1! 6! 574! 43.60%! 32.10%! 1.4! 1.20EN20!
ELF1,SP1! 6! 654! 49.60%! 38.50%! 1.3! 1.70EN18!
ELF1,YY1! 6! 774! 58.70%! 47.70%! 1.2! 1.00EN17!
EBF1,ELF1! 6! 367! 27.80%! 23.10%! 1.2! 9.10EN06!
ELF1,PAX5NC20! 6! 523! 39.70%! 30.50%! 1.3! 1.80EN14!
ELF1,Nrf1,YY1! 6! 369! 28%! 20.70%! 1.4! 7.70EN12!
EgrN1,SP1,YY1! 6! 363! 27.50%! 20.80%! 1.3! 2.20EN10!
EBF1,ELF1,YY1! 6! 282! 21.40%! 16.70%! 1.3! 1.10EN06!
ELF1,TAF1,TBP! 6! 348! 26.40%! 21.50%! 1.2! 3.40EN06!
ELF1,OctN2,YY1! 6! 441! 33.50%! 25.10%! 1.3! 2.60EN13!
Sin3AkN20,ZEB1! 6! 302! 22.90%! 17.40%! 1.3! 3.20EN08!
USFN1,USF2,YY1! 6! 208! 15.80%! 11.50%! 1.4! 2.90EN07!
CTCF,Sin3AkN20! 6! 279! 21.20%! 16.30%! 1.3! 3.60EN07!
Sin3AkN20,USF2! 6! 249! 18.90%! 14.30%! 1.3! 3.70EN07!
EgrN1,Sin3AkN20! 6! 514! 39%! 30.50%! 1.3! 1.20EN12!
ELF1,SP1,TAF1,YY1! 6! 321! 24.40%! 18.20%! 1.3! 1.20EN09!
ELF1,PAX5NC20,TBP! 6! 292! 22.20%! 17.40%! 1.3! 9.40EN07!
ELF1,Sin3AkN20,TBP! 6! 393! 29.80%! 24.40%! 1.2! 8.50EN07!
EgrN1,Sin3AkN20,YY1! 6! 419! 31.80%! 24.30%! 1.3! 2.40EN11!
! 175!
ELF1,OctN2,TAF1,YY1! 6! 314! 23.80%! 17.90%! 1.3! 2.90EN09!
EBF1,ELF1,Sin3AkN20! 6! 285! 21.60%! 16.20%! 1.3! 2.00EN08!
EBF1,ELF1,YY1,Znf143! 6! 153! 11.60%! 8.53%! 1.4! 1.90EN05!
ELF1,Sin3AkN20,Znf143! 6! 397! 30.10%! 21.60%! 1.4! 8.90EN15!
ELF1,RFX5,SP1,TAF1,YY1! 6! 106! 8.04%! 5.44%! 1.5! 1.20EN05!
ELF1,PAX5NC20,Sin3AkN20! 6! 432! 32.80%! 23.80%! 1.4! 1.50EN15!
ELF1,Nrf1,Sin3AkN20,SP1! 6! 267! 20.30%! 13.90%! 1.5! 6.10EN12!
ELF1,OctN2,Sin3AkN20,SP1! 6! 324! 24.60%! 17.50%! 1.4! 3.20EN12!
EgrN1,ELF1,Sin3AkN20,YY1! 6! 402! 30.50%! 23%! 1.3! 1.20EN11!
ELF1,GABP,Sin3AkN20,TBP,YY1! 6! 226! 17.10%! 12.40%! 1.4! 5.50EN08!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 6! 200! 15.20%! 11.40%! 1.3! 3.80EN06!
ELF1,Nrf1,Sin3AkN20,SP1,TCF12! 6! 121! 9.18%! 6.16%! 1.5! 1.90EN06!
ELF1,OctN2,PAX5NC20,Sin3AkN20,TBP,YY1,Znf143! 6! 116! 8.80%! 6.13%! 1.4! 1.80EN05!
SP1,YY1! 7! 360! 42.10%! 32.10%! 1.3! 7.90EN11!
ELF1,YY1! 7! 513! 60%! 47.70%! 1.3! 3.40EN14!
ELF1,SP1! 7! 423! 49.50%! 38.50%! 1.3! 6.00EN12!
YY1,ZEB1! 7! 205! 24%! 18.40%! 1.3! 9.40EN06!
ELF1,TAF1,TBP! 7! 257! 30.10%! 21.50%! 1.4! 5.20EN10!
EgrN1,SP1,YY1! 7! 248! 29%! 20.80%! 1.4! 1.30EN09!
ELF1,PAX5NC20! 7! 330! 38.60%! 30.50%! 1.3! 5.90EN08!
ELF1,OctN2,YY1! 7! 291! 34%! 25.10%! 1.4! 5.90EN10!
EgrN1,Sin3AkN20! 7! 339! 39.60%! 30.50%! 1.3! 1.30EN09!
ELF1,SP1,TAF1,YY1! 7! 218! 25.50%! 18.20%! 1.4! 1.40EN08!
ELF1,PAX5NC20,TBP! 7! 206! 24.10%! 17.40%! 1.4! 8.80EN08!
ELF1,Sin3AkN20,TBP! 7! 295! 34.50%! 24.40%! 1.4! 2.30EN12!
EgrN1,Sin3AkN20,YY1! 7! 283! 33.10%! 24.30%! 1.4! 6.30EN10!
ELF1,OctN2,TAF1,YY1! 7! 218! 25.50%! 17.90%! 1.4! 2.70EN09!
CHD2,EgrN1,ELF1,SP1,TBP! 7! 99! 11.60%! 6.60%! 1.8! 7.80EN09!
ELF1,PAX5NC20,Sin3AkN20! 7! 263! 30.80%! 23.80%! 1.3! 5.50EN07!
ELF1,OctN2,RFX5,TBP,YY1! 7! 70! 8.19%! 4.83%! 1.7! 4.10EN06!
OctN2,Pbx3,SP1,TAF1,TBP! 7! 64! 7.49%! 4.51%! 1.7! 2.00EN05!
EgrN1,ELF1,Sin3AkN20,YY1! 7! 271! 31.70%! 23%! 1.4! 5.60EN10!
ELF1,OctN2,Sin3AkN20,SP1! 7! 204! 23.90%! 17.50%! 1.4! 5.00EN07!
OctN2,RFX5,Sin3AkN20,SP1! 7! 77! 9.01%! 5.30%! 1.7! 1.30EN06!
ELF1,GABP,Sin3AkN20,TBP,YY1! 7! 149! 17.40%! 12.40%! 1.4! 4.60EN06!
CHD2,EgrN1,ELF1,SP1,TAF1,TBP! 7! 76! 8.89%! 5.07%! 1.8! 4.40EN07!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 7! 121! 14.20%! 9.43%! 1.5! 1.40EN06!
EgrN1,ELF1,SP1,SRF,TAF1,USF2,YY1! 7! 33! 3.86%! 1.86%! 2.1! 1.90EN05!
EgrN1,OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1! 7! 95! 11.10%! 7.33%! 1.5! 1.30EN05!
ELF1,SP1! 8! 159! 52.10%! 38.50%! 1.4! 4.00EN07!
ELF1,YY1! 8! 181! 59.30%! 47.70%! 1.2! 1.50EN05!
EgrN1,SP1,YY1! 8! 99! 32.50%! 20.80%! 1.6! 4.90EN07!
Sin3AkN20,USF2! 8! 78! 25.60%! 14.30%! 1.8! 4.50EN08!
ELF1,OctN2,YY1! 8! 109! 35.70%! 25.10%! 1.4! 1.10EN05!
EgrN1,Sin3AkN20! 8! 130! 42.60%! 30.50%! 1.4! 2.10EN06!
ELF1,PAX5NC20,TBP! 8! 83! 27.20%! 17.40%! 1.6! 5.00EN06!
ELF1,Sin3AkN20,TBP! 8! 112! 36.70%! 24.40%! 1.5! 4.30EN07!
EgrN1,Sin3AkN20,YY1! 8! 112! 36.70%! 24.30%! 1.5! 3.30EN07!
ELF1,OctN2,RFX5,TBP,YY1! 8! 35! 11.50%! 4.83%! 2.4! 6.10EN07!
CHD2,EgrN1,ELF1,SP1,TBP! 8! 43! 14.10%! 6.60%! 2.1! 6.90EN07!
ELF1,Nrf1,Sin3AkN20,SP1! 8! 71! 23.30%! 13.90%! 1.7! 2.80EN06!
EgrN1,ELF1,Sin3AkN20,YY1! 8! 109! 35.70%! 23%! 1.6! 1.20EN07!
ELF1,OctN2,Sin3AkN20,SP1! 8! 89! 29.20%! 17.50%! 1.7! 1.40EN07!
OctN2,RFX5,Sin3AkN20,SP1! 8! 35! 11.50%! 5.30%! 2.2! 5.20EN06!
ELF1,GABP,Sin3AkN20,TBP,YY1! 8! 65! 21.30%! 12.40%! 1.7! 3.60EN06!
ELF1,Nrf1,OctN2,RFX5,Sin3AkN20,YY1! 8! 22! 7.21%! 2.55%! 2.8! 3.50EN06!
EgrN1,OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1! 8! 44! 14.40%! 7.33%! 2! 4.80EN06!
ELF1,OctN2,PAX5NC20,Sin3AkN20,TBP,YY1,Znf143! 8! 38! 12.50%! 6.13%! 2! 9.70EN06!
SP1,YY1! 9! 173! 47.30%! 32.10%! 1.5! 3.20EN10!
ELF1,SP1! 9! 199! 54.40%! 38.50%! 1.4! 1.60EN10!
ELF1,YY1! 9! 214! 58.50%! 47.70%! 1.2! 1.20EN05!
! 176!
ELF1,Nrf1,YY1! 9! 114! 31.10%! 20.70%! 1.5! 6.40EN07!
ELF1,OctN2,YY1! 9! 126! 34.40%! 25.10%! 1.4! 2.10EN05!
EgrN1,Sin3AkN20! 9! 152! 41.50%! 30.50%! 1.4! 2.10EN06!
ELF1,SP1,TAF1,YY1! 9! 98! 26.80%! 18.20%! 1.5! 1.40EN05!
ELF1,Sin3AkN20,TBP! 9! 125! 34.20%! 24.40%! 1.4! 7.90EN06!
ELF1,Sin3AkN20,Znf143! 9! 114! 31.10%! 21.60%! 1.4! 6.50EN06!
ELF1,Nrf1,Sin3AkN20,SP1! 9! 101! 27.60%! 13.90%! 2! 9.40EN13!
ELF1,PAX5NC20,Sin3AkN20! 9! 121! 33.10%! 23.80%! 1.4! 1.70EN05!
ELF1,OctN2,Sin3AkN20,SP1! 9! 101! 27.60%! 17.50%! 1.6! 4.60EN07!
ELF1,Nrf1,Sin3AkN20,SP1,TCF12! 9! 51! 13.90%! 6.16%! 2.3! 1.20EN08!
SP1,YY1! 11! 81! 49.40%! 32.10%! 1.5! 1.30EN06!
ELF1,SP1! 11! 99! 60.40%! 38.50%! 1.6! 4.00EN09!
ELF1,YY1! 11! 104! 63.40%! 47.70%! 1.3! 1.70EN05!
ELF1,TAF1,TBP! 11! 61! 37.20%! 21.50%! 1.7! 1.30EN06!
Sin3AkN20,USF2! 11! 51! 31.10%! 14.30%! 2.2! 8.30EN09!
ELF1,OctN2,YY1! 11! 66! 40.20%! 25.10%! 1.6! 6.30EN06!
USFN1,USF2,YY1! 11! 38! 23.20%! 11.50%! 2! 6.50EN06!
ELF1,SP1,TAF1,YY1! 11! 61! 37.20%! 18.20%! 2! 2.10EN09!
ELF1,OctN2,TAF1,YY1! 11! 51! 31.10%! 17.90%! 1.7! 1.10EN05!
ELF1,Sin3AkN20,Znf143! 11! 58! 35.40%! 21.60%! 1.6! 1.70EN05!
ELF1,Nrf1,Sin3AkN20,SP1! 11! 48! 29.30%! 13.90%! 2.1! 7.80EN08!
ELF1,OctN2,Sin3AkN20,SP1! 11! 54! 32.90%! 17.50%! 1.9! 4.90EN07!
OctN2,RFX5,Sin3AkN20,SP1! 11! 23! 14%! 5.30%! 2.6! 5.50EN06!
ELF1,GABP,Sin3AkN20,TBP,YY1! 11! 39! 23.80%! 12.40%! 1.9! 1.70EN05!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 11! 38! 23.20%! 11.40%! 2! 5.10EN06!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 11! 32! 19.50%! 9.43%! 2.1! 2.10EN05!
EBF1,EgrN1,ELF1,Sin3AkN20,USFN1,USF2! 11! 16! 9.76%! 2.96%! 3.3! 7.00EN06!
OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1,Znf143! 11! 24! 14.60%! 5.82%! 2.5! 8.80EN06!











SP1,YY1! 1! 818! 41.50%! 36%! 1.2! 6.10EN09!
ELF1,YY1! 1! 1184! 60.10%! 53%! 1.1! 3.90EN13!
ELF1,SP1! 1! 953! 48.40%! 43%! 1.1! 2.40EN08!
ELF1,TAF1,TBP! 1! 636! 32.30%! 24.50%! 1.3! 4.50EN19!
ELF1,PAX5NC20! 1! 758! 38.50%! 34%! 1.1! 9.40EN07!
ELF1,OctN2,YY1! 1! 704! 35.80%! 28.40%! 1.3! 5.40EN16!
EgrN1,Sin3AkN20! 1! 763! 38.80%! 34.60%! 1.1! 5.50EN06!
ELF1,PAX5NC20,TBP! 1! 503! 25.50%! 19.50%! 1.3! 5.10EN14!
ELF1,SP1,TAF1,YY1! 1! 510! 25.90%! 20.80%! 1.2! 3.80EN10!
ELF1,Sin3AkN20,TBP! 1! 718! 36.50%! 27.60%! 1.3! 1.10EN22!
ELF1,OctN2,TAF1,YY1! 1! 523! 26.60%! 20.40%! 1.3! 3.50EN14!
EgrN1,Sin3AkN20,YY1! 1! 624! 31.70%! 27.70%! 1.1! 3.70EN06!
ELF1,Sin3AkN20,Znf143! 1! 553! 28.10%! 24.30%! 1.2! 5.00EN06!
ELF1,PAX5NC20,Sin3AkN20! 1! 628! 31.90%! 27%! 1.2! 1.90EN08!
ELF1,OctN2,Sin3AkN20,SP1! 1! 490! 24.90%! 20%! 1.2! 6.30EN10!
EgrN1,ELF1,Sin3AkN20,YY1! 1! 593! 30.10%! 26.20%! 1.2! 3.90EN06!
ELF1,GABP,Sin3AkN20,TBP,YY1! 1! 378! 19.20%! 14.10%! 1.4! 8.80EN13!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 1! 349! 17.70%! 13%! 1.4! 3.30EN12!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 1! 268! 13.60%! 10.60%! 1.3! 8.00EN07!
EgrN1,OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1! 1! 218! 11.10%! 8.25%! 1.3! 2.90EN07!
OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1,Znf143! 1! 183! 9.29%! 6.70%! 1.4! 2.30EN07!
EgrN1,ELF1,OctN2,PAX5NC20,Sin3AkN
20,TAF1,TBP,TCF12,YY1,Znf143! 1! 89! 4.52%! 3.06%! 1.5! 1.90EN05!
SP1,YY1! 3! 449! 43.30%! 36%! 1.2! 1.40EN07!
ELF1,YY1! 3! 657! 63.40%! 53%! 1.2! 4.20EN13!
ELF1,SP1! 3! 523! 50.40%! 43%! 1.2! 1.40EN07!
ELF1,Nrf1,YY1! 3! 307! 29.60%! 23.30%! 1.3! 2.40EN07!
! 177!
EgrN1,SP1,YY1! 3! 299! 28.80%! 23.50%! 1.2! 1.00EN05!
ELF1,OctN2,YY1! 3! 360! 34.70%! 28.40%! 1.2! 1.10EN06!
EgrN1,Sin3AkN20! 3! 420! 40.50%! 34.60%! 1.2! 1.00EN05!
ELF1,SP1,TAF1,YY1! 3! 273! 26.30%! 20.80%! 1.3! 2.60EN06!
ELF1,OctN2,TAF1,YY1! 3! 272! 26.20%! 20.40%! 1.3! 6.10EN07!
EgrN1,Sin3AkN20,YY1! 3! 351! 33.80%! 27.70%! 1.2! 1.50EN06!
ELF1,PAX5NC20,Sin3AkN20! 3! 339! 32.70%! 27%! 1.2! 6.40EN06!
EgrN1,ELF1,Sin3AkN20,YY1! 3! 335! 32.30%! 26.20%! 1.2! 1.20EN06!
SP1,YY1! 5! 499! 46.80%! 36%! 1.3! 7.20EN15!
ELF1,YY1! 5! 722! 67.70%! 53%! 1.3! 1.60EN25!
ELF1,SP1! 5! 558! 52.30%! 43%! 1.2! 2.90EN11!
ELF1,PAX5NC20! 5! 456! 42.80%! 34%! 1.3! 8.40EN11!
ELF1,Nrf1,YY1! 5! 333! 31.20%! 23.30%! 1.3! 8.70EN11!
EgrN1,SP1,YY1! 5! 335! 31.40%! 23.50%! 1.3! 1.10EN10!
ELF1,TAF1,TBP! 5! 326! 30.60%! 24.50%! 1.2! 7.40EN07!
EBF1,ELF1,YY1! 5! 252! 23.60%! 18.80%! 1.3! 1.20EN05!
USFN1,USF2,YY1! 5! 207! 19.40%! 13.10%! 1.5! 2.60EN10!
ELF1,OctN2,YY1! 5! 388! 36.40%! 28.40%! 1.3! 7.40EN10!
Sin3AkN20,USF2! 5! 243! 22.80%! 16.40%! 1.4! 3.10EN09!
EgrN1,Sin3AkN20! 5! 448! 42%! 34.60%! 1.2! 3.20EN08!
ELF1,SP1,TAF1,YY1! 5! 294! 27.60%! 20.80%! 1.3! 8.40EN09!
ELF1,Sin3AkN20,TBP! 5! 366! 34.30%! 27.60%! 1.2! 1.20EN07!
EgrN1,Sin3AkN20,YY1! 5! 393! 36.90%! 27.70%! 1.3! 1.30EN12!
ELF1,OctN2,TAF1,YY1! 5! 290! 27.20%! 20.40%! 1.3! 5.30EN09!
ELF1,Sin3AkN20,Znf143! 5! 340! 31.90%! 24.30%! 1.3! 7.70EN10!
ELF1,PAX5NC20,Sin3AkN20! 5! 381! 35.70%! 27%! 1.3! 9.10EN12!
ELF1,Nrf1,Sin3AkN20,SP1! 5! 223! 20.90%! 15.70%! 1.3! 6.20EN07!
EgrN1,ELF1,Sin3AkN20,YY1! 5! 377! 35.40%! 26.20%! 1.4! 6.30EN13!
ELF1,OctN2,Sin3AkN20,SP1! 5! 276! 25.90%! 20%! 1.3! 2.20EN07!
ELF1,GABP,Sin3AkN20,TBP,YY1! 5! 202! 18.90%! 14.10%! 1.3! 1.60EN06!
EgrN1,ELF1,PU.1,Sin3AkN20,YY1! 5! 145! 13.60%! 9.63%! 1.4! 3.10EN06!
OctN2,PAX5NC20,Sin3AkN20,TCF12,USF2! 5! 61! 5.72%! 3.17%! 1.8! 1.20EN06!
SP1,YY1! 6! 207! 45.20%! 36%! 1.3! 1.50EN05!
ELF1,SP1! 6! 249! 54.40%! 43%! 1.3! 2.10EN07!
ELF1,Nrf1,Sin3AkN20,SP1! 6! 109! 23.80%! 15.70%! 1.5! 1.40EN06!
SP1,YY1! 9! 107! 49.30%! 36%! 1.4! 2.00EN05!
ELF1,YY1! 9! 145! 66.80%! 53%! 1.3! 1.10EN05!
ELF1,OctN2,YY1! 9! 90! 41.50%! 28.40%! 1.5! 1.10EN05!
USFN1,USF2,YY1! 9! 50! 23%! 13.10%! 1.8! 1.70EN05!
EgrN1,Sin3AkN20,YY1! 9! 88! 40.60%! 27.70%! 1.5! 1.20EN05!
EgrN1,ELF1,Sin3AkN20,YY1! 9! 85! 39.20%! 26.20%! 1.5! 8.10EN06!
ELF1,Nrf1,OctN2,RFX5,Sin3AkN20,YY1! 9! 18! 8.29%! 2.79%! 3! 9.90EN06!
ELF1,TAF1,TBP! 10! 36! 45.60%! 24.50%! 1.9! 1.30EN05!
ELF1,SP1,TAF1,YY1! 10! 35! 44.30%! 20.80%! 2.1! 6.40EN07!
ELF1,OctN2,TAF1,YY1! 10! 32! 40.50%! 20.40%! 2! 1.20EN05!
ELF1,RFX5,SP1,TAF1,YY1! 10! 16! 20.30%! 6.22%! 3.3! 5.30EN06!
ELF1,OctN2,RFX5,TBP,YY1! 10! 14! 17.70%! 5.45%! 3.3! 1.90EN05!
OctN2,Sin3AkN20,SP1,TAF1,TBP! 10! 24! 30.40%! 13%! 2.3! 1.20EN05!
EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 10! 23! 29.10%! 10.60%! 2.7! 1.10EN06!




Table, A.5!Summary, of, significant, correlation, comparisons, among, seed, genes,, candidate,
genes,and,background,genes!!
The!columns!are!ID!assigned!to!each!test,!combination!of!shared!TFs!from!each!pair!of!seed!




ID, Combination,of,TFs, N.TFs, N.candidate, best.PC, best.p.value,
1! EBF1,EgrN1! 2! 2045! 8! 4.50EN07!
2! ELF1,PAX5NC20! 2! 3760! 7! 1.10EN16!
3! ELF1,SP1! 2! 4746! 4! 7.30EN42!
4! ELF1,YY1! 2! 5877! 7! 2.30EN15!
5! ELF1,ZEB1! 2! 2721! 1! 1.70EN13!
6! IRF4,TBP! 2! 953! 2! 3.90EN06!
7! Sin3AkN20,USF2! 2! 1764! 7! 1.50EN27!
8! Sin3AkN20,ZEB1! 2! 2143! 4! 1.20EN05!
9! SP1,YY1! 2! 3958! 1! 1.40EN35!
10! YY1,ZEB1! 2! 2271! 6! 3.10EN07!
11! CTCF,ELF1,Znf143! 3! 1642! 1! 1.30EN09!
12! EBF1,ELF1,Sin3AkN20! 3! 1997! 4! 3.50EN15!
13! EBF1,ELF1,Sin3AkN20! 3! 1997! 4! 9.50EN11!
14! EBF1,ELF1,YY1! 3! 2056! 1! 4.30EN09!
15! EgrN1,Sin3AkN20,YY1! 3! 2993! 4! 1.30EN27!
16! EgrN1,SP1,YY1! 3! 2564! 1! 5.30EN32!
17! ELF1,Nrf1,YY1! 3! 2553! 1! 2.70EN38!
18! ELF1,OctN2,YY1! 3! 3094! 1! 4.80EN56!
19! ELF1,PAX5NC20,Sin3AkN20! 3! 2931! 7! 2.00EN30!
20! ELF1,PAX5NC20,TBP! 3! 2137! 1! 9.30EN24!
21! ELF1,Sin3AkN20,TBP! 3! 2999! 7! 1.00EN20!
22! ELF1,Sin3AkN20,Znf143! 3! 2667! 6! 1.30EN10!
23! ELF1,TAF1,TBP! 3! 2648! 4! 3.10EN10!
24! USFN1,USF2,YY1! 3! 1420! 7! 5.80EN12!
25! EBF1,EgrN1,ELF1,Nrf1! 4! 758! 1! 9.20EN07!
26! EBF1,ELF1,YY1,Znf143! 4! 1049! 1! 3.60EN15!
27! EgrN1,ELF1,Nrf1,PU.1! 4! 711! 1! 1.20EN13!
28! EgrN1,ELF1,Sin3AkN20,YY1! 4! 2834! 7! 1.60EN19!
29! ELF1,OctN2,Sin3AkN20,SP1! 4! 2158! 7! 3.90EN20!
30! ELF1,OctN2,TAF1,YY1! 4! 2200! 7! 1.70EN50!
31! ELF1,PU.1,SP1,USF2! 4! 577! 7! 9.30EN07!
32! ELF1,SP1,TAF1,YY1! 4! 2239! 4! 3.40EN21!
33! OctN2,RFX5,Sin3AkN20,SP1! 4! 642! 5! 8.90EN08!
34! CHD2,EgrN1,ELF1,SP1,TBP! 5! 811! 2! 1.00EN08!
35! EgrN1,ELF1,PU.1,Sin3AkN20,YY1! 5! 1033! 1! 6.20EN10!
36! ELF1,GABP,PU.1,Sin3AkN20,SP1! 5! 898! 3! 4.60EN09!
37! ELF1,GABP,Sin3AkN20,TBP,YY1! 5! 1528! 1! 1.10EN44!
38! ELF1,Nrf1,Sin3AkN20,SP1,TCF12! 5! 760! 1! 4.00EN10!
39! ELF1,RFX5,SP1,TAF1,YY1! 5! 665! 6! 1.70EN10!
40! OctN2,Pbx3,SP1,TAF1,TBP! 5! 548! 8! 2.50EN07!
41! OctN2,Sin3AkN20,SP1,TAF1,TBP! 5! 1397! 7! 8.60EN19!
42! CHD2,EgrN1,ELF1,SP1,TAF1,TBP! 6! 622! 14! 2.90EN09!
43! CTCF,ELF1,RFX5,Sin3AkN20,SP1,TBP! 6! 231! 1! 1.00EN06!
44! EBF1,EgrN1,ELF1,Sin3AkN20,USFN1,USF2! 6! 369! 9! 9.80EN07!
45! EBF1,EgrN1,ELF1,SP1,YY1,Znf143! 6! 519! 1! 6.50EN10!
46! EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 6! 1160! 2! 8.10EN27!
47! EgrN1,ELF1,PU.1,TAF1,TBP,YY1! 6! 632! 4! 1.90EN16!
48! ELF1,OctN2,Pbx3,SP1,TBP,TCF12! 6! 405! 3! 1.40EN05!
49! CTCF,EgrN1,ELF1,Sin3AkN20,SRF,YY1,Znf143! 7! 320! 1! 3.60EN06!
50! EgrN1,ELF1,SP1,SRF,TAF1,USF2,YY1! 7! 226! 9! 1.10EN06!
51! EgrN1,OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1! 7! 900! 7! 2.20EN26!
52! ELF1,Nrf1,Sin3AkN20,SRF,USFN1,USF2,YY1! 7! 231! 6! 3.30EN07!
! 179!
53! ELF1,OctN2,PAX5NC20,Sin3AkN20,TBP,YY1,Znf143! 7! 749! 4! 9.00EN13!
54! OctN2,Sin3AkN20,SP1,TAF1,TBP,YY1,Znf143! 7! 715! 7! 7.80EN16!
55! cNMyc,ELF1,PAX5NC20,Sin3AkN20,SRF,TBP,USF2,YY1! 8! 133! 12! 1.30EN05!
56! EgrN1,ELF1,GABP,Nrf1,OctN2,Sin3AkN20,TAF1,TBP,YY1! 9! 280! 6! 7.80EN08!
57! ELF1,GABP,MEF2A,PAX5NC20,Sin3AkN
20,SRF,TAF1,TBP,YY1!
9! 250! 7! 1.90EN05!
58! CHD2,EgrN1,ELF1,OctN2,PAX5NC20,Pbx3,Sin3AkN
20,TAF1,TBP,YY1!
10! 170! 7! 3.90EN07!
59! cNMyc,EgrN1,ELF1,IRF4,OctN2,Sin3AkN
20,TAF1,TBP,YY1,Znf143!
10! 133! 21! 3.20EN06!
60! EgrN1,ELF1,OctN2,PAX5NC20,Sin3AkN
20,TAF1,TBP,TCF12,YY1,Znf143!




18! 3! 3! 1.20EN05!
!
Yoruba,Argonne,data,
ID, TF,combination! N.TFs! N.candidate! best.PC! best.p.value!
1! CTCF,Sin3AkN20! 2! 2016! 1! 3.50EN06!
2! ELF1,GABP! 2! 3740! 1! 4.80EN49!
3! ELF1,PAX5NC20! 2! 3770! 4! 6.20EN19!
4! ELF1,PAX5NC20! 2! 3770! 3! 2.60EN19!
5! ELF1,YY1! 2! 5909! 1! 2.40EN60!
6! IRF4,TBP! 2! 955! 2! 6.30EN06!
7! Nrf1,Sin3AkN20! 2! 2786! 3! 1.20EN16!
8! Sin3AkN20,SP1! 2! 3978! 4! 1.90EN09!
9! YY1,ZEB1! 2! 2276! 3! 3.20EN06!
10! EBF1,ELF1,Sin3AkN20! 3! 2006! 4! 8.00EN13!
11! EBF1,Sin3AkN20,TBP! 3! 1167! 4! 2.80EN12!
12! EgrN1,ELF1,YY1! 3! 3624! 1! 3.60EN36!
13! ELF1,Nrf1,PU.1! 3! 1144! 1! 5.70EN14!
14! ELF1,Nrf1,Sin3AkN20! 3! 2569! 1! 3.70EN12!
15! ELF1,Nrf1,YY1! 3! 2560! 3! 3.40EN21!
16! EBF1,ELF1,Sin3AkN20,SP1! 4! 1342! 8! 8.00EN08!
17! EgrN1,Sin3AkN20,SRF,YY1! 4! 1200! 8! 8.40EN10!
18! ELF1,PU.1,SP1,USF2! 4! 576! 5! 1.30EN07!
19! ELF1,Sin3AkN20,YY1,Znf143! 4! 2385! 1! 2.90EN14!
20! ELF1,SP1,TAF1,YY1! 4! 2251! 4! 3.10EN30!
21! ELF1,SP1,TAF1,YY1! 4! 2251! 4! 1.20EN25!
22! ELF1,SP1,TAF1,YY1! 4! 2251! 4! 6.70EN20!
23! RFX5,SP1,TAF1,YY1! 4! 700! 1! 6.30EN11!
24! EgrN1,ELF1,GABP,SRF,YY1! 5! 951! 3! 2.70EN08!
25! ELF1,OctN2,SP1,TBP,TCF12! 5! 1118! 4! 3.20EN13!
26! GABP,Sin3AkN20,SP1,TAF1,YY1! 5! 1197! 4! 4.00EN15!
27! OctN2,PAX5NC20,Sin3AkN20,USFN1,USF2! 5! 466! 8! 3.90EN11!
28! OctN2,Pbx3,SP1,TAF1,TBP! 5! 556! 4! 3.60EN06!
29! CHD2,ELF1,GABP,PAX5NC20,SP1,USF2! 6! 233! 7! 4.90EN08!
30! EBF1,ELF1,PAX5NC20,Sin3AkN20,TBP,YY1! 6! 603! 1! 8.60EN10!
31! EgrN1,ELF1,Nrf1,OctN2,Sin3AkN20,SP1! 6! 674! 8! 1.30EN06!
32! EgrN1,ELF1,OctN2,SP1,TAF1,YY1! 6! 1166! 4! 1.40EN21!
33! ELF1,OctN2,Sin3AkN20,SRF,TAF1,YY1! 6! 934! 2! 2.40EN13!
34! ELF1,PU.1,Sin3AkN20,TAF1,TBP,YY1! 6! 796! 4! 4.10EN13!
35! BCLAF1,EgrN1,ELF1,Sin3AkN20,TAF1,YY1,Znf143! 7! 503! 6! 9.60EN06!
36! CHD2,ELF1,GABP,Sin3AkN20,SP1,YY1,Znf143! 7! 554! 1! 1.30EN05!
37! EBF1,RFX5,Sin3AkN20,SP1,TBP,USFN1,USF2! 7! 80! 8! 3.90EN06!
38! EgrN1,ELF1,OctN2,PAX5NC20,Sin3AkN20,TAF1,YY1! 7! 905! 4! 2.90EN11!
39! ELF1,MEF2A,PAX5NC20,PU.1,Sin3AkN20,TBP,YY1! 7! 256! 4! 3.60EN06!
40! ELF1,Nrf1,OctN2,Sin3AkN20,TAF1,TBP,YY1! 7! 718! 4! 2.50EN10!
41! ATF3,ELF1,PAX5NC20,Sin3AkN20,SP1,USFN1,USF2,YY1! 8! 239! 7! 1.00EN06!
42! cNMyc,ELF1,Nrf1,Sin3AkN20,SP1,TAF1,TBP,YY1! 8! 297! 5! 1.50EN11!
43! EBF1,EgrN1,ELF1,PAX5NC20,Sin3AkN20,SRF,TBP,YY1! 8! 240! 1! 9.20EN10!
44! ELF1,GABP,PAX5NC20,PU.1,Sin3AkN20,SRF,TAF1,YY1! 8! 261! 4! 3.40EN09!
! 180!
45! ELF1,GABP,PAX5NC20,Sin3AkN20,SRF,TAF1,TBP,YY1! 8! 473! 5! 3.20EN12!
46! CHD2,cNMyc,EgrN1,ELF1,Sin3AkN
20,SP1,TAF1,TCF12,YY1!
9! 167! 4! 1.80EN11!
47! cNMyc,EgrN1,ELF1,PU.1,Sin3AkN
20,SP1,TAF1,TCF12,YY1!
9! 136! 4! 9.10EN10!
48! EgrN1,ELF1,GABP,OctN2,PU.1,Sin3AkN20,TAF1,TBP,YY1! 9! 295! 1! 1.00EN06!
49! ELF1,GABP,MEF2A,PAX5NC20,Sin3AkN
20,SRF,TAF1,TBP,YY1!
9! 249! 5! 2.20EN09!
50! cNMyc,EgrN1,ELF1,OctN2,PAX5NC20,Sin3AkN
20,SP1,SRF,USFN1,YY1!
10! 118! 10! 6.20EN08!
51! cNMyc,ELF1,Max,OctN2,Sin3AkN20,SP1,SRF,TAF1,USFN
1,YY1!
10! 54! 10! 1.20EN07!
52! BCL3,BCLAF1,EgrN1,ELF1,ETS1,OctN2,Pbx3,Sin3AkN
20,SP1,TAF1,TBP,TCF12,YY1,ZBTB33,ZEB1!












ID, TF,combination! N.TFs! N.candidate! best.PC! best.p.value!
1! ELF1,GABP! 2! 3152! 1! 9.20EN43!
2! ELF1,Znf143! 2! 2958! 5! 2.20EN06!
3! PAX5NC20,Sin3AkN20,SP1! 3! 1937! 1! 4.00EN11!
4! EgrN1,ELF1,PAX5NC20,YY1! 4! 1745! 3! 1.60EN07!
5! ELF1,ETS1,Sin3AkN20,SP1! 4! 1020! 3! 4.00EN05!
6! ELF1,OctN2,Sin3AkN20,TAF1! 4! 1853! 1! 3.40EN09!
7! ELF1,PAX5NC20,YY1,ZEB1! 4! 1121! 1! 7.80EN11!
8! ELF1,Sin3AkN20,TBP,YY1! 4! 2233! 1! 4.30EN34!
9! ELF1,SP1,TAF1,YY1! 4! 1959! 1! 2.20EN25!
10! cNMyc,EgrN1,ELF1,Sin3AkN20,SP1! 5! 648! 18! 2.00EN08!
11! ELF1,Nrf1,PAX5NC20,YY1,ZEB1! 5! 472! 1! 6.50EN10!
12! ELF1,Nrf1,Sin3AkN20,SP1,TBP! 5! 906! 1! 8.10EN13!
13! ELF1,OctN2,PAX5NC20,SP1,TAF1,YY1! 6! 987! 1! 1.70EN07!
14! ELF1,OctN2,Sin3AkN20,USFN1,USF2,YY1! 6! 584! 2! 9.30EN08!
15! CHD2,EgrN1,ELF1,Nrf1,OctN2,SP1,YY1! 7! 276! 1! 1.50EN06!
16! CHD2,ELF1,ETS1,PAX5NC20,Sin3AkN
20,SP1,TAF1,TBP!
8! 247! 1! 7.80EN06!
17! EBF1,ELF1,IRF4,PU.1,Sin3AkN20,TCF12,YY1,ZEB1! 8! 63! 6! 3.50EN06!
18! ELF1,MEF2A,PAX5NC20,Sin3AkN
20,SRF,TAF1,TBP,YY1!
8! 287! 1! 9.20EN07!
19! EgrN1,ELF1,ETS1,GABP,OctN2,Sin3AkN
20,TAF1,YY1,ZEB1!
9! 189! 11! 2.80EN05!
20! BCL3,BCLAF1,cNMyc,EgrN1,ELF1,NFKB,OctN2,Sin3AkN
20,SP1,SRF,TAF1,TBP,TCF12,YY1,Znf143,ZZZ3!
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0.0 0.2 0.4 0.6 0.80.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.0 0.2 0.4 0.60.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.8
0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8
0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.60.0 0.2 0.4 0.6 0.8
0.0 0.2 0.4 0.60.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.8
0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75
0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.80.0 0.2 0.4 0.6
0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.80.0 0.2 0.4 0.6 0.80.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75
0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.80.0 0.2 0.4 0.6 0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75
0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.80.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.00 0.25 0.50 0.75
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0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.00 0.25 0.50 0.75
0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6
0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.00 0.25 0.50 0.75
0.00 0.25 0.50 0.75 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.0 0.2 0.4 0.6 0.8
Absolute correlation
de
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Caucasian dataset
